3300 files analyzed (sorted by compliance, lowest first)
Showing the 10 files with lowest compliance for prioritized curation.
Files with lowest compliance are listed first to prioritize curation efforts.
| File | Global | Weighted | Populated | Violations |
|---|---|---|---|---|
#1 Nontuberculous_Mycobacterial_Lung_Disease.yaml |
53.3% | 66.7% | 81/152 | |
#2 Klebsiella_Pneumonia.yaml |
54.2% | 63.9% | 58/107 | 1 |
#3 Sturge-Weber_Syndrome.yaml |
58.4% | 63.8% | 73/125 | 1 |
#4 Chikungunya.yaml |
63.7% | 70.9% | 86/135 | |
#5 Uveal_Melanoma.yaml |
64.8% | 65.9% | 70/108 | 1 |
#6 FGFR_Altered_Cholangiocarcinoma.yaml |
66.7% | 70.2% | 58/87 | 1 |
#7 Gastrointestinal_Stromal_Tumor.yaml |
67.2% | 71.3% | 43/64 | 1 |
#8 Pulmonary_hypertension.yaml |
67.4% | 71.4% | 120/178 | |
#9 Diffuse_Large_B_Cell_Lymphoma.yaml |
67.5% | 69.7% | 83/123 | 1 |
#10 IDH_Mutant_Cholangiocarcinoma.yaml |
67.8% | 71.2% | 59/87 | 1 |
IDH_Mutant_Astrocytoma.yaml |
67.9% | 70.6% | 53/78 | 1 |
Spinocerebellar_Ataxia_Type_15_16.yaml |
68.1% | 73.8% | 32/47 | 1 |
HER2_Positive_Gastric_Cancer.yaml |
68.2% | 72.1% | 60/88 | 1 |
RET_Fusion_Thyroid_Cancer.yaml |
68.5% | 70.8% | 50/73 | 1 |
PCDH19_Clustering_Epilepsy.yaml |
68.5% | 70.3% | 85/124 | 1 |
Major_Depressive_Disorder.yaml |
68.6% | 70.0% | 232/338 | 3 |
HIDEA_Syndrome.yaml |
68.7% | 74.0% | 57/83 | 1 |
IDH_Mutant_AML.yaml |
68.7% | 71.0% | 68/99 | 1 |
Pericarditis.yaml |
68.8% | 71.2% | 141/205 | |
Desmoplastic_Small_Round_Cell_Tumor.yaml |
69.0% | 71.6% | 49/71 | |
Medulloblastoma.yaml |
69.2% | 74.6% | 36/52 | |
HPV_Negative_Head_and_Neck_Cancer.yaml |
69.5% | 71.0% | 82/118 | 1 |
Beta_Thalassemia.yaml |
69.5% | 75.0% | 121/174 | |
Infective_Endocarditis.yaml |
69.6% | 71.3% | 103/148 | |
GNAO1-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
70.0% | 73.7% | 105/150 | |
SRPX2-related_Speech_Epilepsy_Polymicrogyria.yaml |
70.0% | 73.1% | 77/110 | 2 |
Primary_Ciliary_Dyskinesia_47_and_Lissencephaly.yaml |
70.2% | 74.6% | 73/104 | |
FGFR_Altered_Urothelial_Carcinoma.yaml |
70.3% | 72.7% | 45/64 | 1 |
Myocardial_Infarction.yaml |
70.3% | 72.0% | 166/236 | 3 |
Tetralogy_of_Fallot.yaml |
70.4% | 73.2% | 119/169 | |
Cutaneous_Melanoma.yaml |
70.4% | 71.0% | 81/115 | 1 |
Mesial_Temporal_Lobe_Epilepsy_with_Hippocampal_Sclerosis.yaml |
70.5% | 70.3% | 55/78 | 1 |
Fibromyalgia.yaml |
70.5% | 73.5% | 103/146 | 1 |
Kaposi_Sarcoma.yaml |
70.6% | 73.2% | 72/102 | 1 |
Rhinovirus_Infection.yaml |
71.1% | 75.9% | 27/38 | |
Camptodactyly.yaml |
71.1% | 74.6% | 59/83 | 1 |
Typhoidal_Tularemia.yaml |
71.2% | 73.1% | 94/132 | 1 |
Mixed_Germ_Cell_Tumor.yaml |
71.5% | 75.0% | 88/123 | |
Medulloblastoma_WNT_Activated.yaml |
71.6% | 73.7% | 58/81 | 1 |
Pneumonic_Plague.yaml |
71.8% | 74.8% | 56/78 | 1 |
Fuhrmann_Syndrome.yaml |
71.9% | 75.9% | 41/57 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_22.yaml |
72.0% | 71.4% | 77/107 | 1 |
Chronic_Lymphocytic_Leukemia.yaml |
72.0% | 73.1% | 85/118 | 1 |
Malignant_Mesothelioma.yaml |
72.0% | 75.0% | 67/93 | 1 |
Obstructive_Sleep_Apnea.yaml |
72.1% | 73.6% | 119/165 | 1 |
FLNA_Intestinal_Pseudoobstruction.yaml |
72.1% | 75.4% | 44/61 | |
Stromal_Corneal_Dystrophy.yaml |
72.2% | 75.8% | 96/133 | 1 |
Leber_Congenital_Amaurosis_with_Early-Onset_Deafness.yaml |
72.3% | 76.3% | 47/65 | |
Cervical_Dystonia.yaml |
72.5% | 73.6% | 50/69 | |
Nasopharyngeal_Carcinoma.yaml |
72.5% | 74.3% | 79/109 | 1 |
Dilated_Cardiomyopathy_1EE.yaml |
72.5% | 75.2% | 66/91 | |
Sinoatrial_Block.yaml |
72.6% | 76.1% | 45/62 | |
Parkinson_Disease_Mitochondrial.yaml |
72.9% | 76.2% | 62/85 | 1 |
Pulmonary_Embolism.yaml |
73.0% | 75.0% | 143/196 | |
Bubonic_Plague.yaml |
73.1% | 76.3% | 57/78 | |
Dravet_syndrome.yaml |
73.2% | 74.0% | 341/466 | 3 |
Timothy_Syndrome.yaml |
73.2% | 75.4% | 104/142 | 4 |
Alpha_1_Antitrypsin_Deficiency.yaml |
73.3% | 73.6% | 222/303 | |
GALNT2-Congenital_Disorder_of_Glycosylation.yaml |
73.3% | 75.3% | 85/116 | |
Osteoarthritis.yaml |
73.3% | 74.7% | 85/116 | 1 |
NTRK_Fusion_Positive_Cancer.yaml |
73.4% | 75.3% | 47/64 | 1 |
Combined_Oxidative_Phosphorylation_Defect_Type_24.yaml |
73.5% | 74.6% | 97/132 | |
Chlamydia_Pneumoniae_Pneumonia.yaml |
73.6% | 77.7% | 64/87 | |
Langerhans_Cell_Histiocytosis.yaml |
73.6% | 78.1% | 64/87 | |
Li-Fraumeni_Syndrome.yaml |
73.6% | 73.9% | 142/193 | 1 |
PKP2_Cardiomyopathy.yaml |
73.7% | 76.9% | 84/114 | |
Chronic_Kidney_Disease.yaml |
73.8% | 75.1% | 149/202 | |
Heart_Failure.yaml |
73.8% | 75.6% | 155/210 | |
Sweeney-Cox_Syndrome.yaml |
73.8% | 78.4% | 158/214 | |
Rheumatic_Heart_Disease.yaml |
73.8% | 75.3% | 144/195 | |
BRAF_Mutant_Thyroid_Cancer.yaml |
73.9% | 75.2% | 65/88 | 1 |
KLHL24-Related_Hypertrophic_Cardiomyopathy.yaml |
73.9% | 77.2% | 167/226 | |
DSP_Cardiomyopathy.yaml |
73.9% | 77.2% | 51/69 | 1 |
Neurodevelopmental_Disorder_With_Dysmorphic_Facies_Sleep_Disturbance_And_Brain_Abnormalities.yaml |
73.9% | 76.5% | 278/376 | 1 |
Rajab_Interstitial_Lung_Disease_With_Brain_Calcifications_1.yaml |
74.0% | 75.2% | 71/96 | |
Coronary_Artery_Disease.yaml |
74.0% | 74.3% | 148/200 | 2 |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_123.yaml |
74.0% | 76.0% | 57/77 | |
DNM1_Encephalopathy.yaml |
74.1% | 74.8% | 80/108 | 2 |
SNF8-Related_Neurodevelopmental_Disorder.yaml |
74.1% | 78.2% | 103/139 | |
Aflatoxin_Related_HCC.yaml |
74.1% | 75.6% | 172/232 | |
STXBP1_Encephalopathy.yaml |
74.1% | 76.0% | 109/147 | 2 |
Gastric_Cancer_H_pylori_Associated.yaml |
74.2% | 77.8% | 89/120 | |
Methylmalonic_Acidemia_With_Homocystinuria_Type_cblJ.yaml |
74.2% | 74.3% | 112/151 | 1 |
Cervical_Cancer.yaml |
74.2% | 76.0% | 92/124 | |
STX1B-Related_Epilepsy.yaml |
74.2% | 74.6% | 69/93 | 2 |
Small_Cell_Lung_Cancer.yaml |
74.2% | 77.0% | 92/124 | |
Epidemic_Typhus.yaml |
74.2% | 75.9% | 98/132 | |
Febrile_Infection-Related_Epilepsy_Syndrome.yaml |
74.3% | 77.0% | 110/148 | 1 |
ORAI1_Deficiency.yaml |
74.4% | 76.7% | 90/121 | |
ADPRS-Related_Stress-Induced_Neurodegeneration.yaml |
74.4% | 76.2% | 230/309 | 1 |
MMADHC-related_Disorder_of_Cobalamin_Metabolism_cblD_Type.yaml |
74.5% | 74.4% | 73/98 | 1 |
Laryngeal_Squamous_Cell_Carcinoma.yaml |
74.6% | 78.3% | 85/114 | |
SURF1-Related_Leigh_Syndrome.yaml |
74.8% | 77.5% | 80/107 | 2 |
Pyridoxine-Dependent_Epilepsy.yaml |
74.8% | 76.2% | 83/111 | 2 |
Thanatophoric_Dysplasia_Type_1.yaml |
74.8% | 76.5% | 166/222 | |
Neurodevelopmental_Disorder_with_Hearing_Loss_and_Spasticity.yaml |
74.8% | 77.5% | 199/266 | |
Immunodeficiency_81.yaml |
74.8% | 77.3% | 116/155 | |
Cutaneous_Squamous_Cell_Carcinoma.yaml |
75.0% | 78.1% | 75/100 | |
Israeli_Tick_Typhus.yaml |
75.0% | 77.3% | 96/128 | |
KRAS_G12C_Mutant_NSCLC.yaml |
75.0% | 77.0% | 63/84 | 1 |
Hypoplastic_Left_Heart_Syndrome.yaml |
75.1% | 76.5% | 151/201 | |
Digitalis_Poisoning.yaml |
75.2% | 76.8% | 152/202 | 1 |
KCNQ2_Developmental_and_Epileptic_Encephalopathy.yaml |
75.3% | 76.9% | 73/97 | 2 |
Rh_Deficiency_Syndrome.yaml |
75.3% | 77.1% | 67/89 | |
Syphilis.yaml |
75.3% | 76.9% | 198/263 | |
MSI_High_Endometrial_Cancer.yaml |
75.3% | 77.4% | 64/85 | 1 |
Jeune_Asphyxiating_Thoracic_Dystrophy.yaml |
75.3% | 76.9% | 125/166 | |
Drug_or_Toxin-Induced_Pulmonary_Arterial_Hypertension.yaml |
75.3% | 77.0% | 61/81 | 2 |
Gallbladder_Cancer.yaml |
75.3% | 78.7% | 110/146 | |
Central_Nervous_System_Germ_Cell_Tumor.yaml |
75.4% | 73.6% | 159/211 | 2 |
Cervical_Squamous_Cell_Carcinoma.yaml |
75.4% | 78.9% | 52/69 | |
Heyn-Sproul-Jackson_syndrome.yaml |
75.4% | 77.7% | 52/69 | 1 |
Pediatric_Autoimmune_Neuropsychiatric_Disorders_Associated_With_Streptococcal_Infections.yaml |
75.4% | 76.9% | 43/57 | |
Hepatocellular_Carcinoma.yaml |
75.5% | 74.9% | 249/330 | 3 |
Immunodeficiency_70.yaml |
75.5% | 77.6% | 37/49 | |
DHRSX-Congenital_Disorder_of_Glycosylation.yaml |
75.5% | 77.2% | 108/143 | |
Diffuse_Astrocytoma.yaml |
75.5% | 79.9% | 71/94 | |
SYN1-Related_Disorder.yaml |
75.6% | 80.0% | 34/45 | |
Gerstmann-Straussler-Scheinker_Syndrome.yaml |
75.6% | 78.7% | 96/127 | 1 |
Mixed_Connective_Tissue_Disease.yaml |
75.6% | 80.1% | 31/41 | |
Constitutional_Megaloblastic_Anemia_With_Severe_Neurologic_Disease.yaml |
75.6% | 77.5% | 59/78 | |
Neurodevelopmental_Disorder_With_Absent_Speech_And_Movement_And_Behavioral_Abnormalities.yaml |
75.7% | 78.6% | 137/181 | |
Ankylosing_Spondylitis.yaml |
75.7% | 77.5% | 159/210 | 2 |
Charcot-Marie-Tooth_Disease-Hearing_Loss-Intellectual_Disability_Syndrome.yaml |
75.8% | 80.1% | 47/62 | |
Glioblastoma_IDH_Wildtype.yaml |
75.8% | 76.3% | 116/153 | 1 |
Progressive_Myoclonus_Epilepsy.yaml |
75.9% | 77.8% | 66/87 | 1 |
Renal_Tubular_Acidosis_Distal_3_With_Or_Without_Sensorineural_Hearing_Loss.yaml |
75.9% | 76.7% | 110/145 | 1 |
KCNB1-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
75.9% | 78.3% | 107/141 | 2 |
Emanuel_Syndrome.yaml |
75.9% | 77.8% | 85/112 | |
Gorham-Stout_disease.yaml |
75.9% | 79.2% | 41/54 | 1 |
Myoclonic_Epilepsy_in_Infancy.yaml |
76.0% | 77.9% | 79/104 | |
PARK7-Related_Early-Onset_Parkinson_Disease.yaml |
76.0% | 75.8% | 158/208 | 2 |
Opioid_Use_Disorder.yaml |
76.0% | 75.8% | 313/412 | 2 |
Postural_Orthostatic_Tachycardia_Syndrome.yaml |
76.0% | 77.3% | 155/204 | |
Kawasaki_Disease.yaml |
76.0% | 77.3% | 329/433 | 1 |
Chromosome_16p12.2-p11.2_Deletion_Syndrome.yaml |
76.0% | 77.7% | 38/50 | |
SCN8A-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
76.0% | 78.5% | 73/96 | |
KINSSHIP_Syndrome.yaml |
76.1% | 77.7% | 54/71 | |
Spondyloepimetaphyseal_Dysplasia_Guo-Campeau_Type.yaml |
76.1% | 78.4% | 54/71 | |
COVID-19.yaml |
76.1% | 77.6% | 169/222 | 2 |
HPV_Positive_Head_and_Neck_Cancer.yaml |
76.1% | 77.2% | 67/88 | 1 |
PCWH_syndrome.yaml |
76.2% | 80.1% | 64/84 | 1 |
Generalized_Anxiety_Disorder.yaml |
76.2% | 78.5% | 93/122 | |
Autosomal_Dominant_Robinow_Syndrome_2.yaml |
76.2% | 78.1% | 77/101 | |
Spotted_Fever_Rickettsiosis.yaml |
76.3% | 76.8% | 129/169 | |
Aicardi_Syndrome.yaml |
76.4% | 79.7% | 113/148 | |
PRR12-Related_Neuroocular_Syndrome.yaml |
76.4% | 78.3% | 236/309 | |
Immunodeficiency_65_IRF9_Deficiency.yaml |
76.5% | 77.4% | 65/85 | |
Merkel_Cell_Carcinoma.yaml |
76.5% | 78.0% | 75/98 | 1 |
Indian_Tick_Typhus.yaml |
76.6% | 79.0% | 95/124 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_14.yaml |
76.7% | 76.2% | 92/120 | |
Pituitary_Tumor.yaml |
76.7% | 80.7% | 46/60 | |
Chromosome_18p_Deletion_Syndrome.yaml |
76.7% | 80.3% | 89/116 | |
HOXC13_Ectodermal_Dysplasia.yaml |
76.7% | 78.0% | 89/116 | |
Oral_Cavity_Squamous_Cell_Carcinoma.yaml |
76.7% | 79.0% | 99/129 | |
Verruga_Peruana.yaml |
76.7% | 78.6% | 66/86 | |
Charcot-Marie-Tooth_Disease_Axonal_Type_2Z.yaml |
76.9% | 78.1% | 103/134 | |
Childhood_Occipital_Visual_Epilepsy.yaml |
76.9% | 79.0% | 103/134 | |
Dihydropyrimidine_Dehydrogenase_Deficiency.yaml |
76.9% | 78.3% | 103/134 | |
Dyskeratosis_Congenita_Autosomal_Recessive_6.yaml |
76.9% | 79.1% | 113/147 | |
Antisocial_Personality_Disorder.yaml |
76.9% | 77.0% | 50/65 | 2 |
Chondrodysplasia_With_Joint_Dislocations_gPAPP_Type.yaml |
76.9% | 79.1% | 60/78 | 1 |
KDM6B-Related_Neurodevelopmental_Disorder.yaml |
77.0% | 79.5% | 224/291 | |
Triple_Negative_Breast_Cancer.yaml |
77.0% | 79.9% | 87/113 | |
STIM1_Deficiency.yaml |
77.0% | 79.0% | 164/213 | |
Central_Areolar_Choroidal_Dystrophy.yaml |
77.0% | 81.1% | 67/87 | |
Clear_Cell_Renal_Cell_Carcinoma.yaml |
77.0% | 79.5% | 94/122 | 1 |
Stiff_Skin_Syndrome.yaml |
77.1% | 79.2% | 74/96 | |
Bazex_Dupre_Christol_Syndrome.yaml |
77.1% | 78.7% | 108/140 | |
Flea_Borne_Spotted_Fever.yaml |
77.2% | 79.5% | 71/92 | |
DOCK2_Deficiency.yaml |
77.2% | 79.0% | 115/149 | |
Spastic_Paraplegia_81.yaml |
77.2% | 79.6% | 88/114 | |
Gastric_Ulcer.yaml |
77.3% | 74.6% | 17/22 | |
Robinow_Syndrome_Autosomal_Recessive_2.yaml |
77.4% | 79.6% | 41/53 | |
Endometriosis.yaml |
77.4% | 79.1% | 175/226 | 1 |
Atypical_Hemolytic_Uremic_Syndrome.yaml |
77.5% | 78.0% | 248/320 | |
Trichotillomania.yaml |
77.5% | 78.8% | 62/80 | |
Gambling_Disorder.yaml |
77.6% | 79.9% | 45/58 | |
Paraneoplastic_Cerebellar_Degeneration.yaml |
77.6% | 79.0% | 149/192 | |
Cervical_Adenocarcinoma.yaml |
77.6% | 80.6% | 52/67 | |
Colobomatous_Microphthalmia-Rhizomelic_Dysplasia_Syndrome.yaml |
77.6% | 79.2% | 52/67 | |
Hearing_Loss_Autosomal_Recessive_108.yaml |
77.7% | 78.2% | 73/94 | 1 |
Alport_Syndrome.yaml |
77.7% | 78.1% | 240/309 | 1 |
HER2_Positive_Breast_Cancer.yaml |
77.7% | 77.5% | 80/103 | 2 |
Peripartum_Cardiomyopathy.yaml |
77.7% | 79.2% | 80/103 | |
TP63_Ectodermal_Dysplasia_Spectrum.yaml |
77.7% | 80.9% | 87/112 | 1 |
Placenta_Previa.yaml |
77.7% | 78.1% | 164/211 | 2 |
CCN2-Related_Kyphomelic_Dysplasia.yaml |
77.8% | 80.9% | 56/72 | |
Cardiomyopathy_Dilated_2E.yaml |
77.8% | 79.2% | 56/72 | |
Combined_Oxidative_Phosphorylation_Deficiency_34.yaml |
77.8% | 79.3% | 98/126 | |
Epithelioid_Sarcoma.yaml |
77.8% | 79.8% | 56/72 | 1 |
Focal_Segmental_Glomerulosclerosis.yaml |
77.8% | 79.2% | 203/261 | 1 |
Hand-Foot-Genital_Syndrome.yaml |
77.8% | 79.0% | 49/63 | |
Mitochondrial_Complex_V_ATP_Synthase_Deficiency_Nuclear_Type_3.yaml |
77.8% | 78.9% | 126/162 | |
Neuroblastoma.yaml |
77.8% | 79.5% | 84/108 | 1 |
Peroxisome_Biogenesis_Disorder_3A_Zellweger.yaml |
77.8% | 78.6% | 105/135 | 1 |
Rhizomelic_Dysplasia_Ain-Naz_Type.yaml |
77.8% | 80.1% | 126/162 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_32.yaml |
77.9% | 78.4% | 116/149 | |
Viral_Encephalitis.yaml |
77.9% | 79.5% | 116/149 | |
SYNGAP1-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
77.9% | 79.7% | 95/122 | 2 |
Volumetric_Muscle_Loss.yaml |
77.9% | 80.4% | 95/122 | 1 |
Neurofibroma.yaml |
77.9% | 81.5% | 74/95 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_24.yaml |
77.9% | 78.0% | 53/68 | |
Deficiency_of_Adenosine_Deaminase_2.yaml |
78.0% | 80.7% | 92/118 | |
Warburg_Micro_Syndrome.yaml |
78.0% | 80.2% | 138/177 | |
Hypertensive_Heart_Disease.yaml |
78.0% | 76.8% | 199/255 | 1 |
Mitochondrial_Spastic_Paraplegia.yaml |
78.1% | 80.1% | 57/73 | |
Spinal_Muscular_Atrophy.yaml |
78.1% | 79.7% | 211/270 | 3 |
SOCS1_Haploinsufficiency.yaml |
78.2% | 80.1% | 93/119 | |
Renal_Cell_Carcinoma.yaml |
78.2% | 78.0% | 136/174 | 2 |
Autosomal_Dominant_Optic_Atrophy_Plus.yaml |
78.3% | 80.0% | 72/92 | 1 |
KATNB1-related_Cortical_Malformation.yaml |
78.3% | 81.8% | 90/115 | 2 |
Spondyloepimetaphyseal_Dysplasia_Krakow_Type.yaml |
78.3% | 81.1% | 54/69 | |
Contractures_Pterygia_and_Spondylocarpotarsal_Fusion_Syndrome_1A.yaml |
78.3% | 80.3% | 83/106 | |
Granular_Cell_Tumor.yaml |
78.3% | 80.8% | 65/83 | |
Campomelic_Dysplasia.yaml |
78.3% | 80.4% | 112/143 | |
Gastroenteropancreatic_Neuroendocrine_Neoplasm.yaml |
78.4% | 82.1% | 105/134 | |
Antley-Bixler_Syndrome_FGFR2-Related.yaml |
78.4% | 80.8% | 58/74 | |
Sickle_Cell_Disease.yaml |
78.4% | 78.6% | 214/273 | |
Chronic_Myeloid_Leukemia.yaml |
78.4% | 79.3% | 120/153 | 2 |
Hemicrania_Continua.yaml |
78.4% | 79.9% | 80/102 | |
Pneumococcal_Pneumonia.yaml |
78.4% | 80.1% | 40/51 | |
TMLHE_Deficiency.yaml |
78.4% | 80.7% | 80/102 | |
Noise_Induced_Hearing_Loss.yaml |
78.5% | 79.3% | 113/144 | |
Autosomal_Recessive_Spastic_Ataxia_9.yaml |
78.5% | 80.6% | 194/247 | |
Mycoplasma_Pneumoniae_Pneumonia.yaml |
78.6% | 81.8% | 33/42 | |
Neutral_Lipid_Storage_Myopathy.yaml |
78.6% | 81.7% | 44/56 | |
Osteogenesis_Imperfecta_Type_I.yaml |
78.6% | 81.0% | 88/112 | |
Peroxisome_Biogenesis_Disorder_2B.yaml |
78.6% | 79.0% | 121/154 | 1 |
Respiratory_Syncytial_Virus_Infection.yaml |
78.6% | 81.3% | 44/56 | |
Huntington_Disease.yaml |
78.6% | 78.3% | 621/790 | 4 |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_11.yaml |
78.6% | 79.8% | 125/159 | |
Human_Monocytic_Ehrlichiosis.yaml |
78.6% | 80.5% | 114/145 | |
Gonorrhea.yaml |
78.6% | 78.9% | 162/206 | 1 |
Mesomelia-Synostoses_Syndrome.yaml |
78.7% | 80.4% | 37/47 | |
FILS_Syndrome.yaml |
78.8% | 81.6% | 63/80 | |
IDH_Mutant_Oligodendroglioma.yaml |
78.8% | 80.3% | 89/113 | 1 |
Dyskeratosis_Congenita_Autosomal_Recessive_2.yaml |
78.8% | 80.5% | 141/179 | |
Coffin-Lowry_Syndrome.yaml |
78.8% | 80.0% | 52/66 | |
IMAGe_Syndrome.yaml |
78.8% | 81.2% | 78/99 | |
Mesomelic_Dysplasia_Savarirayan_Type.yaml |
78.8% | 79.5% | 52/66 | |
Coarctation_of_the_Aorta.yaml |
78.8% | 80.1% | 145/184 | |
Combined_Immunodeficiency_Due_To_CTPS1_Deficiency.yaml |
78.8% | 80.9% | 93/118 | |
KRT74_Ectodermal_Dysplasia.yaml |
78.8% | 82.2% | 41/52 | |
Oculopharyngodistal_Myopathy.yaml |
78.8% | 80.7% | 82/104 | 1 |
Periodontitis.yaml |
78.8% | 80.3% | 123/156 | 1 |
Familial_Hypocalciuric_Hypercalcemia_1.yaml |
78.9% | 79.8% | 97/123 | |
REM_Sleep_Behavior_Disorder.yaml |
78.9% | 81.1% | 56/71 | |
SQSTM1-Related_Childhood-Onset_Neurodegeneration.yaml |
78.9% | 79.8% | 168/213 | 1 |
Fontaine_Progeroid_Syndrome.yaml |
78.9% | 81.0% | 254/322 | |
DONSON-Related_Microcephalic_Primordial_Dwarfism.yaml |
78.9% | 80.0% | 71/90 | |
Langer_Mesomelic_Dysplasia.yaml |
78.9% | 80.5% | 86/109 | |
EDAR_Hypohidrotic_Ectodermal_Dysplasia.yaml |
78.9% | 80.6% | 116/147 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_70.yaml |
78.9% | 79.6% | 75/95 | |
Nocardiosis.yaml |
78.9% | 80.6% | 120/152 | |
Queensland_Tick_Typhus.yaml |
78.9% | 80.3% | 90/114 | 1 |
Sarcoma_Of_Cervix_Uteri.yaml |
78.9% | 83.1% | 75/95 | |
Spondyloepimetaphyseal_Dysplasia_Aggrecan_Type.yaml |
79.0% | 80.9% | 109/138 | |
Usher_Syndrome_Type_4.yaml |
79.0% | 80.1% | 94/119 | 1 |
EDARADD_Hypohidrotic_Ectodermal_Dysplasia.yaml |
79.0% | 81.1% | 79/100 | |
Pigment_Dispersion_Syndrome.yaml |
79.0% | 80.5% | 79/100 | |
Neurodevelopmental_Disorder_with_Early-Onset_Parkinsonism_and_Behavioral_Abnormalities.yaml |
79.0% | 80.4% | 207/262 | |
Balkan_Endemic_Nephropathy.yaml |
79.0% | 81.1% | 64/81 | |
Autosomal_Dominant_Robinow_Syndrome_3.yaml |
79.0% | 79.9% | 305/386 | |
Cornelia_de_Lange_Syndrome_1.yaml |
79.0% | 80.7% | 113/143 | |
Cholangiocarcinoma.yaml |
79.0% | 80.5% | 83/105 | |
SNAP25_Encephalopathy.yaml |
79.0% | 79.4% | 83/105 | 2 |
CASQ2_CPVT.yaml |
79.1% | 79.0% | 317/401 | 1 |
Familial_Visceral_Neuropathy_2.yaml |
79.1% | 80.5% | 68/86 | |
GABRG2-Related_Epilepsy.yaml |
79.1% | 81.8% | 102/129 | 1 |
Human_Granulocytic_Anaplasmosis.yaml |
79.1% | 80.7% | 102/129 | |
Drug-Induced_Methemoglobinemia.yaml |
79.1% | 79.4% | 87/110 | |
Short_Stature_Microcephaly_and_Endocrine_Dysfunction.yaml |
79.1% | 81.3% | 53/67 | |
Immunodeficiency_69.yaml |
79.1% | 80.0% | 125/158 | 1 |
Hereditary_Spastic_Paraplegia_48.yaml |
79.2% | 83.0% | 38/48 | |
Human_Metapneumovirus_Infection.yaml |
79.2% | 81.5% | 38/48 | |
KIT_Mutant_Melanoma.yaml |
79.2% | 81.5% | 76/96 | |
STAT2_Deficiency.yaml |
79.2% | 82.0% | 38/48 | |
KIF5B-Related_Kyphomelic_Dysplasia.yaml |
79.2% | 82.5% | 42/53 | |
Skin_Fragility_Woolly_Hair_Syndrome.yaml |
79.2% | 82.7% | 42/53 | |
Miller-Dieker_Lissencephaly_Syndrome.yaml |
79.3% | 81.6% | 107/135 | 1 |
Immunodeficiency_80_with_or_without_Congenital_Cardiomyopathy.yaml |
79.3% | 80.6% | 111/140 | |
Developmental_and_Epileptic_Encephalopathy_55.yaml |
79.3% | 80.7% | 96/121 | |
Fibrolamellar_Hepatocellular_Carcinoma.yaml |
79.3% | 79.7% | 169/213 | 2 |
Rheumatoid_Arthritis.yaml |
79.3% | 79.9% | 388/489 | 5 |
Glycoprotein_Storage_Disease.yaml |
79.4% | 82.0% | 50/63 | |
Osteogenesis_Imperfecta_Type_XXIII.yaml |
79.4% | 82.4% | 50/63 | 1 |
Benign_Prostatic_Hyperplasia.yaml |
79.4% | 81.2% | 77/97 | 1 |
Distal_Hereditary_Motor_Neuronopathy_Autosomal_Recessive.yaml |
79.4% | 81.6% | 77/97 | |
Immunodeficiency_86.yaml |
79.4% | 82.0% | 77/97 | |
Primary_Bile_Acid_Malabsorption.yaml |
79.4% | 80.7% | 104/131 | |
Hearing_Loss_Autosomal_Dominant_83.yaml |
79.4% | 79.7% | 81/102 | |
Silicosis.yaml |
79.4% | 81.6% | 112/141 | |
Natural_Killer_Cell_and_Glucocorticoid_Deficiency_with_DNA_Repair_Defect.yaml |
79.4% | 80.9% | 85/107 | |
Snijders_Blok-Campeau_Syndrome.yaml |
79.5% | 82.1% | 116/146 | |
Rickettsialpox.yaml |
79.5% | 81.7% | 66/83 | |
Crohn_Disease.yaml |
79.6% | 79.6% | 354/445 | 4 |
Boutonneuse_Fever.yaml |
79.6% | 81.2% | 179/225 | |
Osteoglophonic_Dysplasia.yaml |
79.6% | 82.6% | 113/142 | |
Mabry_Syndrome.yaml |
79.6% | 82.3% | 152/191 | 1 |
Charcot-Marie-Tooth_Disease_Dominant_Intermediate_G.yaml |
79.6% | 80.6% | 117/147 | |
Sennetsu_Fever.yaml |
79.6% | 81.7% | 78/98 | 1 |
Pheochromocytoma_Paraganglioma.yaml |
79.6% | 80.7% | 359/451 | |
Autoimmune_Gastritis.yaml |
79.6% | 80.5% | 121/152 | |
Plague.yaml |
79.6% | 83.0% | 82/103 | |
Encephalopathy_Due_To_Defective_Mitochondrial_And_Peroxisomal_Fission_2.yaml |
79.6% | 81.3% | 90/113 | |
SDHA-Related_Neurodegeneration_With_Ataxia_And_Optic_Atrophy.yaml |
79.6% | 81.6% | 180/226 | |
Secondary_Hypertension.yaml |
79.7% | 83.5% | 47/59 | |
Cardiomyopathy_Dilated_2J.yaml |
79.7% | 79.8% | 98/123 | |
Mitral_Valve_Prolapse.yaml |
79.7% | 81.7% | 98/123 | |
Alpha_Thalassemia.yaml |
79.7% | 81.6% | 114/143 | |
KMT2B-Related_Dystonia.yaml |
79.7% | 80.1% | 181/227 | 1 |
Combined_Immunodeficiency_Due_To_Moesin_Deficiency.yaml |
79.7% | 81.6% | 63/79 | |
Testicular_Germ_Cell_Tumor.yaml |
79.8% | 82.9% | 67/84 | |
Generalized_Epilepsy_with_Febrile_Seizures_Plus.yaml |
79.8% | 80.9% | 138/173 | 1 |
Chronic_Intestinal_Pseudoobstruction.yaml |
79.8% | 82.9% | 71/89 | |
Hutchinson-Gilford_Progeria_Syndrome.yaml |
79.8% | 81.7% | 71/89 | |
Restless_Legs_Syndrome.yaml |
79.8% | 81.1% | 71/89 | |
Frontotemporal_Dementia.yaml |
79.8% | 80.6% | 75/94 | 1 |
Ethylene_Glycol_Poisoning.yaml |
79.8% | 81.1% | 83/104 | |
Immunodeficiency_118.yaml |
79.8% | 81.5% | 99/124 | 1 |
Multiple_Sulfatase_Deficiency.yaml |
79.8% | 80.5% | 198/248 | |
Chronic_Beryllium_Disease.yaml |
79.9% | 83.0% | 111/139 | |
Nerve_Agent_Poisoning.yaml |
79.9% | 80.3% | 115/144 | |
Inherited_Aplastic_Anemia.yaml |
79.9% | 82.1% | 123/154 | |
SLC44A1-Related_Childhood-Onset_Neurodegeneration.yaml |
79.9% | 80.7% | 135/169 | 1 |
FAM111A-Related_Skeletal_Dysplasia.yaml |
79.9% | 81.2% | 147/184 | |
Actinomycosis.yaml |
80.0% | 81.7% | 116/145 | |
Bleeding_Disorder_Platelet-type_21.yaml |
80.0% | 82.6% | 80/100 | |
Cocaine_Intoxication.yaml |
80.0% | 81.1% | 196/245 | |
Coronary_Artery_Congenital_Malformation.yaml |
80.0% | 82.8% | 108/135 | |
Craniofacial_Anomalies_And_Anterior_Segment_Dysgenesis_Syndrome.yaml |
80.0% | 81.3% | 68/85 | |
Duane_Radial_Ray_Syndrome.yaml |
80.0% | 81.9% | 140/175 | |
FGF12-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
80.0% | 81.6% | 80/100 | |
GYG1-related_Disorder_Of_Glycogen_Metabolism.yaml |
80.0% | 82.4% | 72/90 | |
IKK2_Deficiency.yaml |
80.0% | 81.1% | 60/75 | 1 |
Periodic_Fever_Immunodeficiency_and_Thrombocytopenia_Syndrome.yaml |
80.0% | 80.8% | 116/145 | |
Pitt-Hopkins_Syndrome.yaml |
80.0% | 83.0% | 56/70 | |
Progressive_External_Ophthalmoplegia_With_Mitochondrial_DNA_Deletions_Autosomal_Recessive_4.yaml |
80.0% | 81.2% | 112/140 | |
Psoriasis_14_Pustular.yaml |
80.0% | 82.1% | 52/65 | |
STING_Associated_Vasculopathy_with_Onset_in_Infancy.yaml |
80.0% | 81.9% | 52/65 | |
Type_I_Diabetes.yaml |
80.0% | 79.2% | 300/375 | 7 |
Stickler_Syndrome_Type_1.yaml |
80.1% | 81.6% | 141/176 | 1 |
Neuromyelitis_Optica_Spectrum_Disorder_with_Anti-AQP4_Antibodies.yaml |
80.1% | 81.3% | 117/146 | 1 |
Atopic_Dermatitis.yaml |
80.2% | 80.9% | 194/242 | 3 |
Siddiqi_Syndrome.yaml |
80.2% | 81.7% | 81/101 | |
Polycystic_Ovary_Syndrome.yaml |
80.2% | 81.4% | 235/293 | 1 |
Cohen_Syndrome.yaml |
80.2% | 82.0% | 77/96 | |
Immunodeficiency_79.yaml |
80.2% | 82.1% | 73/91 | |
NPM1_Mutant_AML.yaml |
80.2% | 81.8% | 73/91 | 1 |
Idiopathic_Hypersomnia.yaml |
80.2% | 81.6% | 69/86 | |
TUBB8-related_Oocyte_Maturation_Defect.yaml |
80.3% | 80.9% | 126/157 | 1 |
Multiple_Mitochondrial_Dysfunctions_Syndrome_6.yaml |
80.3% | 81.1% | 122/152 | |
Osteogenesis_Imperfecta_Type_XXI.yaml |
80.3% | 83.5% | 61/76 | 1 |
Charcot-Marie-Tooth_Disease_Demyelinating_Type_1G.yaml |
80.3% | 81.6% | 110/137 | |
KCNA2-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
80.3% | 82.1% | 110/137 | 2 |
Hepatitis_E.yaml |
80.3% | 82.5% | 53/66 | |
Hydrops-Lactic_Acidosis-Sideroblastic_Anemia-Multisystemic_Failure_Syndrome.yaml |
80.3% | 81.9% | 106/132 | |
Autosomal_Dominant_Osteopetrosis_Type_II.yaml |
80.3% | 82.0% | 102/127 | |
Stickler_Syndrome_Type_5.yaml |
80.3% | 81.5% | 102/127 | |
Osteogenesis_Imperfecta_Type_II.yaml |
80.3% | 82.5% | 98/122 | 1 |
Autoimmune_Retinopathy.yaml |
80.3% | 81.0% | 94/117 | |
Photosensitive_Occipital_Lobe_Epilepsy.yaml |
80.3% | 82.2% | 94/117 | |
Platelet-type_Bleeding_Disorder_22.yaml |
80.3% | 81.1% | 94/117 | 1 |
X-linked_Dominant_Chondrodysplasia_Chassaing-Lacombe_Type.yaml |
80.3% | 81.0% | 94/117 | |
Mobitz_Type_I_Atrioventricular_Block.yaml |
80.4% | 83.6% | 45/56 | |
Autosomal_Dominant_Robinow_Syndrome_1.yaml |
80.4% | 81.1% | 217/270 | |
Pneumococcal_Meningitis.yaml |
80.4% | 82.4% | 86/107 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_115.yaml |
80.4% | 81.2% | 82/102 | |
Dermoid_Cyst.yaml |
80.4% | 82.9% | 82/102 | |
Infantile-Onset_Multisystem_Neurologic_Endocrine_and_Pancreatic_Disease.yaml |
80.4% | 81.9% | 123/153 | |
Severe_Combined_Immunodeficiency_Due_To_CARD11_Deficiency.yaml |
80.4% | 82.2% | 82/102 | |
COPA_Syndrome.yaml |
80.4% | 81.7% | 185/230 | |
Glycogen_Storage_Disease_Due_To_Lactate_Dehydrogenase_M-subunit_Deficiency.yaml |
80.4% | 81.5% | 111/138 | |
Isolated_Growth_Hormone_Deficiency.yaml |
80.4% | 82.8% | 148/184 | 2 |
TACO1-Related_COX_Deficiency.yaml |
80.4% | 83.9% | 37/46 | |
CCDC115-CDG.yaml |
80.5% | 81.9% | 107/133 | |
Thyroid_Dyshormonogenesis_5.yaml |
80.5% | 83.1% | 70/87 | |
IgA_Pemphigus.yaml |
80.5% | 82.7% | 103/128 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_104.yaml |
80.5% | 82.4% | 99/123 | |
Lymphogranuloma_Venereum.yaml |
80.5% | 82.9% | 66/82 | |
Stankiewicz_Isidor_syndrome.yaml |
80.5% | 82.7% | 66/82 | |
3-hydroxyacyl-CoA_Dehydrogenase_Deficiency.yaml |
80.5% | 82.3% | 128/159 | |
NAGA_Deficiency_Type_3.yaml |
80.5% | 83.0% | 62/77 | |
PHF21A_Related_Neurodevelopmental_Disorder.yaml |
80.5% | 81.9% | 120/149 | |
ISCU_Myopathy.yaml |
80.5% | 80.5% | 149/185 | 2 |
Charcot-Marie-Tooth_Disease_Type_2B2.yaml |
80.6% | 81.5% | 112/139 | |
Immunodeficiency_85_And_Autoimmunity.yaml |
80.6% | 81.6% | 108/134 | 1 |
Juvenile_Myoclonic_Epilepsy.yaml |
80.6% | 81.7% | 79/98 | 1 |
RHYNS_Syndrome.yaml |
80.6% | 81.7% | 104/129 | |
ALG2-Congenital_Disorder_of_Glycosylation.yaml |
80.6% | 81.8% | 129/160 | |
Chorioamnionitis.yaml |
80.6% | 81.0% | 200/248 | 1 |
Chromosome_17q12_Duplication_Syndrome.yaml |
80.7% | 82.4% | 146/181 | |
Immunodeficiency_60.yaml |
80.7% | 80.9% | 192/238 | |
Stickler_Syndrome_Type_4.yaml |
80.7% | 81.2% | 117/145 | |
MOGS-Congenital_Disorder_of_Glycosylation.yaml |
80.7% | 81.8% | 184/228 | |
Bladder_Urothelial_Carcinoma.yaml |
80.7% | 83.2% | 88/109 | 1 |
Flinders_Island_Spotted_Fever.yaml |
80.7% | 82.6% | 88/109 | |
NDE1-related_Microcephaly_Lissencephaly.yaml |
80.7% | 83.9% | 88/109 | 2 |
Glioma.yaml |
80.7% | 82.6% | 109/135 | |
Placenta_Accreta_Spectrum.yaml |
80.8% | 81.6% | 63/78 | 1 |
Filippi_Syndrome.yaml |
80.8% | 82.9% | 164/203 | 1 |
Minimal_Change_Disease.yaml |
80.8% | 81.6% | 164/203 | |
IRF2BPL-Related_Neurodevelopmental_Disorder_with_Regression.yaml |
80.8% | 81.6% | 202/250 | |
MYPN-Related_Cardiomyopathy.yaml |
80.8% | 82.2% | 139/172 | |
Charcot-Marie-Tooth_Disease_Axonal_Type_2P.yaml |
80.8% | 81.8% | 118/146 | 1 |
MSI_High_Colorectal_Cancer.yaml |
80.8% | 82.8% | 97/120 | |
Muckle-Wells_Syndrome.yaml |
80.8% | 83.9% | 97/120 | |
Optic_Atrophy_14.yaml |
80.9% | 82.0% | 76/94 | |
Type_2_Diabetes_Mellitus.yaml |
80.9% | 81.9% | 266/329 | 2 |
Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml |
80.9% | 84.2% | 93/115 | |
Immunodeficiency_14B_Autosomal_Recessive.yaml |
80.9% | 82.5% | 93/115 | |
Chromosome_18q_Deletion_Syndrome.yaml |
80.9% | 83.8% | 89/110 | |
Infantile_Cerebellar-Retinal_Degeneration.yaml |
80.9% | 82.2% | 89/110 | |
Infantile_Spasms.yaml |
80.9% | 81.4% | 140/173 | 1 |
COXFA4-Related_COX_Deficiency.yaml |
81.0% | 83.2% | 34/42 | |
Charcot-Marie-Tooth_Disease_Axonal_Autosomal_Recessive_Type_2A2B.yaml |
81.0% | 81.8% | 119/147 | |
Developmental_Stuttering.yaml |
81.0% | 82.4% | 68/84 | |
Intermittent_Explosive_Disorder.yaml |
81.0% | 82.4% | 68/84 | |
Saul-Wilson_Syndrome.yaml |
81.0% | 82.9% | 119/147 | |
CEDNIK_Syndrome.yaml |
81.0% | 82.4% | 285/352 | |
Hereditary_Spherocytosis.yaml |
81.0% | 83.1% | 183/226 | |
Myoclonus_Dystonia_Syndrome.yaml |
81.0% | 82.6% | 132/163 | |
X-linked_Syndromic_Intellectual_Disability_Turner_Type.yaml |
81.0% | 82.5% | 132/163 | |
Pulmonary_Alveolar_Microlithiasis.yaml |
81.0% | 82.9% | 98/121 | |
LRRK2-Related_Parkinson_Disease.yaml |
81.0% | 82.0% | 81/100 | 2 |
Leukoencephalopathy_Progressive_Infantile-onset_With_Or_Without_Deafness.yaml |
81.0% | 83.3% | 81/100 | |
Coronary_Arterial_Fistulas.yaml |
81.0% | 82.5% | 47/58 | 1 |
PNPO_Deficiency.yaml |
81.0% | 81.8% | 94/116 | 2 |
angioosteohypertrophic_syndrome.yaml |
81.0% | 84.0% | 47/58 | |
Psoriasis.yaml |
81.0% | 83.0% | 201/248 | 1 |
X-Linked_Spondyloepiphyseal_Dysplasia_Tarda.yaml |
81.1% | 82.1% | 77/95 | |
Myhre_Syndrome.yaml |
81.1% | 83.1% | 137/169 | 1 |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_34.yaml |
81.1% | 80.9% | 90/111 | 1 |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_31.yaml |
81.1% | 82.4% | 73/90 | |
Cor_Pulmonale.yaml |
81.1% | 83.7% | 73/90 | 1 |
Progressive_Cardiac_Conduction_Disease.yaml |
81.1% | 85.0% | 43/53 | |
capillary_leak_syndrome.yaml |
81.1% | 82.4% | 43/53 | |
Thoracic_Aortic_Aneurysm.yaml |
81.1% | 81.2% | 142/175 | |
FGFR2-Related_Bent_Bone_Dysplasia.yaml |
81.1% | 83.5% | 99/122 | |
African_Tick-Bite_Fever.yaml |
81.2% | 82.4% | 82/101 | 1 |
Myopathic_Ehlers-Danlos_Syndrome.yaml |
81.2% | 83.2% | 95/117 | |
Torsion_Dystonia_6.yaml |
81.2% | 81.7% | 108/133 | |
Ewing_Sarcoma.yaml |
81.2% | 80.7% | 471/580 | 2 |
Mast_Cell_Activation_Syndrome.yaml |
81.2% | 83.2% | 104/128 | |
Middle_East_Respiratory_Syndrome.yaml |
81.2% | 82.5% | 65/80 | |
Multiple_Epiphyseal_Dysplasia_Al-Gazali_Type.yaml |
81.2% | 84.0% | 39/48 | |
Propofol_Infusion_Syndrome.yaml |
81.2% | 82.7% | 104/128 | |
Fanconi_Anemia.yaml |
81.3% | 82.8% | 1192/1467 | |
Sclerosing_Cholangitis.yaml |
81.3% | 83.0% | 174/214 | |
Chagas_Disease.yaml |
81.3% | 80.9% | 148/182 | 1 |
Intrahepatic_Cholestasis_of_Pregnancy.yaml |
81.3% | 83.3% | 74/91 | 1 |
Congenital_Disorder_of_Glycosylation_Type_IIr.yaml |
81.3% | 82.7% | 122/150 | |
Fallopian_Tube_Cancer.yaml |
81.3% | 83.5% | 61/75 | |
Focal_Dermal_Hypoplasia.yaml |
81.3% | 83.9% | 122/150 | |
HFM1-related_gametogenic_failure.yaml |
81.4% | 84.0% | 48/59 | |
Small_Intestine_Cancer.yaml |
81.4% | 84.6% | 96/118 | |
Tooth_Agenesis.yaml |
81.4% | 83.2% | 144/177 | |
Vulvodynia.yaml |
81.4% | 82.1% | 131/161 | 1 |
Reelin_Pathway_Lissencephaly.yaml |
81.4% | 83.7% | 83/102 | 1 |
MAN2C1-congenital_disorder_of_deglycosylation_2.yaml |
81.4% | 84.8% | 35/43 | |
Immunodeficiency_122.yaml |
81.4% | 83.8% | 127/156 | |
Mucolipidosis_Type_II.yaml |
81.4% | 83.5% | 92/113 | |
Schwannomatosis.yaml |
81.4% | 82.2% | 92/113 | 1 |
Japanese_Spotted_Fever.yaml |
81.4% | 83.5% | 79/97 | |
Chiari_Malformation_Type_I.yaml |
81.5% | 81.7% | 101/124 | |
Typhoid_Fever.yaml |
81.5% | 83.0% | 101/124 | |
Bryant-Li-Bhoj_Neurodevelopmental_Syndrome_2.yaml |
81.5% | 83.4% | 290/356 | |
LAT_Deficiency.yaml |
81.5% | 83.1% | 233/286 | |
Chromophobe_Renal_Cell_Carcinoma.yaml |
81.5% | 82.6% | 141/173 | |
Juvenile_Absence_Epilepsy.yaml |
81.5% | 83.4% | 128/157 | 1 |
Leukocyte_Adhesion_Deficiency_Type_II.yaml |
81.5% | 82.6% | 106/130 | |
Microcephalic_Osteodysplastic_Primordial_Dwarfism_Type_II.yaml |
81.5% | 84.0% | 159/195 | |
Ulcerative_Colitis.yaml |
81.5% | 81.8% | 243/298 | 3 |
Terminal_Osseous_Dysplasia.yaml |
81.6% | 83.7% | 84/103 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_26.yaml |
81.6% | 82.8% | 146/179 | |
Multiple_Mitochondrial_Dysfunctions_Syndrome_9B.yaml |
81.6% | 82.5% | 208/255 | |
COA8-Related_COX_Deficiency.yaml |
81.6% | 83.8% | 62/76 | |
Chronic_Insomnia_Disorder.yaml |
81.6% | 82.1% | 62/76 | |
Dyskeratosis_Congenita_Autosomal_Recessive_8.yaml |
81.6% | 82.7% | 93/114 | |
Kearns-Sayre_Syndrome.yaml |
81.6% | 83.5% | 155/190 | |
Postpartum_Depression.yaml |
81.6% | 83.4% | 124/152 | |
Systemic_Sclerosis.yaml |
81.6% | 84.4% | 93/114 | |
Trachoma.yaml |
81.6% | 79.4% | 31/38 | |
FOXG1_Disorder.yaml |
81.6% | 83.6% | 195/239 | |
Charcot-Marie-Tooth_Disease_Type_4C.yaml |
81.6% | 82.3% | 164/201 | |
X-Linked_Infantile_Spinal_Muscular_Atrophy.yaml |
81.6% | 82.4% | 173/212 | 1 |
Hallermann-Streiff_Syndrome.yaml |
81.6% | 83.6% | 71/87 | |
Charcot-Marie-Tooth_Disease_Type_1E.yaml |
81.6% | 83.8% | 111/136 | |
Cystic_Leukoencephalopathy_Without_Megalencephaly.yaml |
81.6% | 83.2% | 111/136 | |
KRT85_Ectodermal_Dysplasia.yaml |
81.6% | 84.4% | 40/49 | |
Septicemic_Plague.yaml |
81.6% | 84.6% | 40/49 | |
Pendred_Syndrome.yaml |
81.7% | 81.6% | 138/169 | 1 |
Catamenial_Pneumothorax.yaml |
81.7% | 83.2% | 98/120 | |
Leri-Weill_Dyschondrosteosis.yaml |
81.7% | 83.9% | 147/180 | |
Hypertrophic_Cardiomyopathy_25.yaml |
81.7% | 83.8% | 165/202 | |
Familial_Progressive_Hyperpigmentation_With_Or_Without_Hypopigmentation.yaml |
81.7% | 82.7% | 116/142 | |
Reynolds_Syndrome.yaml |
81.7% | 83.1% | 85/104 | |
Periventricular_Nodular_Heterotopia_9.yaml |
81.7% | 83.6% | 94/115 | |
Spondylometaphyseal_Dysplasia_Schmidt_Type.yaml |
81.7% | 83.4% | 103/126 | |
Branchiooculofacial_Syndrome.yaml |
81.8% | 83.9% | 130/159 | |
Breast_Carcinoma.yaml |
81.8% | 83.1% | 99/121 | 1 |
DOORS_Syndrome.yaml |
81.8% | 83.6% | 90/110 | |
Focal_Articular_Cartilage_Defect_of_the_Knee.yaml |
81.8% | 85.2% | 54/66 | |
Gastroesophageal_Reflux_Disease.yaml |
81.8% | 83.6% | 81/99 | |
Granuloma_Inguinale.yaml |
81.8% | 83.6% | 54/66 | |
IRIDA_Syndrome.yaml |
81.8% | 81.8% | 144/176 | 2 |
Inherited_Ichthyosis.yaml |
81.8% | 83.9% | 162/198 | |
Inherited_Retinal_Dystrophy.yaml |
81.8% | 84.6% | 81/99 | 1 |
Scurvy.yaml |
81.8% | 82.1% | 36/44 | 1 |
TLR3_Deficiency.yaml |
81.8% | 81.0% | 45/55 | 2 |
Ritscher-Schinzel_Syndrome_1.yaml |
81.8% | 83.6% | 257/314 | |
Myotonic_Dystrophy_Type_1.yaml |
81.9% | 83.3% | 194/237 | 2 |
VPS4A-Related_Neurodevelopmental_Syndrome.yaml |
81.9% | 84.9% | 176/215 | |
Harderoporphyria.yaml |
81.9% | 82.8% | 104/127 | 1 |
Rickettsia_Parkeri_Spotted_Fever.yaml |
81.9% | 82.8% | 86/105 | 1 |
Solitary_Fibrous_Tumor.yaml |
81.9% | 83.6% | 68/83 | |
CHST3-Related_Skeletal_Dysplasia.yaml |
82.0% | 84.0% | 218/266 | |
UNC13A_NDD_with_Seizures_and_Movement_Disorder.yaml |
82.0% | 83.0% | 109/133 | 2 |
Hereditary_Hemorrhagic_Telangiectasia_4.yaml |
82.0% | 83.0% | 50/61 | |
NAD_P_HX_Dehydratase_Deficiency.yaml |
82.0% | 81.9% | 123/150 | 1 |
Global_Developmental_Delay_Progressive_Ataxia_and_Elevated_Glutamine.yaml |
82.1% | 83.9% | 64/78 | |
Spondyloepiphyseal_Dysplasia_Nishimura_Type.yaml |
82.1% | 82.8% | 192/234 | |
Hypoparathyroidism_Deafness_Renal_Disease_Syndrome.yaml |
82.1% | 83.3% | 183/223 | |
Von_Hippel-Lindau_Disease.yaml |
82.1% | 82.4% | 119/145 | |
Giant_Cell_Hepatitis_With_Autoimmune_Hemolytic_Anemia.yaml |
82.1% | 84.7% | 87/106 | |
Dorfman_Chanarin_Disease.yaml |
82.1% | 84.9% | 55/67 | |
Papillon-Lefevre_Disease.yaml |
82.1% | 83.7% | 165/201 | |
Saethre-Chotzen_Syndrome.yaml |
82.1% | 85.3% | 55/67 | |
Gorlin_Syndrome.yaml |
82.1% | 83.0% | 298/363 | 1 |
Neurodevelopmental_Disorder_with_Dysmorphic_Facies_and_Distal_Skeletal_Anomalies.yaml |
82.1% | 83.3% | 257/313 | |
Podoconiosis.yaml |
82.1% | 81.4% | 179/218 | 1 |
Platelet-type_Bleeding_Disorder_20.yaml |
82.1% | 84.2% | 101/123 | |
TUBGCP2-related_Lissencephaly_Spectrum_Disorder.yaml |
82.1% | 83.4% | 147/179 | |
Borrelia_Miyamotoi_Disease.yaml |
82.1% | 83.4% | 69/84 | |
Immunodeficiency_82_With_Systemic_Inflammation.yaml |
82.1% | 83.1% | 115/140 | |
Methylcobalamin_Deficiency_Type_cblG.yaml |
82.1% | 83.5% | 115/140 | |
Proximal_Tubulopathy-Diabetes_Mellitus-Cerebellar_Ataxia_Syndrome.yaml |
82.1% | 84.4% | 69/84 | 1 |
Rhabdoid_Tumor_Predisposition_Syndrome_2.yaml |
82.1% | 83.7% | 46/56 | |
Paraquat_Poisoning.yaml |
82.2% | 83.5% | 175/213 | |
CHD8-Related_Neurodevelopmental_Disorder_with_Overgrowth.yaml |
82.2% | 82.4% | 456/555 | 1 |
Ovarian_High-Grade_Serous_Carcinoma.yaml |
82.2% | 81.8% | 226/275 | 2 |
Autism_Spectrum_Disorder-Epilepsy-Arthrogryposis_Syndrome.yaml |
82.2% | 84.5% | 143/174 | |
Immunodeficiency_49.yaml |
82.2% | 83.7% | 203/247 | |
Mesomelic_Dysplasia_Kantaputra_Type.yaml |
82.2% | 82.8% | 60/73 | |
Osmotic_Demyelination_Syndrome.yaml |
82.2% | 84.2% | 60/73 | |
Primary_Carnitine_Deficiency.yaml |
82.2% | 83.6% | 157/191 | |
Infantile_Cataract_Skin_Abnormalities_Glutamate_Excess_and_Impaired_Intellectual_Development.yaml |
82.2% | 83.7% | 97/118 | |
Ullrich_Congenital_Muscular_Dystrophy.yaml |
82.2% | 83.6% | 231/281 | |
Combined_Oxidative_Phosphorylation_Defect_Type_23.yaml |
82.2% | 83.1% | 148/180 | |
Patent_Ductus_Arteriosus.yaml |
82.2% | 83.7% | 74/90 | |
Manganism.yaml |
82.3% | 82.4% | 218/265 | 1 |
Autoimmune_Hemolytic_Anemia.yaml |
82.3% | 82.7% | 348/423 | |
Siberian_Tick_Typhus.yaml |
82.3% | 83.7% | 65/79 | 1 |
Cyanosis_Transient_Neonatal.yaml |
82.3% | 83.5% | 79/96 | |
CLOVES_Syndrome.yaml |
82.3% | 84.0% | 191/232 | |
Siderius_Type_X-Linked_Intellectual_Disability.yaml |
82.3% | 83.6% | 219/266 | |
COX10-Related_COX_Deficiency.yaml |
82.4% | 86.0% | 28/34 | |
Chemotherapy_Induced_Neutropenia.yaml |
82.4% | 85.6% | 70/85 | |
Combined_Saposin_Deficiency.yaml |
82.4% | 85.4% | 42/51 | |
EBV_Associated_Gastric_Cancer.yaml |
82.4% | 84.7% | 84/102 | |
Episodic_Ataxia.yaml |
82.4% | 83.9% | 70/85 | 1 |
Hemiconvulsion-Hemiplegia-Epilepsy_Syndrome.yaml |
82.4% | 83.6% | 98/119 | |
Hereditary_Sensory_and_Autonomic_Neuropathy_Type_1C.yaml |
82.4% | 84.0% | 56/68 | |
Prurigo_Nodularis.yaml |
82.4% | 81.6% | 14/17 | |
Wiskott_Aldrich_Syndrome.yaml |
82.4% | 83.8% | 182/221 | |
Peroxisome_Biogenesis_Disorder.yaml |
82.4% | 81.9% | 229/278 | 1 |
Immunodeficiency_120.yaml |
82.4% | 84.2% | 131/159 | |
Sideroblastic_Anemia_3.yaml |
82.4% | 84.5% | 89/108 | |
Van_Buchem_Disease.yaml |
82.4% | 83.1% | 89/108 | |
NF1_Microdeletion_Syndrome.yaml |
82.4% | 84.8% | 61/74 | |
Methotrexate_Toxicity.yaml |
82.4% | 82.5% | 216/262 | 1 |
TUBB_TUBB5-related_Microcephaly.yaml |
82.4% | 84.2% | 108/131 | 2 |
Cardiomyopathy-Hypotonia-Lactic_Acidosis_Syndrome.yaml |
82.5% | 82.3% | 254/308 | 1 |
Dupuytrens_Contracture.yaml |
82.5% | 82.5% | 80/97 | 1 |
GATA2_Deficiency.yaml |
82.5% | 84.2% | 99/120 | |
Oroya_Fever.yaml |
82.5% | 83.6% | 99/120 | |
Muggenthaler-Chowdhury-Chioza_Syndrome.yaml |
82.5% | 84.0% | 85/103 | |
Omodysplasia.yaml |
82.5% | 83.6% | 170/206 | |
Bacillary_Angiomatosis.yaml |
82.5% | 84.4% | 104/126 | |
Self-Limited_Epilepsy_with_Autonomic_Seizures.yaml |
82.5% | 83.6% | 104/126 | |
Vulvar_Carcinoma.yaml |
82.5% | 82.9% | 227/275 | 3 |
Sanjad-Sakati_Syndrome.yaml |
82.6% | 84.4% | 123/149 | |
CRX_Related_Retinopathy.yaml |
82.6% | 84.5% | 71/86 | |
Relapsing_Fever.yaml |
82.6% | 83.5% | 109/132 | |
KBG_Syndrome.yaml |
82.6% | 85.0% | 128/155 | |
Imerslund-Grasbeck_Syndrome_Type_1.yaml |
82.6% | 83.5% | 147/178 | |
Dystroglycanopathy.yaml |
82.6% | 84.6% | 242/293 | 2 |
COX5A-Related_COX_Deficiency.yaml |
82.6% | 85.1% | 38/46 | |
Caroli_Disease.yaml |
82.6% | 84.9% | 133/161 | |
Congenital_Heart_Defects_Multiple_Types_2.yaml |
82.6% | 83.2% | 95/115 | 1 |
EDN3_EDNRB_Waardenburg_Shah.yaml |
82.6% | 85.4% | 57/69 | |
Preaxial_Digit_Brachydactyly-Webbed_Fingers.yaml |
82.6% | 85.6% | 38/46 | |
Short-Rib_Polydactyly_Syndrome.yaml |
82.6% | 84.2% | 114/138 | |
Tatton-Brown-Rahman_overgrowth_syndrome.yaml |
82.6% | 85.1% | 38/46 | |
Spondyloepimetaphyseal_Dysplasia_Missouri_Type.yaml |
82.6% | 83.7% | 100/121 | 1 |
DECR_Deficiency.yaml |
82.7% | 85.1% | 124/150 | |
IREB2-Related_Neurodegeneration.yaml |
82.7% | 83.4% | 248/300 | 1 |
Pseudomyxoma_Peritonei.yaml |
82.7% | 83.8% | 124/150 | |
Immunodeficiency_89_And_Autoimmunity.yaml |
82.7% | 84.1% | 67/81 | |
Primary_Tonsillar_Lymphoma.yaml |
82.7% | 83.4% | 134/162 | 1 |
YWHAG_Syndrome.yaml |
82.7% | 84.5% | 134/162 | |
Aflatoxicosis.yaml |
82.7% | 83.3% | 91/110 | |
Orofaciodigital_Syndrome_Type_I.yaml |
82.7% | 84.5% | 115/139 | |
Sarcoidosis.yaml |
82.8% | 83.3% | 355/429 | 2 |
Chancroid.yaml |
82.8% | 84.0% | 72/87 | 1 |
Retinal_Arterial_Tortuosity.yaml |
82.8% | 84.2% | 72/87 | |
Usmani-Riazuddin_Syndrome_Autosomal_Recessive.yaml |
82.8% | 84.9% | 72/87 | 1 |
Neurodevelopmental_Disorder_with_Microcephaly_Movement_Abnormalities_and_Seizures.yaml |
82.8% | 84.4% | 173/209 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_102.yaml |
82.8% | 84.4% | 77/93 | |
Craniodiaphyseal_Dysplasia.yaml |
82.8% | 84.5% | 164/198 | |
BRAF_V600E_Mutant_Colorectal_Cancer.yaml |
82.9% | 82.5% | 174/210 | 1 |
Complement_Component_4A_Deficiency.yaml |
82.9% | 85.1% | 58/70 | 1 |
Erysipelothrix_Rhusiopathiae_Infectious_Disease.yaml |
82.9% | 84.2% | 58/70 | |
Anthrax.yaml |
82.9% | 84.6% | 121/146 | |
Mevalonate_Kinase_Deficiency.yaml |
82.9% | 84.7% | 121/146 | |
Cherubism.yaml |
82.9% | 85.3% | 92/111 | |
Hereditary_Spastic_Paraplegia_46.yaml |
82.9% | 83.7% | 92/111 | 2 |
Light_Chain_Deposition_Disease.yaml |
82.9% | 84.5% | 92/111 | |
Tuberous_Sclerosis_Complex.yaml |
82.9% | 83.9% | 436/526 | |
Spastic_Paraparesis-cataracts-speech_Delay_Syndrome.yaml |
82.9% | 84.5% | 107/129 | |
STT3A-Congenital_Disorder_of_Glycosylation.yaml |
83.0% | 84.0% | 253/305 | |
HROB-related_gametogenic_failure.yaml |
83.0% | 84.7% | 73/88 | |
CYCS-Related_Thrombocytopenia.yaml |
83.0% | 85.8% | 39/47 | |
Focal_Cortical_Dysplasia_Type_II.yaml |
83.0% | 84.5% | 122/147 | |
Cornelia_de_Lange_Syndrome.yaml |
83.0% | 84.2% | 205/247 | |
Congenital_Prothrombin_Deficiency.yaml |
83.0% | 83.2% | 166/200 | 1 |
GM1_Gangliosidosis_Type_3.yaml |
83.0% | 85.2% | 44/53 | |
Heart_Defect_Tongue_Hamartoma_Polysyndactyly_Syndrome.yaml |
83.0% | 85.8% | 44/53 | |
Mucolipidosis_Type_IV.yaml |
83.0% | 86.3% | 44/53 | |
Hereditary_Elliptocytosis.yaml |
83.0% | 84.4% | 181/218 | |
Hypertrophic_Cardiomyopathy_13.yaml |
83.1% | 86.7% | 49/59 | |
Familial_Adenomatous_Polyposis.yaml |
83.1% | 83.5% | 103/124 | |
Pemphigus_Foliaceus.yaml |
83.1% | 83.9% | 103/124 | |
Persistent_Truncus_Arteriosus.yaml |
83.1% | 83.6% | 167/201 | 1 |
Charcot-Marie-Tooth_Disease_X-linked_Recessive_4.yaml |
83.1% | 85.1% | 123/148 | |
Spondyloepimetaphyseal_Dysplasia_Sponastrime_Type.yaml |
83.1% | 84.6% | 123/148 | |
Posterior_Myocardial_Infarction.yaml |
83.1% | 82.9% | 64/77 | 1 |
DYRK1A_Syndrome.yaml |
83.1% | 85.2% | 133/160 | |
Acrodermatitis_Enteropathica.yaml |
83.1% | 84.8% | 69/83 | |
Muenke_Syndrome.yaml |
83.1% | 85.2% | 69/83 | |
Autosomal_Recessive_Osteopetrosis_1.yaml |
83.1% | 83.8% | 217/261 | |
DeSanto-Shinawi_Syndrome.yaml |
83.1% | 84.0% | 74/89 | |
Dystrophic_Epidermolysis_Bullosa.yaml |
83.1% | 83.9% | 222/267 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_12.yaml |
83.1% | 84.6% | 74/89 | |
Developmental_And_Epileptic_Encephalopathy_81.yaml |
83.2% | 84.0% | 153/184 | |
Andersen-Tawil_Syndrome.yaml |
83.2% | 84.5% | 232/279 | |
Elsahy-Waters_Syndrome.yaml |
83.2% | 86.3% | 79/95 | |
10q22.3q23.3_Microduplication_Syndrome.yaml |
83.2% | 85.5% | 89/107 | |
Pelizaeus_Merzbacher_Disease.yaml |
83.2% | 84.8% | 188/226 | |
Thanatophoric_Dysplasia.yaml |
83.2% | 84.3% | 114/137 | |
Leber_Congenital_Amaurosis_13.yaml |
83.2% | 83.7% | 124/149 | 1 |
Primary_Central_Nervous_System_Lymphoma.yaml |
83.2% | 84.7% | 144/173 | 1 |
Microcephalic_Osteodysplastic_Primordial_Dwarfism_Type_I.yaml |
83.2% | 84.5% | 149/179 | |
Chemotherapy_Induced_Diarrhea.yaml |
83.3% | 84.3% | 174/209 | |
Autosomal_Recessive_Progressive_External_Ophthalmoplegia_1.yaml |
83.3% | 84.5% | 214/257 | |
Joubert_syndrome.yaml |
83.3% | 84.3% | 563/676 | |
Deoxyhypusine_Synthase_Deficiency.yaml |
83.3% | 84.7% | 100/120 | |
FASTKD5-Related_COX_Deficiency.yaml |
83.3% | 85.4% | 35/42 | |
Frank-Ter_Haar_Syndrome.yaml |
83.3% | 84.6% | 90/108 | |
Generalized_Resistance_to_Thyroid_Hormone.yaml |
83.3% | 84.9% | 90/108 | |
Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml |
83.3% | 85.0% | 130/156 | |
Hypokalemic_Tubulopathy_and_Deafness.yaml |
83.3% | 84.4% | 75/90 | |
MTO1_Deficiency.yaml |
83.3% | 84.3% | 215/258 | |
Midface_Hypoplasia_Hearing_Impairment_Elliptocytosis_And_Nephrocalcinosis.yaml |
83.3% | 82.8% | 110/132 | 1 |
Post-Traumatic_Epilepsy.yaml |
83.3% | 84.0% | 110/132 | |
Progressive_Myoclonic_Epilepsy_Type_8.yaml |
83.3% | 85.3% | 80/96 | |
Rhabdoid_Tumor.yaml |
83.3% | 85.0% | 75/90 | |
Rickettsia_Helvetica_Spotted_Fever.yaml |
83.3% | 85.3% | 85/102 | |
SARS1-Related_Neurodevelopmental_Disorder.yaml |
83.3% | 84.8% | 220/264 | |
THUMPD1-Related_Neurodevelopmental_Disorder.yaml |
83.3% | 85.4% | 55/66 | |
Temporal_Lobe_Epilepsy.yaml |
83.3% | 84.9% | 30/36 | |
Temtamy_Preaxial_Brachydactyly_Syndrome.yaml |
83.3% | 84.9% | 130/156 | 1 |
PPM-X_Syndrome.yaml |
83.4% | 84.4% | 201/241 | |
Guanidinoacetate_Methyltransferase_Deficiency.yaml |
83.4% | 84.6% | 181/217 | |
ALG3-Congenital_Disorder_of_Glycosylation.yaml |
83.4% | 85.0% | 146/175 | |
Multiple_Congenital_Anomalies-Hypotonia-Seizures_Syndrome.yaml |
83.4% | 84.6% | 141/169 | 1 |
Smith-Magenis_Syndrome.yaml |
83.4% | 85.7% | 141/169 | |
Wolcott-Rallison_Syndrome.yaml |
83.4% | 84.5% | 141/169 | 2 |
Cockayne_Syndrome.yaml |
83.4% | 84.5% | 272/326 | |
MEPAN_Syndrome.yaml |
83.4% | 84.5% | 126/151 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_21.yaml |
83.5% | 84.5% | 116/139 | |
Peroxisome_Biogenesis_Disorder_11B.yaml |
83.5% | 84.3% | 106/127 | |
Immunodeficiency_28.yaml |
83.5% | 85.8% | 101/121 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_33.yaml |
83.5% | 83.7% | 192/230 | |
Preterm_Premature_Rupture_of_the_Membranes.yaml |
83.5% | 84.9% | 182/218 | 1 |
Human_African_Trypanosomiasis.yaml |
83.5% | 83.2% | 86/103 | |
Medullary_Thyroid_Carcinoma.yaml |
83.5% | 85.1% | 81/97 | 1 |
Ebola_Virus_Disease_EVD.yaml |
83.5% | 82.9% | 157/188 | 2 |
Campylobacter_Fetus_Infectious_Disease.yaml |
83.5% | 84.7% | 76/91 | |
Deafness-Dystonia-Optic_Neuronopathy_Syndrome.yaml |
83.5% | 83.0% | 152/182 | 1 |
SCO2-Related_Fatal_Infantile_Cardioencephalomyopathy.yaml |
83.5% | 85.5% | 76/91 | |
Hereditary_Pancreatitis.yaml |
83.5% | 83.7% | 71/85 | 1 |
Rett_Syndrome.yaml |
83.5% | 84.5% | 213/255 | |
Kniest_Dysplasia.yaml |
83.5% | 84.5% | 137/164 | 1 |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_18.yaml |
83.5% | 83.2% | 137/164 | 1 |
Sarcopenia.yaml |
83.5% | 83.2% | 411/492 | 1 |
CTCF-related_Neurodevelopmental_Disorder.yaml |
83.5% | 86.1% | 132/158 | |
Ficolin_3_Deficiency.yaml |
83.5% | 85.8% | 66/79 | |
Growth_Restriction_Hypoplastic_Kidneys_Alopecia_And_Distinctive_Facies.yaml |
83.5% | 82.7% | 132/158 | 1 |
Hartsfield_Syndrome.yaml |
83.6% | 85.4% | 61/73 | |
Congenital_Dyserythropoietic_Anemia.yaml |
83.6% | 85.6% | 168/201 | |
Primary_Sclerosing_Cholangitis.yaml |
83.6% | 84.6% | 56/67 | |
Peroxisome_Biogenesis_Disorder_12A_Zellweger.yaml |
83.6% | 84.5% | 209/250 | |
Brachyolmia.yaml |
83.6% | 85.1% | 204/244 | |
Scott_Syndrome.yaml |
83.6% | 84.2% | 51/61 | 1 |
CANVAS.yaml |
83.6% | 83.9% | 393/470 | |
Adult-Onset_Proximal_Spinal_Muscular_Atrophy_Autosomal_Dominant.yaml |
83.6% | 84.1% | 184/220 | |
Hydrolethalus_Syndrome_2.yaml |
83.6% | 86.0% | 46/55 | |
Multiple_System_Atrophy.yaml |
83.6% | 85.4% | 138/165 | |
PAICS_Deficiency.yaml |
83.6% | 84.7% | 92/110 | |
Pemphigus_Erythematosus.yaml |
83.6% | 85.2% | 46/55 | |
Bipolar_Disorder.yaml |
83.7% | 83.4% | 174/208 | 1 |
Loeys-Dietz_Syndrome_4.yaml |
83.7% | 84.5% | 261/312 | |
Pantothenate_Kinase-Associated_Neurodegeneration.yaml |
83.7% | 85.5% | 87/104 | |
Stromme_Syndrome.yaml |
83.7% | 84.9% | 174/208 | |
Fibrous_Dysplasia.yaml |
83.7% | 85.1% | 215/257 | |
Hypertrophic_Cardiomyopathy_30_Atrial.yaml |
83.7% | 85.1% | 169/202 | 1 |
CD16_Deficiency.yaml |
83.7% | 84.7% | 82/98 | |
Chromosome_3q29_Microduplication_Syndrome.yaml |
83.7% | 84.6% | 82/98 | |
Diabetes_Deafness_Developmental_Delay_and_Short_Stature_Syndrome.yaml |
83.7% | 85.1% | 82/98 | |
SNIP1-Related_Neurodevelopmental_Disorder.yaml |
83.7% | 85.1% | 405/484 | |
Cornelia_de_Lange_Syndrome_4.yaml |
83.7% | 84.2% | 118/141 | |
Autosomal_Dominant_Sensory_Ataxia_1.yaml |
83.7% | 84.8% | 195/233 | |
Congenital_Bile_Acid_Synthesis_Defect_5.yaml |
83.7% | 85.0% | 149/178 | |
Revesz_Syndrome.yaml |
83.7% | 84.2% | 185/221 | |
Pasteurellosis.yaml |
83.7% | 85.5% | 72/86 | |
Pyruvate_Kinase_Deficiency.yaml |
83.7% | 85.8% | 72/86 | |
Combined_Oxidative_Phosphorylation_Defect_Type_4.yaml |
83.7% | 85.0% | 103/123 | |
Spondylometaphyseal_Dysplasia_Kozlowski_Type.yaml |
83.8% | 85.5% | 134/160 | |
Hereditary_Sensory_and_Autonomic_Neuropathy_Type_2.yaml |
83.8% | 85.7% | 98/117 | |
Aneurysm-Osteoarthritis_Syndrome.yaml |
83.8% | 85.2% | 191/228 | |
46_XY_Sex_Reversal_5.yaml |
83.8% | 83.7% | 217/259 | |
Malan_Syndrome.yaml |
83.8% | 86.1% | 93/111 | |
Oculodentodigital_Dysplasia.yaml |
83.8% | 85.9% | 155/185 | |
Retinitis_Pigmentosa_With_or_Without_Situs_Inversus.yaml |
83.8% | 84.8% | 124/148 | |
Congenital_Factor_X_Deficiency.yaml |
83.8% | 83.9% | 145/173 | 1 |
Peeling_Skin_Syndrome.yaml |
83.8% | 85.4% | 140/167 | |
Core_Binding_Factor_AML.yaml |
83.8% | 86.4% | 83/99 | |
Far_Eastern_Spotted_Fever.yaml |
83.8% | 85.3% | 83/99 | 1 |
ACTH-independent_Macronodular_Adrenal_Hyperplasia_3.yaml |
83.8% | 85.4% | 109/130 | |
Inclusion_Body_Myopathy_with_Paget_Disease_of_Bone_and_Frontotemporal_Dementia.yaml |
83.8% | 85.2% | 218/260 | |
NEUROD2-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
83.8% | 84.6% | 109/130 | 1 |
alpha-Methylacyl-CoA_Racemase_Deficiency.yaml |
83.9% | 84.7% | 135/161 | 1 |
Alzheimer_Disease.yaml |
83.9% | 81.1% | 852/1016 | 6 |
Prostate_Adenocarcinoma.yaml |
83.9% | 84.1% | 213/254 | 2 |
DEPDC5-Related_Epilepsy.yaml |
83.9% | 85.5% | 104/124 | 1 |
Holoprosencephaly_12_With_or_Without_Pancreatic_Agenesis.yaml |
83.9% | 84.9% | 156/186 | 1 |
Hypomyelinating_Leukodystrophy_4.yaml |
83.9% | 85.2% | 208/248 | |
Multiple_Synostoses_Syndrome.yaml |
83.9% | 85.6% | 78/93 | |
NRAS_Mutant_Melanoma.yaml |
83.9% | 86.0% | 78/93 | 1 |
Trench_Fever.yaml |
83.9% | 85.5% | 78/93 | |
Multiple_Myeloma.yaml |
83.9% | 86.3% | 125/149 | 1 |
PTEN_Hamartoma_Tumor_Syndrome.yaml |
83.9% | 85.6% | 125/149 | |
TNF_Receptor-Associated_Periodic_Syndrome.yaml |
83.9% | 84.8% | 125/149 | 2 |
Geleophysic_Dysplasia.yaml |
83.9% | 85.7% | 198/236 | |
Lymphangioleiomyomatosis.yaml |
83.9% | 85.0% | 99/118 | |
Severe_X-linked_Mitochondrial_Encephalomyopathy.yaml |
83.9% | 85.0% | 245/292 | |
Hypertrophic_Cardiomyopathy_20.yaml |
83.9% | 86.6% | 73/87 | |
2q37_Microdeletion_Syndrome.yaml |
83.9% | 85.1% | 120/143 | |
H3_K27_Altered_Diffuse_Midline_Glioma.yaml |
83.9% | 85.4% | 120/143 | 1 |
Holt-Oram_Syndrome.yaml |
83.9% | 85.2% | 120/143 | 2 |
LAMA5-Related_Bent_Bone_Dysplasia.yaml |
83.9% | 85.7% | 120/143 | |
Cardiomyopathy_Dilated_2G.yaml |
83.9% | 87.2% | 47/56 | |
Dermatofibrosarcoma_Protuberans.yaml |
83.9% | 84.7% | 47/56 | 2 |
Leishmaniasis.yaml |
83.9% | 83.6% | 141/168 | 1 |
Subacute_Inflammatory_Demyelinating_Polyneuropathy.yaml |
83.9% | 86.1% | 47/56 | 1 |
Local_Anesthetic_Systemic_Toxicity.yaml |
84.0% | 84.4% | 136/162 | 1 |
Coal_Workers_Pneumoconiosis.yaml |
84.0% | 84.2% | 246/293 | 1 |
Burn-McKeown_Syndrome.yaml |
84.0% | 84.7% | 267/318 | |
Peripheral_Artery_Disease.yaml |
84.0% | 85.7% | 89/106 | |
Bronchiectasis_And_Nasal_Polyposis.yaml |
84.0% | 85.2% | 110/131 | |
Juvenile_Myelomonocytic_Leukemia.yaml |
84.0% | 84.5% | 110/131 | |
Combined_Oxidative_Phosphorylation_Deficiency_35.yaml |
84.0% | 84.9% | 173/206 | |
Kleine-Levin_Syndrome.yaml |
84.0% | 85.8% | 63/75 | |
Larsen-like_Syndrome_B3GAT3_Type.yaml |
84.0% | 86.1% | 247/294 | |
Boucher-Neuhauser_Syndrome.yaml |
84.0% | 84.7% | 142/169 | 1 |
Dengue.yaml |
84.0% | 84.8% | 79/94 | 1 |
Monoclonal_Mast_Cell_Activation_Syndrome.yaml |
84.0% | 84.3% | 79/94 | 1 |
Dracunculiasis.yaml |
84.1% | 83.1% | 58/69 | 1 |
Autoimmune_Polyendocrine_Syndrome_Type_1.yaml |
84.1% | 84.7% | 153/182 | |
Congenital_Myelofibrosis_With_Anemia_Neutropenia_Developmental_Delay_And_Ocular_Abnormalities.yaml |
84.1% | 85.7% | 111/132 | |
Distal_Myopathy_7_Adult-Onset_X-Linked.yaml |
84.1% | 85.6% | 106/126 | |
Mitochondrial_Complex_V_ATP_Synthase_Deficiency_Nuclear_Type_1.yaml |
84.1% | 85.5% | 53/63 | |
Childhood_Absence_Epilepsy.yaml |
84.1% | 86.0% | 122/145 | |
Scapuloperoneal_Spinal_Muscular_Atrophy.yaml |
84.1% | 86.7% | 69/82 | |
Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml |
84.1% | 85.3% | 138/164 | 1 |
Dacryocystitis-Osteopoikilosis_Syndrome.yaml |
84.2% | 86.4% | 85/101 | |
Mendelian_Susceptibility_To_Mycobacterial_Diseases_Due_To_Partial_IRF8_Deficiency.yaml |
84.2% | 86.2% | 85/101 | |
Hypochondroplasia.yaml |
84.2% | 85.9% | 186/221 | |
Denys-Drash_Syndrome.yaml |
84.2% | 85.3% | 101/120 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_13.yaml |
84.2% | 85.0% | 101/120 | |
Thiamine-Responsive_Megaloblastic_Anemia_Syndrome.yaml |
84.2% | 85.1% | 117/139 | |
CLCN2-Related_Leukoencephalopathy.yaml |
84.2% | 86.3% | 250/297 | |
Alveolar_Rhabdomyosarcoma.yaml |
84.2% | 82.7% | 298/354 | 3 |
Bernard-Soulier_Syndrome.yaml |
84.2% | 84.8% | 197/234 | |
Nicolaides-Baraitser_Syndrome.yaml |
84.2% | 85.6% | 213/253 | |
Aicardi_Goutieres_Syndrome.yaml |
84.2% | 84.9% | 261/310 | |
Charcot-Marie-Tooth_Disease_Type_4K.yaml |
84.2% | 86.0% | 64/76 | |
Classical-like_Ehlers-Danlos_Syndrome.yaml |
84.2% | 85.8% | 144/171 | |
Hereditary_Breast_and_Ovarian_Cancer_Syndrome.yaml |
84.2% | 84.6% | 112/133 | 1 |
Hypomyelinating_Leukodystrophy_23.yaml |
84.2% | 85.8% | 112/133 | |
IL6ST-Related_Stuve-Wiedemann_Syndrome.yaml |
84.2% | 85.5% | 112/133 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_36.yaml |
84.2% | 84.2% | 144/171 | |
Monkeypox.yaml |
84.2% | 84.1% | 160/190 | 2 |
Neurofibromatosis_Type_1.yaml |
84.2% | 85.7% | 160/190 | |
Neuromyelitis_Optica.yaml |
84.2% | 82.9% | 144/171 | 5 |
Onchocerciasis.yaml |
84.2% | 85.4% | 80/95 | |
SCN1B-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
84.2% | 85.8% | 208/247 | |
Tooth_and_Nail_Syndrome.yaml |
84.2% | 85.3% | 64/76 | 1 |
X-linked_Mendelian_Susceptibility_to_Mycobacterial_Diseases_due_to_CYBB_Deficiency.yaml |
84.2% | 85.6% | 96/114 | |
Isoniazid_Toxicity.yaml |
84.2% | 84.5% | 139/165 | |
Developmental_And_Epileptic_Encephalopathy_16.yaml |
84.2% | 84.7% | 246/292 | |
Streptococcal_Pharyngitis.yaml |
84.3% | 86.5% | 107/127 | |
Autosomal_Dominant_Charcot-Marie-Tooth_Disease_Type_2W.yaml |
84.3% | 86.0% | 91/108 | |
Retinoblastoma.yaml |
84.3% | 85.0% | 91/108 | 1 |
Congenital_Heart_Disease.yaml |
84.3% | 84.6% | 316/375 | |
X-linked_Dilated_Cardiomyopathy.yaml |
84.3% | 85.0% | 134/159 | |
LAMB1-Related_Cobblestone_Lissencephaly.yaml |
84.3% | 85.7% | 118/140 | 2 |
Axial_Spondylometaphyseal_Dysplasia.yaml |
84.3% | 84.1% | 220/261 | |
MyD88_Deficiency.yaml |
84.3% | 85.0% | 161/191 | 1 |
Fragile_X_Syndrome.yaml |
84.3% | 85.8% | 247/293 | |
Brain_Arteriovenous_Malformation.yaml |
84.3% | 84.4% | 231/274 | |
Hemophilia_A.yaml |
84.3% | 84.8% | 129/153 | |
Krabbe_Disease_Due_To_Saposin_A_Deficiency.yaml |
84.3% | 87.9% | 43/51 | |
MED11-Related_Disorder.yaml |
84.3% | 87.2% | 43/51 | |
Mitochondrial_Complex_V_ATP_Synthase_Deficiency_Nuclear_Type_2.yaml |
84.3% | 85.2% | 86/102 | |
RUNX1_Familial_Platelet_Disorder.yaml |
84.3% | 85.9% | 86/102 | |
Spinocerebellar_Ataxia_Autosomal_Recessive_31.yaml |
84.3% | 87.3% | 86/102 | |
Developmental_And_Epileptic_Encephalopathy_77.yaml |
84.3% | 84.6% | 199/236 | |
IgA_Nephropathy.yaml |
84.3% | 85.5% | 156/185 | |
Hearing_Loss_Autosomal_Dominant_78.yaml |
84.3% | 85.1% | 70/83 | |
Mitochondrial_Complex_II_Deficiency_Nuclear_Type_1.yaml |
84.3% | 86.0% | 70/83 | 1 |
Niemann_Pick_Disease_Type_C.yaml |
84.3% | 85.5% | 210/249 | |
UNC13A_Congenital_NDD_with_Epilepsy.yaml |
84.4% | 84.6% | 151/179 | 2 |
Epithelioid_Hemangioendothelioma.yaml |
84.4% | 85.8% | 216/256 | |
Hereditary_Spastic_Paraplegia.yaml |
84.4% | 86.2% | 351/416 | |
Pentanucleotide_Repeat_Familial_Adult_Myoclonus_Epilepsy.yaml |
84.4% | 84.9% | 173/205 | 1 |
Paroxysmal_Dyskinesia.yaml |
84.4% | 85.5% | 292/346 | 2 |
Chordoma.yaml |
84.4% | 85.0% | 119/141 | |
Acute_Post-Surgical_Pain.yaml |
84.4% | 86.2% | 92/109 | |
Q_Fever.yaml |
84.4% | 85.4% | 65/77 | |
Small_Intestinal_Bacterial_Overgrowth.yaml |
84.4% | 86.7% | 65/77 | |
Autosomal_Recessive_Congenital_Ichthyosis.yaml |
84.4% | 84.9% | 271/321 | |
Dysostosis_Multiplex_Ain-Naz_Type.yaml |
84.4% | 85.3% | 141/167 | |
Charcot-Marie-Tooth_Disease.yaml |
84.4% | 85.0% | 76/90 | |
Charcot-Marie-Tooth_Disease_Axonal_Type_2JJ.yaml |
84.4% | 86.4% | 76/90 | |
Lemierre_Syndrome.yaml |
84.5% | 86.8% | 87/103 | |
Resistance_to_Thyroid_Hormone_Alpha.yaml |
84.5% | 83.6% | 272/322 | 1 |
Combined_Oxidative_Phosphorylation_Deficiency_42.yaml |
84.5% | 84.0% | 98/116 | 1 |
Dilated_Cardiomyopathy_1I.yaml |
84.5% | 87.6% | 49/58 | |
Periodontal_Ehlers-Danlos_Syndrome.yaml |
84.5% | 86.0% | 98/116 | |
Scrub_Typhus.yaml |
84.5% | 86.0% | 207/245 | 1 |
Werner_Syndrome.yaml |
84.5% | 84.5% | 289/342 | 1 |
Lathosterolosis.yaml |
84.5% | 86.2% | 120/142 | |
Platelet-type_Bleeding_Disorder_19.yaml |
84.5% | 86.4% | 60/71 | |
Paraneoplastic_Pemphigus.yaml |
84.5% | 83.1% | 131/155 | 1 |
HER2_Positive_Colorectal_Cancer.yaml |
84.5% | 86.8% | 71/84 | 1 |
Ovarian_Mucinous_Carcinoma.yaml |
84.5% | 87.7% | 71/84 | |
GM1_Gangliosidosis_Type_1.yaml |
84.5% | 85.6% | 153/181 | |
Lyme_Disease.yaml |
84.5% | 85.3% | 186/220 | |
Roifman-syndrome.yaml |
84.6% | 84.6% | 104/123 | |
Hantavirus_Hemorrhagic_Fever_with_Renal_Syndrome.yaml |
84.6% | 86.3% | 219/259 | |
Rosai-Dorfman_Disease.yaml |
84.6% | 87.0% | 115/136 | |
SZT2-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
84.6% | 86.3% | 137/162 | |
G6PC3_Deficiency.yaml |
84.6% | 85.0% | 192/227 | 3 |
COX6A2-Related_COX_Deficiency.yaml |
84.6% | 87.3% | 33/39 | |
Cerebral_Palsy.yaml |
84.6% | 85.9% | 176/208 | 1 |
Congenital_Hypofibrinogenemia.yaml |
84.6% | 87.0% | 44/52 | |
Lipoid_Proteinosis.yaml |
84.6% | 86.5% | 110/130 | |
Nijmegen_Breakage_Syndrome-like_Disorder.yaml |
84.6% | 85.7% | 253/299 | |
Papillary_Thyroid_Carcinoma.yaml |
84.6% | 85.7% | 77/91 | |
SOX10_Neurocristopathy_Spectrum.yaml |
84.6% | 87.3% | 66/78 | |
Testicular_Seminoma.yaml |
84.6% | 87.4% | 88/104 | |
Thanatophoric_Dysplasia_Type_2.yaml |
84.6% | 85.3% | 176/208 | |
X-Linked_Combined_Immunodeficiency.yaml |
84.6% | 85.6% | 132/156 | |
Early-onset_Generalized_Limb-onset_Dystonia.yaml |
84.7% | 84.4% | 182/215 | |
Embryonal_Carcinoma.yaml |
84.7% | 86.7% | 138/163 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_15.yaml |
84.7% | 85.3% | 138/163 | |
Alveolar_Capillary_Dysplasia_with_Misalignment_of_Pulmonary_Veins.yaml |
84.7% | 85.6% | 116/137 | |
Hypertrophic_Cardiomyopathy_1.yaml |
84.7% | 85.2% | 232/274 | |
Developmental_And_Epileptic_Encephalopathy_46.yaml |
84.7% | 86.0% | 221/261 | |
Hypomyelinating_Leukodystrophy_27.yaml |
84.7% | 86.3% | 105/124 | |
Pica.yaml |
84.7% | 86.1% | 72/85 | |
Rocky_Mountain_Spotted_Fever.yaml |
84.7% | 85.4% | 266/314 | |
Bulimia_Nervosa.yaml |
84.7% | 85.1% | 250/295 | |
Dentin_Dysplasia_Type_II.yaml |
84.7% | 85.7% | 100/118 | |
Ellis-van_Creveld_Syndrome.yaml |
84.7% | 86.1% | 100/118 | |
MED17-Related_Disorder.yaml |
84.7% | 87.0% | 50/59 | |
Parainfluenza_Virus_Infection.yaml |
84.7% | 86.3% | 50/59 | |
PLS3-Related_X-Linked_Osteoporosis.yaml |
84.8% | 85.3% | 178/210 | |
Ring_Chromosome_20_Syndrome.yaml |
84.8% | 85.3% | 178/210 | |
Dilated_Cardiomyopathy_1O.yaml |
84.8% | 85.5% | 167/197 | |
Congenital_Sialidosis_Type_2.yaml |
84.8% | 87.5% | 39/46 | |
EAST_Syndrome.yaml |
84.8% | 86.4% | 78/92 | 1 |
Basal_Cell_Carcinoma.yaml |
84.8% | 85.4% | 145/171 | |
Wieacker_Wolff_Syndrome.yaml |
84.8% | 85.7% | 212/250 | |
Hereditary_Spastic_Paraplegia_77.yaml |
84.8% | 85.9% | 173/204 | |
DENND5A-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
84.8% | 86.1% | 201/237 | 1 |
Pyomyositis.yaml |
84.8% | 86.5% | 67/79 | |
Developmental_And_Epileptic_Encephalopathy_19.yaml |
84.8% | 86.2% | 162/191 | |
Neurodevelopmental_Disorder_with_Hypotonia_and_Speech_Delay.yaml |
84.8% | 86.3% | 190/224 | |
Cranioectodermal_Dysplasia.yaml |
84.8% | 86.5% | 179/211 | |
DGAT1_Deficiency.yaml |
84.8% | 88.2% | 56/66 | |
Lichen_Myxedematosus.yaml |
84.8% | 86.0% | 84/99 | |
Familial_Partial_Lipodystrophy.yaml |
84.9% | 86.6% | 185/218 | |
Congenital_Zika_Syndrome.yaml |
84.9% | 85.7% | 202/238 | 2 |
Hearing_Loss_Autosomal_Dominant_34_With_Or_Without_Inflammation.yaml |
84.9% | 86.8% | 101/119 | |
Influenza.yaml |
84.9% | 87.0% | 101/119 | |
Methylmalonic_Aciduria_and_Homocystinuria_cblL_Type.yaml |
84.9% | 85.7% | 101/119 | |
ZNF407-Related_Neurodevelopmental_Disorder.yaml |
84.9% | 86.4% | 174/205 | |
Mixed_Neuronal-Glial_Tumor.yaml |
84.9% | 87.5% | 73/86 | |
Proteus_syndrome.yaml |
84.9% | 86.1% | 191/225 | |
Dilated_Cardiomyopathy_1D.yaml |
84.9% | 88.1% | 45/53 | |
Dilated_Cardiomyopathy_1S.yaml |
84.9% | 88.1% | 45/53 | |
Madras_Motor_Neuron_Disease.yaml |
84.9% | 87.9% | 45/53 | |
aceruloplasminemia.yaml |
84.9% | 86.2% | 90/106 | |
Congenital_Hydrocephalus.yaml |
84.9% | 85.9% | 304/358 | |
Primrose_Syndrome.yaml |
84.9% | 86.7% | 152/179 | |
Cardiomyopathy_Dilated_2H.yaml |
84.9% | 85.7% | 107/126 | |
Cisplatin_Toxicity.yaml |
84.9% | 85.9% | 141/166 | |
Heavy_Chain_Disease.yaml |
84.9% | 85.8% | 316/372 | 1 |
USP8-related_pituitary_adenoma_4.yaml |
84.9% | 88.5% | 79/93 | |
Glaucoma.yaml |
85.0% | 85.6% | 96/113 | 1 |
Bleeding_Disorder_of_Unknown_Cause.yaml |
85.0% | 85.2% | 209/246 | |
MYH2-Related_Myopathy.yaml |
85.0% | 85.4% | 209/246 | |
Behcets_Disease.yaml |
85.0% | 86.8% | 113/133 | |
Bronchopulmonary_Dysplasia.yaml |
85.0% | 85.8% | 113/133 | |
Primary_Ciliary_Dyskinesia_9.yaml |
85.0% | 86.5% | 113/133 | |
Spondylometaphyseal_Dysplasia_with_Corneal_Dystrophy.yaml |
85.0% | 86.3% | 113/133 | |
CHOPS_Syndrome.yaml |
85.0% | 86.1% | 317/373 | |
Hemimegalencephaly.yaml |
85.0% | 86.4% | 119/140 | |
Loeys-Dietz_Syndrome.yaml |
85.0% | 85.7% | 272/320 | |
Non-24-Hour_Sleep-Wake_Rhythm_Disorder.yaml |
85.0% | 87.2% | 51/60 | |
Osteopetrosis.yaml |
85.0% | 85.9% | 221/260 | |
Platelet-type_Bleeding_Disorder_12.yaml |
85.0% | 86.1% | 102/120 | |
STAT5B_Deficiency.yaml |
85.0% | 86.0% | 176/207 | |
Necrotizing_Enterocolitis.yaml |
85.0% | 84.5% | 233/274 | 1 |
Kilquist_Syndrome.yaml |
85.0% | 85.5% | 108/127 | |
Osteogenesis_Imperfecta_Type_III.yaml |
85.0% | 86.6% | 108/127 | |
Acute_Opioid_Poisoning.yaml |
85.0% | 86.6% | 91/107 | |
Post-SSRI_Sexual_Dysfunction.yaml |
85.1% | 86.1% | 165/194 | |
Cornelia_de_Lange_Syndrome_5.yaml |
85.1% | 86.2% | 148/174 | |
Hearing_Loss_Autosomal_Dominant_75.yaml |
85.1% | 85.8% | 74/87 | |
Hereditary_Leiomyomatosis_and_Renal_Cell_Cancer.yaml |
85.1% | 86.5% | 74/87 | |
Paroxysmal_Extreme_Pain_Disorder.yaml |
85.1% | 87.1% | 74/87 | |
Action_Myoclonus-Renal_Failure_Syndrome.yaml |
85.1% | 85.9% | 131/154 | 1 |
X-linked_Chondrodysplasia_Punctata_2.yaml |
85.1% | 86.2% | 131/154 | |
Congenital_Central_Hypoventilation_Syndrome.yaml |
85.1% | 85.9% | 97/114 | |
MED13_Syndrome.yaml |
85.1% | 85.5% | 291/342 | 1 |
Monilethrix.yaml |
85.1% | 86.9% | 97/114 | |
Superior_Mesenteric_Artery_Syndrome.yaml |
85.1% | 85.8% | 160/188 | 1 |
MHC_Class_II_Deficiency.yaml |
85.1% | 86.2% | 252/296 | |
Malignant_Atrophic_Papulosis.yaml |
85.1% | 86.8% | 63/74 | |
Immunoskeletal_Dysplasia_with_Neurodevelopmental_Abnormalities.yaml |
85.1% | 86.2% | 258/303 | |
Vitamin_D-Dependent_Rickets_Type_2A.yaml |
85.2% | 85.3% | 195/229 | 1 |
Kashin-Beck_Disease.yaml |
85.2% | 83.8% | 350/411 | 2 |
Epilepsy_with_Myoclonic_Absences.yaml |
85.2% | 86.4% | 132/155 | |
Dubin-Johnson_Syndrome.yaml |
85.2% | 87.5% | 46/54 | |
HAO1-Related_Glycolate_Oxidase_Deficiency.yaml |
85.2% | 89.0% | 23/27 | |
MED27-Related_Disorder.yaml |
85.2% | 87.9% | 46/54 | |
Nizon-Isidor_Syndrome.yaml |
85.2% | 87.9% | 46/54 | |
Sjogren-Larsson_Syndrome.yaml |
85.2% | 86.6% | 138/162 | |
Tall_Stature-Intellectual_Disability-Renal_Anomalies_Syndrome.yaml |
85.2% | 87.1% | 69/81 | |
X-linked_Lymphoproliferative_Disease_Due_To_SH2D1A_Deficiency.yaml |
85.2% | 86.1% | 167/196 | |
SLC25A12-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
85.2% | 86.6% | 144/169 | 1 |
Congenital_Myasthenic_Syndrome_7.yaml |
85.2% | 86.3% | 121/142 | |
CAGSSS_Syndrome.yaml |
85.2% | 85.9% | 271/318 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_77.yaml |
85.2% | 85.9% | 173/203 | |
Dilated_Cardiomyopathy_1X.yaml |
85.2% | 86.5% | 75/88 | |
Intellectual_Disability_Autosomal_Dominant_34.yaml |
85.2% | 85.5% | 231/271 | 2 |
Esophageal_Carcinoma.yaml |
85.2% | 85.8% | 104/122 | |
Spirillary_Rat-Bite_Fever.yaml |
85.2% | 86.4% | 52/61 | |
Tay-Sachs_Disease_AB_Variant.yaml |
85.2% | 87.9% | 52/61 | |
Alagille_syndrome.yaml |
85.3% | 86.1% | 237/278 | 2 |
ADCA-DN.yaml |
85.3% | 85.9% | 272/319 | |
Charcot-Marie-Tooth_Disease_Dominant_Intermediate_B.yaml |
85.3% | 85.8% | 110/129 | |
Combined_Immunodeficiency_Due_To_GINS1_Deficiency.yaml |
85.3% | 86.1% | 139/163 | |
Hereditary_Spastic_Paraplegia_5A.yaml |
85.3% | 86.0% | 87/102 | |
MTHFD1_Deficiency.yaml |
85.3% | 86.0% | 145/170 | |
SLC26A1-Related_Oxalate_Transporter_Deficiency.yaml |
85.3% | 89.0% | 29/34 | |
POLR-Related_Leukodystrophy.yaml |
85.3% | 86.8% | 267/313 | |
Centronuclear_Myopathy.yaml |
85.3% | 86.9% | 180/211 | |
Hypermobile_Ehlers-Danlos_Syndrome.yaml |
85.3% | 85.5% | 180/211 | 2 |
Keratosis_Follicularis_Spinulosa_Decalvans.yaml |
85.3% | 87.0% | 151/177 | |
Mixed_Phenotype_Acute_Leukemia.yaml |
85.3% | 86.8% | 314/368 | |
Colon_Adenocarcinoma.yaml |
85.3% | 85.4% | 128/150 | 1 |
SYT1_Baker-Gordon_Syndrome.yaml |
85.3% | 87.8% | 64/75 | |
H_Syndrome.yaml |
85.3% | 86.9% | 163/191 | |
Neurodevelopmental_Disorder_with_Microcephaly_Hypotonia_and_Absent_Language.yaml |
85.4% | 87.5% | 134/157 | |
Staphylococcal_Scalded_Skin_Syndrome.yaml |
85.4% | 85.9% | 169/198 | |
Autosomal_Dominant_Aplasia_And_Myelodysplasia.yaml |
85.4% | 85.5% | 70/82 | |
BBOX1-Related_Carnitine_Biosynthesis_Deficiency.yaml |
85.4% | 85.9% | 140/164 | |
Good_Syndrome.yaml |
85.4% | 86.1% | 105/123 | |
Hepatitis_A.yaml |
85.4% | 86.7% | 70/82 | |
Neuralgic_Amyotrophy.yaml |
85.4% | 85.5% | 105/123 | |
RCBTB1-Related_Retinopathy.yaml |
85.4% | 88.3% | 70/82 | |
Autosomal_Dominant_Polycystic_Liver_Disease.yaml |
85.4% | 85.2% | 286/335 | 1 |
Dieulafoy_Lesion.yaml |
85.4% | 87.1% | 41/48 | |
Odontochondrodysplasia.yaml |
85.4% | 86.6% | 123/144 | |
Pneumocystis_Pneumonia.yaml |
85.4% | 86.2% | 41/48 | |
Cogan_Syndrome.yaml |
85.4% | 86.3% | 170/199 | |
Formaldehyde_Poisoning.yaml |
85.4% | 86.6% | 276/323 | |
Asthma.yaml |
85.5% | 84.6% | 417/488 | 5 |
Cataract_13_With_Adult_I_Phenotype.yaml |
85.5% | 86.7% | 47/55 | |
Peroxisome_Biogenesis_Disorder_8B.yaml |
85.5% | 86.4% | 141/165 | |
Rubinstein-Taybi_Syndrome.yaml |
85.5% | 87.1% | 141/165 | |
Trisomy_13.yaml |
85.5% | 87.8% | 47/55 | |
FG_Syndrome_1.yaml |
85.5% | 86.7% | 341/399 | |
Delpire-McNeill_Syndrome.yaml |
85.5% | 86.8% | 106/124 | |
Pearson_Syndrome.yaml |
85.5% | 87.4% | 53/62 | |
Neurodevelopmental_Disorder_with_Hypotonia_Feeding_Difficulties_Facial_Dysmorphism_and_Brain_Abnormalities.yaml |
85.5% | 86.7% | 218/255 | |
Primary_Coenzyme_Q10_Deficiency.yaml |
85.5% | 87.6% | 224/262 | |
Ehlers-Danlos_Syndrome.yaml |
85.5% | 84.6% | 230/269 | 1 |
TMEM165-Congenital_Disorder_of_Glycosylation.yaml |
85.5% | 86.4% | 301/352 | |
Purine_Nucleoside_Phosphorylase_Deficiency.yaml |
85.5% | 86.6% | 183/214 | |
Hypomyelinating_Leukodystrophy_15.yaml |
85.5% | 86.5% | 124/145 | |
Charcot-Marie-Tooth_Disease_Axonal_Type_2S.yaml |
85.5% | 86.0% | 130/152 | |
SLC12A5-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
85.6% | 87.5% | 166/194 | |
ER_Positive_Breast_Cancer.yaml |
85.6% | 87.5% | 89/104 | 1 |
EYA1-Related_Branchiootorenal_Spectrum.yaml |
85.6% | 86.6% | 184/215 | |
POT1_Tumor_Predisposition_Syndrome.yaml |
85.6% | 86.5% | 95/111 | |
Optic_Atrophy_3.yaml |
85.6% | 86.7% | 107/125 | |
Bacterial_Vaginosis.yaml |
85.6% | 85.3% | 220/257 | 1 |
Ehlers-Danlos_Syndrome_COL5A1-related.yaml |
85.6% | 86.6% | 113/132 | |
Kleefstra_Syndrome.yaml |
85.6% | 87.7% | 113/132 | |
Mandibulofacial_Dysostosis_with_Microcephaly.yaml |
85.6% | 86.9% | 113/132 | |
Self-Limited_Epilepsy_with_Centrotemporal_Spikes.yaml |
85.6% | 86.3% | 113/132 | 1 |
SPTAN1-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
85.6% | 87.0% | 125/146 | |
Spondyloepimetaphyseal_Dysplasia_Short_Limb_Abnormal_Calcification_Syndrome.yaml |
85.6% | 86.3% | 125/146 | |
Ritscher-Schinzel_Syndrome.yaml |
85.6% | 87.7% | 149/174 | |
Byssinosis.yaml |
85.6% | 85.9% | 155/181 | |
Immunodeficiency_88.yaml |
85.7% | 86.0% | 215/251 | |
Adenoid_Cystic_Carcinoma.yaml |
85.7% | 86.9% | 174/203 | |
CERKL-Related_Retinopathy.yaml |
85.7% | 88.1% | 54/63 | |
Charcot-Marie-Tooth_Disease_Type_X.yaml |
85.7% | 87.2% | 168/196 | |
Chromosome_17q12_Deletion_Syndrome.yaml |
85.7% | 86.4% | 156/182 | |
DEF6_Deficiency.yaml |
85.7% | 87.5% | 96/112 | |
Dilated_Cardiomyopathy_1HH.yaml |
85.7% | 88.6% | 54/63 | |
Familial_Hyperaldosteronism_Type_I.yaml |
85.7% | 86.2% | 120/140 | |
Glanders.yaml |
85.7% | 86.4% | 60/70 | |
Hereditary_Sensory_and_Autonomic_Neuropathy_Type_1A.yaml |
85.7% | 86.3% | 192/224 | |
Hypoplasminogenemia.yaml |
85.7% | 87.0% | 78/91 | 1 |
Immunodeficiency_15A.yaml |
85.7% | 86.3% | 126/147 | |
Kanzaki_Disease.yaml |
85.7% | 88.2% | 54/63 | |
Keratosis_Pilaris_Atrophicans.yaml |
85.7% | 87.6% | 96/112 | |
Metatropic_Dysplasia.yaml |
85.7% | 87.5% | 114/133 | |
Microscopic_Polyangiitis.yaml |
85.7% | 87.2% | 150/175 | |
PET117-Related_COX_Deficiency.yaml |
85.7% | 88.2% | 30/35 | |
Rhabdoid_Tumor_Predisposition_Syndrome_1.yaml |
85.7% | 86.5% | 60/70 | |
SLC26A6-Related_Hyperoxaluria_and_Nephrolithiasis.yaml |
85.7% | 88.7% | 36/42 | |
Spondylo-megaepiphyseal-metaphyseal_Dysplasia.yaml |
85.7% | 86.8% | 114/133 | |
Stickler_Syndrome_Type_1_Nonsyndromic_Ocular.yaml |
85.7% | 86.8% | 120/140 | |
Streptobacillary_Rat-Bite_Fever.yaml |
85.7% | 87.1% | 54/63 | |
Thymic_Carcinoma.yaml |
85.7% | 87.5% | 108/126 | |
Vein_of_Galen_Aneurysm.yaml |
85.7% | 84.7% | 174/203 | 2 |
erythromelalgia.yaml |
85.7% | 87.7% | 48/56 | |
Autosomal_Dominant_Optic_Atrophy.yaml |
85.8% | 86.2% | 181/211 | |
Deployment-Related_Constrictive_Bronchiolitis.yaml |
85.8% | 86.8% | 169/197 | |
KDM1A-Related_Neurodevelopmental_Disorder.yaml |
85.8% | 87.9% | 127/148 | |
Pelvic_Organ_Prolapse.yaml |
85.8% | 86.1% | 236/275 | |
Congenital_Laryngomalacia.yaml |
85.8% | 86.1% | 109/127 | 1 |
EML1_Ribbon_Heterotopia.yaml |
85.8% | 87.3% | 103/120 | 2 |
Immunodeficiency_123_With_HPV-related_Verrucosis.yaml |
85.8% | 87.8% | 103/120 | |
Osteogenesis_Imperfecta_Type_VII.yaml |
85.8% | 86.6% | 97/113 | |
Thymic_Neuroendocrine_Carcinoma.yaml |
85.8% | 87.0% | 285/332 | |
Clouston_Syndrome.yaml |
85.8% | 87.3% | 91/106 | |
Glycogen_Storage_Disease_Due_to_Muscle_Beta-Enolase_Deficiency.yaml |
85.8% | 87.4% | 91/106 | |
Neutrophil_Immunodeficiency_Syndrome.yaml |
85.9% | 86.3% | 85/99 | |
Epilepsy.yaml |
85.9% | 87.1% | 316/368 | |
CARMIL2_Deficiency.yaml |
85.9% | 85.8% | 468/545 | |
Intellectual_Disability_Anterior_Maxillary_Protrusion_and_Strabismus.yaml |
85.9% | 87.9% | 146/170 | |
Periventricular_Nodular_Heterotopia.yaml |
85.9% | 87.2% | 146/170 | 1 |
Dilated_Cardiomyopathy_1DD.yaml |
85.9% | 88.0% | 67/78 | |
Ogden_syndrome.yaml |
85.9% | 86.8% | 128/149 | |
Platelet-type_Bleeding_Disorder_18.yaml |
85.9% | 86.5% | 61/71 | 1 |
Opsismodysplasia.yaml |
85.9% | 87.4% | 171/199 | |
Salivary_Gland_Polymorphous_Adenocarcinoma.yaml |
85.9% | 87.5% | 171/199 | |
Diamond-Blackfan_Anemia.yaml |
85.9% | 86.5% | 226/263 | |
RAB33B-Related_Smith-McCort_Dysplasia_2.yaml |
85.9% | 88.3% | 55/64 | |
RET_Rearranged_NSCLC.yaml |
85.9% | 85.5% | 165/192 | 1 |
Paroxysmal_Nocturnal_Hemoglobinuria.yaml |
86.0% | 87.8% | 104/121 | |
Perrault_Syndrome.yaml |
86.0% | 87.4% | 282/328 | |
RFT1-congenital_disorder_of_glycosylation.yaml |
86.0% | 86.9% | 141/164 | |
GNPTG-Mucolipidosis.yaml |
86.0% | 88.0% | 92/107 | |
Systemic_Mastocytosis.yaml |
86.0% | 87.3% | 135/157 | |
Mitchell-Riley_Syndrome.yaml |
86.0% | 87.1% | 178/207 | |
Seasonal_Coronavirus_Infection.yaml |
86.0% | 87.3% | 43/50 | |
15q11q13_Microduplication_Syndrome.yaml |
86.0% | 87.2% | 209/243 | |
Amatoxin_Poisoning.yaml |
86.0% | 86.2% | 209/243 | 1 |
CACNA1E-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
86.0% | 86.6% | 246/286 | |
Dilated_Cardiomyopathy_1AA.yaml |
86.0% | 87.1% | 203/236 | |
Mandibulofacial_Dysostosis_With_Alopecia.yaml |
86.0% | 87.5% | 80/93 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_39.yaml |
86.0% | 87.1% | 80/93 | |
Phosphoglycerate_Kinase_1_Deficiency.yaml |
86.0% | 87.1% | 154/179 | |
Alcoholic_Liver_Disease.yaml |
86.0% | 85.2% | 191/222 | 2 |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_79.yaml |
86.0% | 87.0% | 111/129 | |
Jet_Lag.yaml |
86.0% | 86.6% | 74/86 | |
Severe_Neonatal-Onset_Encephalopathy_With_Microcephaly.yaml |
86.1% | 86.5% | 401/466 | |
BEST1_Bestrophinopathies.yaml |
86.1% | 86.2% | 253/294 | |
Anaerobic_Pneumonia.yaml |
86.1% | 86.2% | 105/122 | 1 |
Dilated_Cardiomyopathy_1V.yaml |
86.1% | 86.5% | 105/122 | |
Chromosome_2q32-q33_Deletion_Syndrome.yaml |
86.1% | 87.8% | 173/201 | |
MSTO1-Related_Mitochondrial_Myopathy.yaml |
86.1% | 87.1% | 266/309 | 2 |
Charcot-Marie-Tooth_Disease_Dominant_Intermediate_E.yaml |
86.1% | 86.8% | 130/151 | |
Infantile_Liver_Failure_Syndrome_1.yaml |
86.1% | 87.2% | 130/151 | |
COX11-Related_COX_Deficiency.yaml |
86.1% | 88.9% | 31/36 | |
Optic_Atrophy_13_With_Retinal_And_Foveal_Abnormalities.yaml |
86.1% | 87.3% | 93/108 | |
Rhizomelic_Chondrodysplasia_Punctata_Type_5.yaml |
86.1% | 87.7% | 93/108 | |
Chronic_Mucocutaneous_Candidiasis.yaml |
86.1% | 87.2% | 329/382 | |
Immunodeficiency_67.yaml |
86.1% | 86.6% | 118/137 | 1 |
Choroideremia-Deafness-Obesity_Syndrome.yaml |
86.1% | 87.8% | 87/101 | |
Hemophilia.yaml |
86.1% | 87.0% | 87/101 | |
Allan-Herndon-Dudley_Syndrome.yaml |
86.1% | 86.6% | 286/332 | |
Autosomal_Dominant_Progressive_External_Ophthalmoplegia.yaml |
86.1% | 87.0% | 342/397 | |
Dilated_Cardiomyopathy_1G.yaml |
86.2% | 88.9% | 56/65 | |
Floating-Harbor_syndrome.yaml |
86.2% | 88.7% | 56/65 | |
Prolidase_Deficiency.yaml |
86.2% | 88.0% | 193/224 | |
Intellectual_Disability_X-linked_100.yaml |
86.2% | 87.0% | 137/159 | |
Urea_Cycle_Disorder.yaml |
86.2% | 86.7% | 218/253 | 1 |
Multiple_Mitochondrial_Dysfunctions_Syndrome_2.yaml |
86.2% | 86.9% | 162/188 | |
Dilated_Cardiomyopathy_1E.yaml |
86.2% | 89.2% | 50/58 | |
Hailey-Hailey_Disease.yaml |
86.2% | 87.8% | 75/87 | 1 |
Hereditary_Arterial_and_Articular_Multiple_Calcification_Syndrome.yaml |
86.2% | 87.9% | 75/87 | 1 |
Spondylometaphyseal_Dysplasia_with_Cone-Rod_Dystrophy.yaml |
86.2% | 87.9% | 100/116 | |
TUBA8-related_Polymicrogyria_with_Optic_Nerve_Hypoplasia.yaml |
86.2% | 86.9% | 100/116 | |
Chuvash_Polycythemia.yaml |
86.2% | 86.7% | 188/218 | |
HHAT-Related_Chondrodysplasia_with_46XY_Disorder_of_Sex_Development.yaml |
86.2% | 87.3% | 163/189 | |
Agoraphobia.yaml |
86.2% | 86.9% | 69/80 | |
Huntington_Disease-like_2.yaml |
86.2% | 87.0% | 69/80 | |
Patent_Ductus_Arteriosus_3.yaml |
86.3% | 86.5% | 182/211 | |
Restrictive_Cardiomyopathy.yaml |
86.3% | 88.0% | 157/182 | |
Distal_Hereditary_Motor_Neuronopathy_Type_9.yaml |
86.3% | 87.5% | 88/102 | |
GPR101-related_pituitary_adenoma_2.yaml |
86.3% | 88.6% | 88/102 | |
LRBA_Deficiency.yaml |
86.3% | 88.8% | 88/102 | |
Methanol_Poisoning.yaml |
86.3% | 88.2% | 132/153 | |
SCO1-Related_COX_Deficiency.yaml |
86.3% | 88.7% | 44/51 | |
Cartilage-Hair_Hypoplasia.yaml |
86.3% | 86.3% | 384/445 | |
Niemann-Pick_Disease_Type_B.yaml |
86.3% | 88.5% | 63/73 | |
Spondylometaphyseal_Dysplasia_Corner_Fracture_Type.yaml |
86.3% | 87.6% | 145/168 | |
Rhinoscleroma.yaml |
86.3% | 87.9% | 82/95 | |
Giant_Axonal_Neuropathy_1.yaml |
86.3% | 87.2% | 221/256 | |
Mediator_Complex_Neurodevelopmental_Disorder.yaml |
86.3% | 86.7% | 398/461 | 1 |
Combined_Oxidative_Phosphorylation_Deficiency_36.yaml |
86.3% | 87.6% | 158/183 | |
Bone_Marrow_Failure_Syndrome_6.yaml |
86.4% | 87.0% | 114/132 | |
Calvarial_Doughnut_Lesions-bone_Fragility_Syndrome.yaml |
86.4% | 87.4% | 133/154 | |
Cervical_Artery_Dissection.yaml |
86.4% | 87.6% | 57/66 | |
Panuveitis.yaml |
86.4% | 87.6% | 76/88 | 1 |
Paratyphoid_Fever.yaml |
86.4% | 87.2% | 76/88 | |
Tularemia.yaml |
86.4% | 86.7% | 114/132 | |
Cardiofacioneurodevelopmental_Syndrome.yaml |
86.4% | 86.8% | 317/367 | |
Odonto-Onycho-Dermal_Dysplasia.yaml |
86.4% | 88.2% | 127/147 | |
Cardiac_Valvular_Ehlers-Danlos_Syndrome.yaml |
86.4% | 87.6% | 197/228 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_28.yaml |
86.4% | 87.2% | 140/162 | |
Retinitis_Pigmentosa_59.yaml |
86.4% | 87.3% | 210/243 | |
Chromosome_Xq_Duplication.yaml |
86.4% | 87.8% | 255/295 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_3.yaml |
86.4% | 86.6% | 153/177 | |
Neuromuscular_Disease_And_Ocular_Or_Auditory_Anomalies_With_Or_Without_Seizures.yaml |
86.4% | 87.2% | 102/118 | |
Complement_Component_2_Deficiency.yaml |
86.5% | 88.3% | 83/96 | |
Immunodeficiency_Common_Variable_4.yaml |
86.5% | 88.1% | 83/96 | |
Ovarian_Endometrioid_Carcinoma.yaml |
86.5% | 88.2% | 83/96 | |
Muscular_Dystrophy_Limb-girdle_Autosomal_Recessive_28.yaml |
86.5% | 87.3% | 179/207 | |
Nevus_of_Ota.yaml |
86.5% | 88.6% | 64/74 | |
Spinocerebellar_Ataxia_Type_1.yaml |
86.5% | 86.8% | 269/311 | |
WWOX-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
86.5% | 87.9% | 205/237 | |
Celiac_Disease.yaml |
86.5% | 87.1% | 276/319 | |
COX16-Related_COX_Deficiency.yaml |
86.5% | 88.7% | 45/52 | |
Chronic_Granulomatous_Disease.yaml |
86.5% | 87.5% | 180/208 | |
Hypercholanemia_Familial_2.yaml |
86.5% | 87.4% | 90/104 | |
Nestor-Guillermo_progeria_syndrome.yaml |
86.5% | 88.7% | 45/52 | |
Osteogenesis_Imperfecta_Type_V.yaml |
86.5% | 88.8% | 90/104 | |
Rotor_Syndrome.yaml |
86.5% | 88.9% | 45/52 | |
B4GALT1-Congenital_Disorder_of_Glycosylation.yaml |
86.5% | 87.3% | 148/171 | 1 |
Synovial_Sarcoma.yaml |
86.6% | 86.2% | 103/119 | 1 |
Autoimmune_Lymphoproliferative_Syndrome.yaml |
86.6% | 87.9% | 58/67 | |
Dementia_with_Lewy_Bodies.yaml |
86.6% | 87.0% | 58/67 | |
ZRS-Related_Limb_Malformation.yaml |
86.6% | 87.8% | 174/201 | |
Abetalipoproteinemia.yaml |
86.6% | 87.5% | 303/350 | |
CDKL5_Deficiency_Disorder.yaml |
86.6% | 87.1% | 400/462 | 1 |
Hereditary_Hyperekplexia.yaml |
86.6% | 87.9% | 200/231 | |
CAMLG-CDG.yaml |
86.6% | 87.3% | 213/246 | |
Leiomyosarcoma.yaml |
86.6% | 88.3% | 71/82 | |
Sulfur_Mustard_Poisoning.yaml |
86.6% | 87.6% | 284/328 | |
Epidermolytic_Hyperkeratosis_2.yaml |
86.6% | 87.3% | 168/194 | 1 |
FLT3_Mutant_AML.yaml |
86.6% | 88.6% | 97/112 | |
Familial_Congenital_Mirror_Movements.yaml |
86.6% | 88.4% | 97/112 | |
Microcephaly_Short_Stature_and_Impaired_Glucose_Metabolism_2.yaml |
86.6% | 87.9% | 194/224 | |
Craniometaphyseal_Dysplasia.yaml |
86.6% | 87.7% | 246/284 | |
Lennox-Gastaut_Syndrome.yaml |
86.6% | 86.3% | 214/247 | 1 |
DEGCAGS_Syndrome.yaml |
86.6% | 87.4% | 344/397 | |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_68.yaml |
86.7% | 86.7% | 182/210 | 1 |
COX18-Related_COX_Deficiency.yaml |
86.7% | 89.1% | 39/45 | |
Cholesteryl_Ester_Storage_Disease.yaml |
86.7% | 89.3% | 52/60 | |
Hypertrophic_Cardiomyopathy_11.yaml |
86.7% | 89.6% | 52/60 | |
Intellectual_Developmental_Disorder_X-linked_114.yaml |
86.7% | 87.1% | 208/240 | |
Isolated_Growth_Hormone_Deficiency_Type_IA.yaml |
86.7% | 85.4% | 78/90 | 2 |
Long-Chain_3-Hydroxyacyl-CoA_Dehydrogenase_Deficiency.yaml |
86.7% | 88.0% | 182/210 | |
Long_QT_Syndrome.yaml |
86.7% | 87.4% | 299/345 | 4 |
Reversible_Infantile_Cytochrome_c_Oxidase_Deficiency.yaml |
86.7% | 88.3% | 65/75 | |
TEX11-related_spermatogenic_failure.yaml |
86.7% | 88.8% | 65/75 | |
8p_Inverted_Duplication_Deletion_Syndrome.yaml |
86.7% | 87.7% | 306/353 | |
Congenital_Heart_Defects_and_Skeletal_Malformations_Syndrome.yaml |
86.7% | 87.8% | 254/293 | |
Leukoencephalopathy_With_Vanishing_White_Matter.yaml |
86.7% | 86.7% | 202/233 | 4 |
Familial_Nonmedullary_Thyroid_Carcinoma.yaml |
86.7% | 87.3% | 333/384 | |
Keratoconus.yaml |
86.7% | 87.3% | 196/226 | 1 |
Hajdu-Cheney_Syndrome.yaml |
86.7% | 88.6% | 85/98 | |
Griscelli_Syndrome_Type_2.yaml |
86.7% | 88.9% | 72/83 | |
Spondylocarpotarsal_Synostosis_Syndrome.yaml |
86.8% | 88.3% | 131/151 | |
Charcot-Marie-Tooth_Disease_Type_4D.yaml |
86.8% | 87.5% | 249/287 | |
Multiple_Mitochondrial_Dysfunctions_Syndrome_1.yaml |
86.8% | 87.1% | 177/204 | 1 |
Neuronal_Ceroid_Lipofuscinosis_1.yaml |
86.8% | 89.4% | 59/68 | |
UCHL1-Related_Neurodegeneration_with_Optic_Atrophy_and_Spastic_Paraplegia.yaml |
86.8% | 87.7% | 223/257 | |
TUBB4A-related_Neurologic_Disorder.yaml |
86.8% | 87.5% | 210/242 | |
Hypereosinophilic_Syndrome.yaml |
86.8% | 88.4% | 151/174 | |
Brody_Myopathy.yaml |
86.8% | 86.2% | 276/318 | 1 |
Darier_Disease.yaml |
86.8% | 88.6% | 92/106 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_35.yaml |
86.8% | 87.2% | 158/182 | |
GUCY2D-Related_Retinopathy.yaml |
86.8% | 89.6% | 79/91 | |
Histiocytoid_Cardiomyopathy.yaml |
86.8% | 86.8% | 237/273 | 1 |
Omphalocele.yaml |
86.8% | 88.0% | 79/91 | |
White-Sutton_Syndrome.yaml |
86.8% | 87.8% | 237/273 | |
Liposarcoma.yaml |
86.8% | 88.0% | 112/129 | |
Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml |
86.8% | 87.3% | 211/243 | 1 |
Atrial_Standstill.yaml |
86.8% | 88.2% | 165/190 | |
FLVCR1-Related_Retinopathy.yaml |
86.8% | 89.3% | 66/76 | |
Hepatosplenic_T_Cell_Lymphoma.yaml |
86.8% | 88.5% | 99/114 | |
Selective_IgM_Deficiency.yaml |
86.8% | 88.7% | 66/76 | |
Nasu-Hakola_Disease.yaml |
86.9% | 88.3% | 152/175 | |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_3A.yaml |
86.9% | 87.9% | 119/137 | |
MICPCH_Syndrome.yaml |
86.9% | 87.8% | 238/274 | |
SLC1A2-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
86.9% | 87.6% | 172/198 | 2 |
Congenital_Hypomyelinating_Neuropathy.yaml |
86.9% | 88.1% | 106/122 | |
Distal_Hereditary_Motor_Neuronopathy_Autosomal_Dominant.yaml |
86.9% | 88.1% | 159/183 | |
Orofaciodigital_Syndrome_17.yaml |
86.9% | 89.6% | 53/61 | |
BPTF-Related_Neurodevelopmental_Disorder.yaml |
86.9% | 87.6% | 338/389 | 1 |
HCN1-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
86.9% | 89.6% | 73/84 | |
IGF1_Deficiency.yaml |
86.9% | 88.8% | 73/84 | |
Polycythemia_Vera.yaml |
86.9% | 87.8% | 146/168 | 1 |
Lethal_Polymalformative_Syndrome_Boissel_Type.yaml |
86.9% | 88.0% | 239/275 | |
Neonatal_Diabetes_Mellitus_With_Congenital_Hypothyroidism.yaml |
86.9% | 88.0% | 206/237 | |
FBXL4-Related_Mitochondrial_DNA_Depletion_Syndrome.yaml |
86.9% | 87.4% | 346/398 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_1.yaml |
86.9% | 87.3% | 193/222 | |
Weill-Marchesani_Syndrome.yaml |
86.9% | 87.4% | 253/291 | |
Dilated_Cardiomyopathy_1R.yaml |
87.0% | 87.5% | 140/161 | |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_25.yaml |
87.0% | 87.6% | 167/192 | |
Anauxetic_Dysplasia.yaml |
87.0% | 88.4% | 214/246 | |
Shashi-Pena_Syndrome.yaml |
87.0% | 88.7% | 107/123 | |
Paranasal_Sinus_Squamous_Cell_Carcinoma.yaml |
87.0% | 88.7% | 87/100 | |
Complex_Hereditary_Spastic_Paraplegia.yaml |
87.0% | 88.1% | 469/539 | |
Fragile_X-Associated_Tremor_Ataxia_Syndrome.yaml |
87.0% | 88.6% | 134/154 | |
Hepatitis_D.yaml |
87.0% | 88.5% | 67/77 | |
Myocarditis.yaml |
87.0% | 87.5% | 275/316 | |
LETM1-Related_Childhood-Onset_Neurodegeneration.yaml |
87.0% | 88.2% | 235/270 | |
SETD1A-Related_Early-Onset_Epilepsy.yaml |
87.0% | 87.6% | 141/162 | |
Dilated_Cardiomyopathy_1GG.yaml |
87.1% | 87.9% | 121/139 | |
Short_QT_Syndrome.yaml |
87.1% | 87.9% | 121/139 | |
Hypopigmentation_Organomegaly_And_Delayed_Myelination_And_Development.yaml |
87.1% | 87.7% | 148/170 | |
Primary_Ciliary_Dyskinesia_30.yaml |
87.1% | 88.1% | 148/170 | |
Melanoma_in_Congenital_Melanocytic_Nevus.yaml |
87.1% | 86.3% | 128/147 | 2 |
Gastric_Adenocarcinoma.yaml |
87.1% | 87.6% | 364/418 | |
Gnathodiaphyseal_Dysplasia.yaml |
87.1% | 87.5% | 236/271 | 1 |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_4B.yaml |
87.1% | 87.7% | 108/124 | |
Buruli_Ulcer.yaml |
87.1% | 85.9% | 54/62 | |
COX8A-Related_COX_Deficiency.yaml |
87.1% | 90.3% | 27/31 | |
Narcolepsy-Cataplexy_Syndrome.yaml |
87.1% | 88.7% | 81/93 | |
Dilated_Cardiomyopathy_1A.yaml |
87.1% | 87.5% | 345/396 | |
Dilated_Cardiomyopathy_1U.yaml |
87.1% | 87.8% | 115/132 | |
Marfan_Syndrome.yaml |
87.1% | 86.7% | 264/303 | 2 |
Progressive_Myoclonic_Epilepsy_Type_7.yaml |
87.1% | 89.4% | 88/101 | |
THOC2-Related_Intellectual_Disability.yaml |
87.1% | 87.7% | 237/272 | |
Prader-Willi_Syndrome.yaml |
87.1% | 87.6% | 210/241 | |
Rumination_Disorder.yaml |
87.1% | 88.3% | 61/70 | |
Dilated_Cardiomyopathy_1FF.yaml |
87.2% | 88.5% | 156/179 | |
Vascular_Ehlers-Danlos_Syndrome.yaml |
87.2% | 88.3% | 95/109 | |
Hypomyelinating_Leukodystrophy_12.yaml |
87.2% | 88.3% | 102/117 | |
Immunodeficiency_105.yaml |
87.2% | 88.8% | 68/78 | |
Neurodevelopmental_Disorder_with_Severe_Motor_Impairment_and_Absent_Language.yaml |
87.2% | 88.5% | 136/156 | |
Paroxysmal_Familial_Ventricular_Fibrillation.yaml |
87.2% | 90.9% | 68/78 | |
Primary_Triglyceride_Deposit_Cardiomyovasculopathy.yaml |
87.2% | 91.0% | 34/39 | |
Myasthenia_Gravis.yaml |
87.2% | 88.3% | 211/242 | |
SPTBN4-Related_Neurodevelopmental_Disorder.yaml |
87.2% | 88.8% | 286/328 | |
Aromatic_L_Amino_Acid_Decarboxylase_Deficiency.yaml |
87.2% | 87.3% | 368/422 | |
Dentici-Novelli_neurodevelopmental_syndrome.yaml |
87.2% | 89.2% | 75/86 | |
TUBA4A-related_Disorder.yaml |
87.2% | 88.2% | 75/86 | |
Simpson-Golabi-Behmel_Syndrome_Type_1.yaml |
87.2% | 88.5% | 116/133 | |
LIFR-Related_Stuve-Wiedemann_Syndrome.yaml |
87.2% | 88.4% | 198/227 | 1 |
Combined_Oxidative_Phosphorylation_Deficiency_28.yaml |
87.2% | 87.9% | 123/141 | |
Diethylene_Glycol_Poisoning.yaml |
87.2% | 88.2% | 164/188 | |
Juvenile_Paget_Disease.yaml |
87.2% | 88.3% | 164/188 | |
Spinal_Muscular_Atrophy_with_Respiratory_Distress_Type_1.yaml |
87.2% | 89.3% | 82/94 | |
Cone-rod_Dystrophy_And_Hearing_Loss_1.yaml |
87.3% | 88.1% | 89/102 | |
Otofacial_Neurodevelopmental_Syndrome.yaml |
87.3% | 89.2% | 178/204 | |
TRIM28-Related_Wilms_Tumor_Predisposition.yaml |
87.3% | 87.8% | 89/102 | |
TRIO-Related_Neurodevelopmental_Disorder.yaml |
87.3% | 90.0% | 89/102 | |
Obesity.yaml |
87.3% | 88.3% | 185/212 | |
Temple-Baraitser_Syndrome.yaml |
87.3% | 88.8% | 144/165 | |
Neurodevelopmental_Disorder_with_Epilepsy_Spasticity_and_Brain_Atrophy.yaml |
87.3% | 88.2% | 295/338 | |
Pelger-Huet-like_Anomaly_And_Episodic_Fever_With_Abdominal_Pain.yaml |
87.3% | 88.5% | 158/181 | |
PIK3CA_Mutant_Breast_Cancer.yaml |
87.3% | 91.0% | 55/63 | |
Autosomal_Recessive_Robinow_Syndrome.yaml |
87.3% | 88.1% | 413/473 | 1 |
HNRNPU-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
87.3% | 88.3% | 179/205 | |
Koolen_de_Vries_syndrome.yaml |
87.3% | 89.5% | 62/71 | |
Avascular_Necrosis_Of_Femoral_Head_Primary_2.yaml |
87.3% | 87.0% | 138/158 | |
Bietti_Crystalline_Dystrophy.yaml |
87.3% | 89.8% | 69/79 | |
FLNC-Related_Dilated_Cardiomyopathy.yaml |
87.3% | 90.9% | 69/79 | |
Fragile_X-Associated_Primary_Ovarian_Insufficiency.yaml |
87.3% | 88.9% | 138/158 | |
Esophageal_Squamous_Cell_Carcinoma.yaml |
87.3% | 88.4% | 145/166 | |
Black_Widow_Spider_Envenomation.yaml |
87.4% | 88.0% | 152/174 | |
Acute_Motor_and_Sensory_Axonal_Neuropathy.yaml |
87.4% | 88.1% | 235/269 | |
Intracranial_Berry_Aneurysm.yaml |
87.4% | 90.0% | 83/95 | |
Aniridia.yaml |
87.4% | 90.3% | 173/198 | |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_17.yaml |
87.4% | 88.2% | 90/103 | |
LPIN1-Related_Recurrent_Myoglobinuria.yaml |
87.4% | 87.1% | 180/206 | 2 |
McKusick-Kaufman_Syndrome.yaml |
87.4% | 88.9% | 90/103 | |
CINCA_Syndrome.yaml |
87.4% | 87.6% | 277/317 | 2 |
Mitochondrial_DNA_Depletion_Syndrome_Myopathic_Form.yaml |
87.4% | 87.4% | 305/349 | |
Ischemic_Stroke.yaml |
87.4% | 88.9% | 104/119 | |
Adamantinoma.yaml |
87.4% | 88.1% | 111/127 | 1 |
Hypertrophic_Cardiomyopathy_15.yaml |
87.4% | 88.2% | 111/127 | |
Weiss-Kruszka_Syndrome.yaml |
87.4% | 89.0% | 118/135 | |
Corneal_Dystrophy.yaml |
87.4% | 88.9% | 132/151 | |
Complex_Regional_Pain_Syndrome_Type_1.yaml |
87.4% | 87.9% | 139/159 | |
Down_syndrome.yaml |
87.4% | 88.3% | 146/167 | |
RARB-related_syndromic_microphthalmia.yaml |
87.4% | 89.0% | 174/199 | |
Central_Core_Myopathy.yaml |
87.4% | 88.7% | 181/207 | |
SAPHO_Syndrome.yaml |
87.4% | 87.5% | 209/239 | 2 |
Idiopathic_Multicentric_Castleman_Disease.yaml |
87.5% | 88.0% | 335/383 | |
Blepharophimosis-Impaired_Intellectual_Development_Syndrome.yaml |
87.5% | 89.4% | 105/120 | |
Cardiofaciocutaneous_Syndrome.yaml |
87.5% | 88.8% | 119/136 | |
Chronic_Pancreatitis.yaml |
87.5% | 87.9% | 91/104 | |
Combined_Immunodeficiency_Due_To_DOCK8_Deficiency.yaml |
87.5% | 88.2% | 273/312 | |
Craniofacial_Microsomia.yaml |
87.5% | 88.6% | 245/280 | |
Dorsalgia.yaml |
87.5% | 100.0% | 7/8 | |
E-Cigarette_or_Vaping_Product_Use-Associated_Lung_Injury.yaml |
87.5% | 88.6% | 105/120 | |
Leigh_Syndrome.yaml |
87.5% | 89.2% | 147/168 | |
Lichen_Simplex_Chronicus.yaml |
87.5% | 100.0% | 7/8 | |
MED13L_Syndrome.yaml |
87.5% | 87.4% | 329/376 | 1 |
Postinfectious_Vasculitis.yaml |
87.5% | 90.3% | 77/88 | |
Schwannoma.yaml |
87.5% | 89.2% | 98/112 | |
UBA5-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
87.5% | 89.0% | 175/200 | |
Uveitis.yaml |
87.5% | 88.4% | 154/176 | 1 |
Advanced_Sleep_Phase_Syndrome.yaml |
87.5% | 87.3% | 316/361 | 2 |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_50.yaml |
87.6% | 86.6% | 211/241 | 1 |
Xeroderma_Pigmentosum.yaml |
87.6% | 88.2% | 176/201 | |
GUCA1A-Related_Retinopathy.yaml |
87.6% | 88.5% | 141/161 | |
Dientamoebiasis.yaml |
87.6% | 88.9% | 134/153 | |
Epilepsy_with_Generalized_Tonic-Clonic_Seizures_Alone.yaml |
87.6% | 88.0% | 134/153 | 1 |
Glanzmann_Thrombasthenia.yaml |
87.6% | 89.1% | 134/153 | |
Mayer-Rokitansky-Kuster-Hauser_Syndrome.yaml |
87.6% | 88.0% | 261/298 | |
Cori_Forbes_Disease.yaml |
87.6% | 88.7% | 120/137 | |
Argininosuccinic_Aciduria.yaml |
87.6% | 87.5% | 233/266 | |
Central_Serous_Chorioretinopathy.yaml |
87.6% | 89.6% | 106/121 | |
Left_Ventricular_Noncompaction_10.yaml |
87.6% | 87.5% | 205/234 | 1 |
Familial_Sick_Sinus_Syndrome.yaml |
87.6% | 89.1% | 99/113 | |
Hepatic_Fibrinogen_Storage_Disease.yaml |
87.6% | 89.0% | 99/113 | |
CATSHL_Syndrome.yaml |
87.6% | 88.3% | 283/323 | |
Charcot-Marie-Tooth_Disease_Recessive_Intermediate_D.yaml |
87.6% | 89.5% | 92/105 | |
Hereditary_Sensory_and_Autonomic_Neuropathy.yaml |
87.6% | 89.8% | 92/105 | |
DEE_with_Spike-Wave_Activation_in_Sleep.yaml |
87.6% | 88.9% | 149/170 | |
Congenital_Tufting_Enteropathy.yaml |
87.7% | 89.6% | 71/81 | |
COX4I1-Related_COX_Deficiency.yaml |
87.7% | 90.1% | 64/73 | |
Dissociative_Identity_Disorder.yaml |
87.7% | 89.5% | 64/73 | |
MYO6_Hearing_Loss.yaml |
87.7% | 88.1% | 64/73 | 1 |
Normal_Pressure_Hydrocephalus.yaml |
87.7% | 87.7% | 128/146 | 1 |
TUBA1A-related_Tubulinopathy.yaml |
87.7% | 88.4% | 128/146 | 2 |
Diastrophic_Dysplasia.yaml |
87.7% | 88.5% | 178/203 | |
Dyskeratosis_Congenita.yaml |
87.7% | 88.1% | 413/471 | |
Immunodeficiency_92.yaml |
87.7% | 89.0% | 114/130 | |
Loeys-Dietz_Syndrome_6.yaml |
87.7% | 88.5% | 171/195 | |
Renal_Tubular_Acidosis_Distal_2_With_Progressive_Sensorineural_Hearing_Loss.yaml |
87.7% | 88.8% | 114/130 | |
COQ4-Related_Neonatal_Encephalomyopathy.yaml |
87.7% | 88.4% | 221/252 | |
Multiple_Mitochondrial_Dysfunctions_Syndrome_5.yaml |
87.7% | 88.9% | 164/187 | |
Hereditary_Spastic_Paraplegia_44.yaml |
87.7% | 87.9% | 107/122 | |
Kariminejad_Neurodevelopmental_Syndrome.yaml |
87.7% | 88.8% | 107/122 | |
Gestational_Diabetes_Mellitus.yaml |
87.7% | 89.0% | 93/106 | |
PMM2-Congenital_Disorder_of_Glycosylation.yaml |
87.7% | 88.8% | 179/204 | |
Spinocerebellar_Ataxia_27B.yaml |
87.7% | 89.6% | 179/204 | |
GNE_Myopathy.yaml |
87.8% | 88.2% | 172/196 | |
Inborn_Disorder_of_Cobalamin_Metabolism_and_Transport.yaml |
87.8% | 89.5% | 172/196 | |
Lambert-Eaton_Myasthenic_Syndrome.yaml |
87.8% | 88.8% | 86/98 | |
NUP62-Related_Infantile_Bilateral_Striatal_Necrosis.yaml |
87.8% | 90.1% | 43/49 | |
Severe_Congenital_Neutropenia_7_Autosomal_Recessive.yaml |
87.8% | 88.7% | 122/139 | |
Sweet_Syndrome.yaml |
87.8% | 88.7% | 122/139 | |
Sea-Blue_Histiocyte_Syndrome.yaml |
87.8% | 89.5% | 79/90 | |
Combined_Oxidative_Phosphorylation_Defect_Type_37.yaml |
87.8% | 88.6% | 115/131 | |
Neonatal_Epileptic_Encephalopathy_Due_to_Glutaminase_Deficiency.yaml |
87.8% | 89.2% | 115/131 | |
CD25_Deficiency.yaml |
87.8% | 87.9% | 417/475 | 1 |
X-linked_Hypohidrotic_Ectodermal_Dysplasia.yaml |
87.8% | 88.9% | 151/172 | |
Hypertrophic_Cardiomyopathy_8.yaml |
87.8% | 88.3% | 187/213 | 1 |
Aconitine_Poisoning.yaml |
87.8% | 89.4% | 144/164 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_48.yaml |
87.8% | 87.6% | 180/205 | |
Follicular_Lymphoma.yaml |
87.8% | 88.5% | 144/164 | |
Hypertrophic_Cardiomyopathy_7.yaml |
87.8% | 88.3% | 209/238 | |
Immunodeficiency_93_and_Hypertrophic_Cardiomyopathy.yaml |
87.8% | 88.8% | 173/197 | |
Abdominal_Aortic_Aneurysm.yaml |
87.8% | 88.4% | 137/156 | |
McLeod_Neuroacanthocytosis_Syndrome.yaml |
87.8% | 89.5% | 137/156 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_93.yaml |
87.8% | 87.9% | 166/189 | 1 |
Glycogen_Storage_Disease_Type_0a.yaml |
87.8% | 88.1% | 166/189 | |
Essential_Tremor.yaml |
87.9% | 88.8% | 94/107 | |
Severe_X-linked_Intellectual_Disability_Gustavson_Type.yaml |
87.9% | 88.9% | 123/140 | |
Nipah_Virus_Disease.yaml |
87.9% | 88.2% | 152/173 | |
Diamond-Blackfan_Anemia_14_With_Mandibulofacial_Dysostosis.yaml |
87.9% | 87.8% | 210/239 | |
Astrakhan_Spotted_Fever.yaml |
87.9% | 89.7% | 58/66 | |
Clear_Cell_Ovarian_Carcinoma.yaml |
87.9% | 90.0% | 58/66 | |
Interleukin-10_Receptor_Deficiency.yaml |
87.9% | 90.0% | 58/66 | |
Pertussis.yaml |
87.9% | 88.6% | 87/99 | |
TBX6-Associated_Congenital_Scoliosis.yaml |
87.9% | 91.7% | 29/33 | |
LCA5-Related_Retinopathy.yaml |
87.9% | 91.2% | 80/91 | |
Parkinsons_Disease.yaml |
87.9% | 88.2% | 662/753 | 2 |
CYB561-Related_Orthostatic_Hypotension.yaml |
87.9% | 87.4% | 131/149 | 1 |
Hypertrophic_Cardiomyopathy_10.yaml |
88.0% | 88.3% | 219/249 | |
Cadmium_Poisoning.yaml |
88.0% | 87.9% | 336/382 | 1 |
Epilepsy_with_Myoclonic_Atonic_Seizures.yaml |
88.0% | 90.1% | 95/108 | |
Malignant_Non_Dysgerminomatous_Germ_Cell_Tumor_Of_Ovary.yaml |
88.0% | 87.9% | 117/133 | 1 |
Megacystis-Microcolon-Intestinal_Hypoperistalsis_Syndrome_2.yaml |
88.0% | 87.3% | 139/158 | 1 |
TRAPPC12-Related_Encephalopathy.yaml |
88.0% | 88.8% | 271/308 | |
DICER1_Tumor_Predisposition_Syndrome.yaml |
88.0% | 89.6% | 66/75 | |
Duchenne_Muscular_Dystrophy.yaml |
88.0% | 88.5% | 352/400 | 3 |
KRT1_Keratinopathies.yaml |
88.0% | 90.5% | 88/100 | |
Morgagni-Stewart-Morel_Syndrome.yaml |
88.0% | 88.7% | 132/150 | |
Niemann-Pick_Disease_Type_A.yaml |
88.0% | 90.2% | 66/75 | |
STRA6-related_syndromic_microphthalmia.yaml |
88.0% | 89.8% | 81/92 | |
X-linked_Retinoschisis.yaml |
88.0% | 90.2% | 81/92 | |
CAPN5-Related_Vitreoretinopathy.yaml |
88.1% | 89.3% | 118/134 | |
Central_Retinal_Artery_Occlusion.yaml |
88.1% | 89.4% | 59/67 | |
Chromosome_1p36_Deletion_Syndrome.yaml |
88.1% | 90.5% | 59/67 | |
Combined_Oxidative_Phosphorylation_Defect_Type_15.yaml |
88.1% | 89.8% | 59/67 | |
Oculocerebrodental_Syndrome.yaml |
88.1% | 90.1% | 59/67 | |
Angiosarcoma.yaml |
88.1% | 88.1% | 192/218 | |
TRAF3_Haploinsufficiency.yaml |
88.1% | 89.6% | 133/151 | |
ACAN-Related_Short_Stature_Spectrum.yaml |
88.1% | 88.2% | 207/235 | |
Cystic_Echinococcosis.yaml |
88.1% | 87.6% | 74/84 | |
Frias_Syndrome.yaml |
88.1% | 90.1% | 111/126 | |
Primary_Progressive_Apraxia_of_Speech.yaml |
88.1% | 90.6% | 37/42 | |
Spermatogenic_Failure_43.yaml |
88.1% | 88.6% | 111/126 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_30.yaml |
88.1% | 88.3% | 126/143 | |
RHOBTB2-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
88.1% | 89.4% | 126/143 | |
CAPRIN1_Related_Neurodevelopmental_Disorder.yaml |
88.1% | 89.2% | 341/387 | |
Cauda_Equina_Syndrome.yaml |
88.1% | 89.1% | 89/101 | 1 |
Spondyloepimetaphyseal_Dysplasia_Maroteaux_Type.yaml |
88.1% | 89.6% | 89/101 | |
Guillouet-Gordon_Syndrome.yaml |
88.1% | 90.6% | 52/59 | |
Keratitis-Ichthyosis-Deafness_Syndrome.yaml |
88.1% | 89.3% | 208/236 | |
Platelet-type_Bleeding_Disorder_8.yaml |
88.1% | 90.4% | 52/59 | |
Molybdenum_Cofactor_Deficiency_Type_A.yaml |
88.1% | 89.7% | 119/135 | |
Thrombocytopenia_11_with_Multiple_Congenital_Anomalies_and_Dysmorphic_Facies.yaml |
88.1% | 90.0% | 119/135 | |
Brachydactyly_Type_B2.yaml |
88.2% | 90.0% | 67/76 | |
Congenital_Disorder_of_Glycosylation_Type_IIw.yaml |
88.2% | 89.1% | 134/152 | |
Crigler-Najjar_Syndrome.yaml |
88.2% | 90.0% | 67/76 | |
Cushing_Disease.yaml |
88.2% | 89.7% | 149/169 | |
Marshall_Syndrome.yaml |
88.2% | 88.9% | 149/169 | |
D-Bifunctional_Protein_Deficiency.yaml |
88.2% | 89.6% | 82/93 | |
NR5A1_Related_Sex_Development_Disorder.yaml |
88.2% | 89.2% | 164/186 | |
TGFBI_Corneal_Dystrophies.yaml |
88.2% | 89.5% | 82/93 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_97.yaml |
88.2% | 88.8% | 112/127 | |
Diamond-Blackfan_Anemia_15_With_Mandibulofacial_Dysostosis.yaml |
88.2% | 89.2% | 127/144 | |
Exfoliation_Syndrome.yaml |
88.2% | 88.5% | 254/288 | |
Neurodevelopmental_Disorder_with_Neuromuscular_and_Skeletal_Abnormalities.yaml |
88.2% | 89.4% | 254/288 | |
PGM1-Congenital_Disorder_of_Glycosylation.yaml |
88.2% | 89.4% | 344/390 | |
Autosomal_Dominant_Polycystic_Kidney_Disease.yaml |
88.2% | 89.0% | 195/221 | |
Craniofacial-Deafness-Hand_Syndrome.yaml |
88.2% | 90.1% | 165/187 | |
Linear_Skin_Defects_with_Multiple_Congenital_Anomalies_1.yaml |
88.2% | 90.2% | 120/136 | |
Mulibrey_Nanism.yaml |
88.2% | 88.8% | 165/187 | |
Oculoglandular_Tularemia.yaml |
88.2% | 89.9% | 60/68 | |
Spinocerebellar_Ataxia_Type_6.yaml |
88.2% | 89.1% | 120/136 | |
Thrombophilia.yaml |
88.3% | 88.6% | 203/230 | |
Peutz_Jeghers_polyp.yaml |
88.3% | 90.1% | 143/162 | |
XFE_Progeroid_Syndrome.yaml |
88.3% | 89.1% | 128/145 | |
Hydatidiform_Mole.yaml |
88.3% | 89.3% | 113/128 | |
Sezary_Syndrome.yaml |
88.3% | 88.8% | 113/128 | |
Toxic_Oil_Syndrome.yaml |
88.3% | 88.9% | 211/239 | |
Maroteaux-Lamy_syndrome.yaml |
88.3% | 89.7% | 98/111 | |
Genital_Lichen_Sclerosus.yaml |
88.3% | 89.4% | 83/94 | |
KLC4-Related_Early-Childhood-Onset_Neurodegeneration.yaml |
88.3% | 88.7% | 83/94 | |
DK1-congenital_disorder_of_glycosylation.yaml |
88.3% | 89.3% | 136/154 | |
Dilated_Cardiomyopathy_2B.yaml |
88.3% | 89.1% | 204/231 | |
Gas_Gangrene.yaml |
88.3% | 90.2% | 68/77 | |
Chronic_Primary_Adrenal_Insufficiency.yaml |
88.3% | 89.7% | 121/137 | |
PRPS1_Superactivity.yaml |
88.3% | 89.1% | 121/137 | |
Skeletal_Fluorosis.yaml |
88.3% | 87.5% | 333/377 | |
COX20-Related_COX_Deficiency.yaml |
88.3% | 90.0% | 53/60 | |
Choroideremia.yaml |
88.3% | 91.4% | 53/60 | |
Klinefelter_Syndrome.yaml |
88.3% | 88.1% | 159/180 | 1 |
Piebaldism.yaml |
88.3% | 90.5% | 53/60 | |
Platelet-type_Bleeding_Disorder_16.yaml |
88.3% | 88.8% | 212/240 | |
Green_Tobacco_Sickness.yaml |
88.4% | 88.8% | 129/146 | |
Autosomal_Dominant_Mendelian_Susceptibility_To_Mycobacterial_Diseases_Due_To_Partial_IFNgammaR1_Deficiency.yaml |
88.4% | 87.9% | 167/189 | 1 |
Familial_Thoracic_Aortic_Aneurysm_and_Aortic_Dissection.yaml |
88.4% | 89.9% | 167/189 | 1 |
Deafness_Dystonia_and_Cerebral_Hypomyelination.yaml |
88.4% | 89.4% | 152/172 | |
Donnai-Barrow_syndrome.yaml |
88.4% | 89.9% | 114/129 | |
Immunodeficiency_91_And_Hyperinflammation.yaml |
88.4% | 89.9% | 152/172 | |
Osteogenesis_Imperfecta_Type_IV.yaml |
88.4% | 89.1% | 114/129 | |
Spermatogenic_Failure_98.yaml |
88.4% | 89.8% | 76/86 | |
Testicular_Sex_Cord_Stromal_Neoplasm.yaml |
88.4% | 90.8% | 114/129 | |
Vici_Syndrome.yaml |
88.4% | 89.6% | 228/258 | |
SOX11-Related_Neurodevelopmental_Disorder.yaml |
88.4% | 89.5% | 251/284 | |
Familial_Atrial_Fibrillation.yaml |
88.4% | 88.9% | 198/224 | |
Immunodeficiency_97_With_Autoinflammation.yaml |
88.4% | 89.6% | 99/112 | |
PUS3-Related_Neurodevelopmental_Disorder.yaml |
88.4% | 89.9% | 198/224 | |
Marshall-Smith_Syndrome.yaml |
88.4% | 90.0% | 122/138 | |
Muscular_Dystrophy_Congenital_Hearing_Loss_And_Ovarian_Insufficiency_Syndrome.yaml |
88.4% | 89.3% | 244/276 | |
Familial_Exudative_Vitreoretinopathy.yaml |
88.4% | 89.7% | 206/233 | |
Brachydactyly_Type_B1.yaml |
88.4% | 89.7% | 84/95 | |
Autosomal_Dominant_Hypocalcemia_1.yaml |
88.4% | 88.8% | 214/242 | |
SLC35A1-Congenital_Disorder_of_Glycosylation.yaml |
88.4% | 89.9% | 107/121 | |
Bronchiectasis_With_Or_Without_Elevated_Sweat_Chloride_1.yaml |
88.5% | 89.5% | 92/104 | 1 |
Maculopapular_Cutaneous_Mastocytosis.yaml |
88.5% | 90.0% | 92/104 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_31.yaml |
88.5% | 90.4% | 115/130 | |
Opitz_GBBB_Syndrome.yaml |
88.5% | 90.4% | 92/104 | |
Spasticity-Ataxia-Gait_Anomalies_Syndrome.yaml |
88.5% | 90.7% | 69/78 | |
Brain_Abnormalities_Neurodegeneration_and_Dysosteosclerosis.yaml |
88.5% | 89.4% | 261/295 | |
Systemic_Lupus_Erythematosus.yaml |
88.5% | 87.6% | 461/521 | 3 |
Hyperkalemic_Periodic_Paralysis.yaml |
88.5% | 88.7% | 231/261 | 2 |
Acute_Ackee_Fruit_Intoxication.yaml |
88.5% | 87.9% | 285/322 | |
Dominant_Beta-Thalassemia.yaml |
88.5% | 90.0% | 108/122 | |
HOIP_Deficiency.yaml |
88.5% | 89.3% | 270/305 | |
KCNV2_Related_Retinopathy.yaml |
88.5% | 91.3% | 54/61 | |
Liver_Cirrhosis.yaml |
88.5% | 89.1% | 216/244 | |
Neurodevelopmental_Disorder_with_Microcephaly_Seizures_and_Cortical_Atrophy.yaml |
88.5% | 90.0% | 216/244 | |
Trisomy_X.yaml |
88.5% | 90.9% | 54/61 | |
FG_Syndrome_4.yaml |
88.5% | 90.1% | 85/96 | |
Thiopurine_S-methyltransferase_Deficiency.yaml |
88.5% | 89.6% | 85/96 | |
IgA_Vasculitis.yaml |
88.5% | 89.9% | 116/131 | |
GRIN1-Related_Neurodevelopmental_Disorder.yaml |
88.6% | 90.9% | 147/166 | |
SLC6A1-Related_Disorder.yaml |
88.6% | 90.0% | 147/166 | 2 |
Asbestosis.yaml |
88.6% | 89.0% | 178/201 | 1 |
Alexander_Disease.yaml |
88.6% | 88.7% | 248/280 | |
Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml |
88.6% | 90.8% | 62/70 | |
Human_Papillomavirus_Infection.yaml |
88.6% | 89.6% | 93/105 | |
Microvillus_Inclusion_Disease.yaml |
88.6% | 90.7% | 62/70 | |
Renal_Agenesis.yaml |
88.6% | 89.7% | 124/140 | |
Osteoporosis.yaml |
88.6% | 88.3% | 233/263 | 1 |
Severe_Combined_Immunodeficiency_Due_To_CORO1A_Deficiency.yaml |
88.6% | 89.5% | 241/272 | |
Clear_Cell_Sarcoma.yaml |
88.6% | 89.5% | 70/79 | |
Papular_Xanthoma.yaml |
88.6% | 90.2% | 39/44 | |
Postcricoid_Region_Cancer.yaml |
88.6% | 90.0% | 78/88 | |
Spastic_Paraplegia_89_Autosomal_Recessive.yaml |
88.6% | 89.9% | 117/132 | |
MEGF8-Related_Carpenter_Syndrome.yaml |
88.7% | 90.5% | 125/141 | |
Leber_Congenital_Amaurosis_9.yaml |
88.7% | 89.5% | 133/150 | |
Bartter_Syndrome.yaml |
88.7% | 89.5% | 313/353 | |
Mowat-Wilson_syndrome.yaml |
88.7% | 90.0% | 94/106 | |
Primary_Hyperoxaluria_Type_1.yaml |
88.7% | 89.7% | 47/53 | |
Schinzel-Giedion_Syndrome.yaml |
88.7% | 88.8% | 47/53 | |
Yao_Syndrome.yaml |
88.7% | 88.2% | 235/265 | 1 |
Mendelian_Susceptibility_To_Mycobacterial_Diseases_Due_To_Complete_IL12B_Deficiency.yaml |
88.7% | 87.9% | 102/115 | 1 |
MECP2_Duplication_Syndrome.yaml |
88.7% | 89.4% | 110/124 | |
PRPF31-Related_Retinopathy.yaml |
88.7% | 91.5% | 55/62 | |
Ochoa_Syndrome.yaml |
88.7% | 89.9% | 134/151 | |
CDH2-Related_ACOG_Syndrome.yaml |
88.8% | 90.4% | 213/240 | |
CHIME_syndrome.yaml |
88.8% | 90.6% | 71/80 | |
Dysembryoplastic_Neuroepithelial_Tumor.yaml |
88.8% | 89.8% | 71/80 | 2 |
Dilated_Cardiomyopathy_1Z.yaml |
88.8% | 90.0% | 221/249 | |
Intellectual_Disability_Autosomal_Dominant_6.yaml |
88.8% | 90.3% | 150/169 | |
Dilated_Cardiomyopathy_1NN.yaml |
88.8% | 90.4% | 87/98 | |
EGFR_Mutant_NSCLC.yaml |
88.8% | 88.7% | 206/232 | |
Pontiac_Fever.yaml |
88.8% | 89.0% | 103/116 | |
Dilated_Cardiomyopathy_1P.yaml |
88.8% | 89.4% | 214/241 | |
Early-Infantile_Developmental_and_Epileptic_Encephalopathy.yaml |
88.8% | 89.2% | 238/268 | 2 |
Eiken_Syndrome.yaml |
88.8% | 89.9% | 119/134 | |
IFAP_Syndrome_1.yaml |
88.8% | 90.1% | 119/134 | |
Progressive_Familial_Intrahepatic_Cholestasis.yaml |
88.8% | 89.7% | 397/447 | |
Epidermolysis_Bullosa_Simplex_7_With_Nephropathy_And_Deafness.yaml |
88.8% | 89.0% | 159/179 | |
Organophosphate_Poisoning.yaml |
88.8% | 89.5% | 175/197 | |
Dilated_Cardiomyopathy_1W.yaml |
88.8% | 89.6% | 223/251 | 1 |
Fatal_Familial_Insomnia.yaml |
88.8% | 89.8% | 239/269 | |
MERRF_Syndrome.yaml |
88.8% | 89.9% | 247/278 | |
Autism_Susceptibility_to_X-Linked_3.yaml |
88.9% | 90.0% | 80/90 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_124.yaml |
88.9% | 89.4% | 168/189 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_26.yaml |
88.9% | 89.1% | 96/108 | |
Chronic_Traumatic_Encephalopathy.yaml |
88.9% | 89.9% | 40/45 | |
Congenital_Diaphragmatic_Hernia.yaml |
88.9% | 89.3% | 312/351 | |
Developmental_Delay_Hypotonia_Musculoskeletal_Defects_And_Behavioral_Abnormalities.yaml |
88.9% | 90.3% | 136/153 | |
Hypertrophic_Cardiomyopathy_9.yaml |
88.9% | 90.6% | 88/99 | |
Hypophosphatasia.yaml |
88.9% | 89.3% | 200/225 | |
Immunodeficiency_11B_With_Atopic_Dermatitis.yaml |
88.9% | 90.2% | 200/225 | |
Lysosomal_Acid_Phosphatase_Deficiency.yaml |
88.9% | 92.7% | 24/27 | |
Marginal_Zone_Lymphoma.yaml |
88.9% | 90.8% | 48/54 | |
Meester-Loeys_Syndrome.yaml |
88.9% | 89.0% | 88/99 | 1 |
Sphingosine_Phosphate_Lyase_Insufficiency_Syndrome.yaml |
88.9% | 89.7% | 248/279 | |
neuroferritinopathy.yaml |
88.9% | 89.7% | 96/108 | |
Pancreatic_Ductal_Adenocarcinoma.yaml |
88.9% | 88.8% | 506/569 | 3 |
Peroxisome_Biogenesis_Disorder_11A_Zellweger.yaml |
88.9% | 89.7% | 225/253 | |
Fuchs_Endothelial_Corneal_Dystrophy.yaml |
89.0% | 89.6% | 153/172 | |
Neurofibromatosis.yaml |
89.0% | 90.3% | 145/163 | |
Familial_Cold_Autoinflammatory_Syndrome.yaml |
89.0% | 89.9% | 137/154 | |
Intermediate_Charcot-Marie-Tooth_Disease.yaml |
89.0% | 90.7% | 137/154 | |
Protein_S_Deficiency.yaml |
89.0% | 89.7% | 137/154 | |
Gout.yaml |
89.0% | 89.7% | 129/145 | |
CAPOS_Syndrome.yaml |
89.0% | 90.2% | 218/245 | 2 |
PAPA_Syndrome.yaml |
89.0% | 90.5% | 105/118 | |
Ring_Chromosome_14.yaml |
89.0% | 89.8% | 186/209 | 1 |
Isolated_Anophthalmia-Microphthalmia_Syndrome.yaml |
89.0% | 89.5% | 364/409 | |
Greenberg_Dysplasia.yaml |
89.0% | 90.1% | 89/100 | |
Spondyloepiphyseal_Dysplasia_Kondo-Fu_Type.yaml |
89.0% | 89.8% | 170/191 | 1 |
Autosomal_Recessive_Optic_Atrophy_OPA7_Type.yaml |
89.0% | 88.5% | 162/182 | |
Autosomal_Recessive_Spinocerebellar_Ataxia_15.yaml |
89.0% | 90.1% | 154/173 | |
ZAP70_Deficiency.yaml |
89.0% | 89.1% | 227/255 | 1 |
Nail-patella_Syndrome.yaml |
89.0% | 90.1% | 146/164 | |
Hyperostosis_Cranialis_Interna.yaml |
89.0% | 89.8% | 138/155 | |
Neurooculorenal_Syndrome.yaml |
89.0% | 90.1% | 138/155 | |
Chronic_Canaliculitis.yaml |
89.0% | 90.5% | 65/73 | |
Buschke-Ollendorff_Syndrome.yaml |
89.1% | 88.9% | 244/274 | 2 |
Hypertrophic_Cardiomyopathy_3.yaml |
89.1% | 89.3% | 244/274 | 1 |
Emery_Dreifuss_Muscular_Dystrophy.yaml |
89.1% | 90.7% | 179/201 | |
Gray_Platelet_Syndrome.yaml |
89.1% | 89.7% | 171/192 | |
Hereditary_Pheochromocytoma-Paraganglioma_Syndrome.yaml |
89.1% | 90.0% | 114/128 | |
Malignant_Germ_Cell_Tumor_of_Ovary.yaml |
89.1% | 89.8% | 269/302 | |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_2B.yaml |
89.1% | 89.0% | 106/119 | |
Combined_Oxidative_Phosphorylation_Defect_Type_26.yaml |
89.1% | 89.7% | 147/165 | |
Retinopathy_of_Prematurity.yaml |
89.1% | 90.3% | 49/55 | |
Bone_Marrow_Failure_Syndrome_4.yaml |
89.1% | 89.8% | 327/367 | |
Spina_Bifida_Cystica.yaml |
89.1% | 89.5% | 139/156 | 1 |
Noonan_Syndrome_11.yaml |
89.1% | 90.0% | 229/257 | |
Alsahan-Harris_Syndrome.yaml |
89.1% | 91.2% | 131/147 | |
Alternating_Hemiplegia_of_Childhood.yaml |
89.1% | 89.6% | 123/138 | |
Hearing_Loss_Autosomal_Recessive_100.yaml |
89.1% | 90.0% | 82/92 | |
Penttinen_Premature_Aging_Syndrome.yaml |
89.1% | 91.2% | 41/46 | |
Chopra-Amiel-Gordon_Syndrome.yaml |
89.2% | 90.4% | 296/332 | 1 |
Avoidant_Restrictive_Food_Intake_Disorder.yaml |
89.2% | 88.8% | 181/203 | |
Hypertrophic_Cardiomyopathy_26.yaml |
89.2% | 89.8% | 214/240 | 1 |
Hereditary_Angioedema.yaml |
89.2% | 89.3% | 387/434 | |
Acquired_Epidermolysis_Bullosa.yaml |
89.2% | 89.6% | 264/296 | |
Hereditary_Pulmonary_Alveolar_Proteinosis.yaml |
89.2% | 89.5% | 165/185 | |
Jackson-Weiss_Syndrome.yaml |
89.2% | 91.1% | 66/74 | |
Neuronal_Ceroid_Lipofuscinosis_2.yaml |
89.2% | 91.2% | 66/74 | |
STAG3-related_gametogenic_failure.yaml |
89.2% | 90.7% | 66/74 | |
Congenital_Adrenal_Hyperplasia.yaml |
89.2% | 90.0% | 190/213 | |
Melioidosis.yaml |
89.2% | 89.7% | 157/176 | |
Facioscapulohumeral_Muscular_Dystrophy.yaml |
89.2% | 89.5% | 281/315 | |
Malignant_Hyperthermia_of_Anesthesia.yaml |
89.2% | 90.1% | 124/139 | 4 |
Unicentric_Castleman_Disease.yaml |
89.2% | 91.0% | 124/139 | |
Luscan-Lumish_Syndrome.yaml |
89.2% | 91.0% | 91/102 | |
Chronic_Obstructive_Pulmonary_Disease.yaml |
89.2% | 89.2% | 323/362 | 1 |
Hearing_Loss_Autosomal_Dominant_84.yaml |
89.2% | 88.9% | 116/130 | 1 |
Hearing_Loss_Autosomal_Dominant_72.yaml |
89.2% | 90.1% | 83/93 | |
Epilepsy_of_Infancy_with_Migrating_Focal_Seizures.yaml |
89.3% | 90.4% | 108/121 | |
Mucopolysaccharidosis-Plus_Syndrome.yaml |
89.3% | 90.2% | 258/289 | |
Adenylosuccinate_Lyase_Deficiency.yaml |
89.3% | 89.5% | 225/252 | |
GRIN2B-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
89.3% | 91.4% | 100/112 | |
Mucopolysaccharidosis_type_IX.yaml |
89.3% | 93.1% | 50/56 | |
Potocki-Lupski_Syndrome.yaml |
89.3% | 91.1% | 75/84 | |
Pseudohypoparathyroidism.yaml |
89.3% | 90.0% | 125/140 | |
Spinocerebellar_Ataxia_Type_8.yaml |
89.3% | 90.1% | 150/168 | |
Platelet-type_Bleeding_Disorder_15.yaml |
89.3% | 89.8% | 167/187 | |
Aspergillosis.yaml |
89.3% | 90.1% | 284/318 | |
Murine_Typhus.yaml |
89.3% | 91.0% | 142/159 | |
Kummell_Disease.yaml |
89.3% | 89.5% | 117/131 | 1 |
Distal_Hereditary_Motor_Neuronopathy_Type_2A.yaml |
89.3% | 90.4% | 92/103 | |
Marchiafava_Bignami_Disease.yaml |
89.3% | 90.6% | 92/103 | |
Aminoglycoside-Induced_Hearing_Loss.yaml |
89.3% | 88.4% | 251/281 | 1 |
Combined_Oxidative_Phosphorylation_Defect_Type_7.yaml |
89.3% | 89.7% | 134/150 | |
Autism_Spectrum_Disorder.yaml |
89.3% | 88.8% | 218/244 | 2 |
NARP_syndrome.yaml |
89.3% | 89.7% | 109/122 | 1 |
Brachydactyly_Type_E1.yaml |
89.4% | 90.4% | 84/94 | |
Congenital_Sodium_Diarrhea.yaml |
89.4% | 91.1% | 84/94 | |
HHV-8-Associated_Multicentric_Castleman_Disease.yaml |
89.4% | 91.0% | 143/160 | 1 |
Invasive_Non-Typhoidal_Salmonellosis.yaml |
89.4% | 90.0% | 177/198 | |
MALT_Lymphoma.yaml |
89.4% | 90.2% | 59/66 | |
Heritable_Pulmonary_Arterial_Hypertension.yaml |
89.4% | 89.7% | 253/283 | 3 |
Spondyloepiphyseal_Dysplasia_Congenita.yaml |
89.4% | 90.3% | 194/217 | |
Galloway-Mowat_Syndrome.yaml |
89.4% | 90.8% | 211/236 | |
Costello_Syndrome.yaml |
89.4% | 89.6% | 169/189 | 1 |
Dental_Caries.yaml |
89.4% | 89.3% | 93/104 | |
Vitamin_D-Dependent_Rickets_Type_2B.yaml |
89.4% | 89.1% | 127/142 | 1 |
3-Hydroxyisobutyryl-CoA_Hydrolase_Deficiency.yaml |
89.5% | 88.8% | 221/247 | 2 |
Idiopathic_Spontaneous_Coronary_Artery_Dissection.yaml |
89.5% | 90.7% | 85/95 | |
Late_Complement_Component_Deficiency.yaml |
89.5% | 90.6% | 136/152 | |
Otopalatodigital_Spectrum_Disorders.yaml |
89.5% | 91.5% | 85/95 | |
Vitiligo.yaml |
89.5% | 88.4% | 247/276 | 3 |
Addisons_Disease.yaml |
89.5% | 89.9% | 179/200 | 1 |
Seckel_Syndrome.yaml |
89.5% | 90.5% | 162/181 | |
Tyrosinemia_Type_III.yaml |
89.5% | 92.3% | 145/162 | |
Silent_Sinus_Syndrome.yaml |
89.5% | 90.3% | 128/143 | |
Trichohepatoenteric_Syndrome.yaml |
89.5% | 90.8% | 128/143 | |
PHARC_syndrome.yaml |
89.5% | 90.3% | 94/105 | 1 |
Transient_Neonatal_Pustular_Melanosis.yaml |
89.5% | 91.1% | 77/86 | |
Dilated_Cardiomyopathy_1BB.yaml |
89.5% | 90.2% | 257/287 | |
Deeah_Syndrome.yaml |
89.6% | 91.1% | 120/134 | |
SUCLA2-Related_Mitochondrial_DNA_Depletion_Syndrome.yaml |
89.6% | 89.9% | 249/278 | |
CACNA1F-Related_Retinopathy.yaml |
89.6% | 91.3% | 86/96 | 1 |
Ectodermal_Dysplasia_and_Immunodeficiency_2.yaml |
89.6% | 91.3% | 86/96 | |
Karyomegalic_Interstitial_Nephritis.yaml |
89.6% | 89.2% | 129/144 | 1 |
Bethlem_Myopathy.yaml |
89.6% | 89.9% | 457/510 | |
Dowling-Degos_Disease.yaml |
89.6% | 91.7% | 69/77 | |
Fibrosarcoma.yaml |
89.6% | 89.8% | 69/77 | |
Dermatosparaxis_Ehlers-Danlos_Syndrome.yaml |
89.6% | 89.9% | 164/183 | 1 |
Cyclosporiasis.yaml |
89.6% | 90.2% | 121/135 | 1 |
Familial_Chylomicronemia_Syndrome.yaml |
89.6% | 90.5% | 147/164 | |
Hypertrophic_Cardiomyopathy_2.yaml |
89.7% | 90.9% | 104/116 | |
Trisomy_18.yaml |
89.7% | 91.6% | 52/58 | |
Osteonecrosis.yaml |
89.7% | 90.7% | 139/155 | |
Combined_Oxidative_Phosphorylation_Defect_Type_13.yaml |
89.7% | 90.3% | 226/252 | |
Primary_Myelofibrosis.yaml |
89.7% | 90.3% | 200/223 | 1 |
Aromatase_Excess_Syndrome.yaml |
89.7% | 90.7% | 87/97 | |
Intellectual_Developmental_Disorder_Autosomal_Recessive_67.yaml |
89.7% | 90.9% | 148/165 | |
VCP-associated_Multisystem_Proteinopathy.yaml |
89.7% | 90.3% | 148/165 | |
Wolfram_Syndrome.yaml |
89.7% | 90.0% | 331/369 | |
GLUT1_Deficiency_Syndrome.yaml |
89.7% | 89.2% | 392/437 | 3 |
Ectopic_Pregnancy.yaml |
89.7% | 90.9% | 183/204 | 1 |
NGLY1-congenital_disorder_of_deglycosylation.yaml |
89.7% | 90.4% | 183/204 | |
Dilated_Cardiomyopathy_1J.yaml |
89.7% | 90.8% | 157/175 | |
Mitochondrial_DNA_Depletion_Syndrome_3_Hepatocerebral_Type.yaml |
89.7% | 90.3% | 288/321 | |
Claes-Jensen_Type_X-Linked_Intellectual_Disability.yaml |
89.7% | 90.9% | 245/273 | |
Congenital_Primary_Megaureter.yaml |
89.7% | 91.2% | 105/117 | |
Fountain_Syndrome.yaml |
89.7% | 90.5% | 105/117 | |
IFAP_Syndrome_2.yaml |
89.7% | 91.4% | 140/156 | |
Developmental_And_Epileptic_Encephalopathy_116.yaml |
89.8% | 91.1% | 149/166 | |
Subacute_Delirium.yaml |
89.8% | 90.2% | 149/166 | |
Finnish_Type_Amyloidosis.yaml |
89.8% | 91.3% | 79/88 | |
Primary_Cutaneous_Amyloidosis.yaml |
89.8% | 90.9% | 237/264 | |
Scarlet_Fever.yaml |
89.8% | 90.5% | 79/88 | 1 |
Thunderstorm_Asthma.yaml |
89.8% | 91.0% | 79/88 | 1 |
MCM8-related_gametogenic_failure.yaml |
89.8% | 91.2% | 88/98 | |
Porphyria-Related_Leukoencephalopathy.yaml |
89.8% | 90.5% | 132/147 | |
Primary_Hyperoxaluria_Type_2.yaml |
89.8% | 92.4% | 44/49 | |
Diets-Jongmans_Syndrome.yaml |
89.8% | 91.3% | 185/206 | |
Charcot-Marie-Tooth_Disease_Axonal_Type_2C.yaml |
89.8% | 90.7% | 97/108 | |
Choroid_Plexus_Carcinoma.yaml |
89.8% | 91.1% | 97/108 | |
Leber_Congenital_Amaurosis_10.yaml |
89.8% | 91.2% | 97/108 | |
Congenital_Pulmonary_Airway_Malformation.yaml |
89.8% | 90.1% | 106/118 | |
Familial_Sleep_Related_Hypermotor_Epilepsy.yaml |
89.8% | 91.4% | 159/177 | |
Juvenile_Temporal_Arteritis.yaml |
89.8% | 89.1% | 53/59 | 2 |
Pineoblastoma.yaml |
89.8% | 90.6% | 106/118 | |
Spinocerebellar_Ataxia_Autosomal_Recessive_32.yaml |
89.8% | 90.5% | 318/354 | |
DLG4-Related_Synaptopathy.yaml |
89.8% | 91.0% | 283/315 | |
Keutel_Syndrome.yaml |
89.8% | 91.0% | 115/128 | |
Oculogastrointestinal-Neurodevelopmental_Syndrome.yaml |
89.9% | 92.3% | 62/69 | |
Monomelic_Amyotrophy.yaml |
89.9% | 91.9% | 71/79 | |
Fallopian_Tube_Benign_Neoplasm.yaml |
89.9% | 90.1% | 80/89 | 1 |
Pediatric_Acute-Onset_Neuropsychiatric_Syndrome.yaml |
89.9% | 91.0% | 80/89 | |
Soil_Transmitted_Helminthiases.yaml |
89.9% | 90.0% | 80/89 | |
Undifferentiated_Connective_Tissue_Syndrome.yaml |
89.9% | 90.1% | 89/99 | |
Free_Sialic_Acid_Storage_Disease.yaml |
89.9% | 90.6% | 187/208 | |
Peutz_Jeghers_Syndrome.yaml |
89.9% | 90.6% | 187/208 | |
Congenital_Leptin_Deficiency.yaml |
89.9% | 90.8% | 107/119 | |
X-linked_Chondrodysplasia_Punctata_1.yaml |
89.9% | 91.1% | 107/119 | |
Immunodeficiency_Centromeric_Instability_Facial_Anomalies_Syndrome.yaml |
89.9% | 90.7% | 223/248 | |
Neurodevelopmental_Disorder_with_or_without_Anomalies_of_the_Brain_Eye_or_Heart.yaml |
89.9% | 91.0% | 232/258 | |
Adenomyosis.yaml |
89.9% | 91.0% | 170/189 | |
B-Lymphoblastic_Leukemia_Lymphoma_With_Recurrent_Genetic_Abnormality.yaml |
89.9% | 90.7% | 170/189 | |
Netherton_Syndrome.yaml |
90.0% | 90.2% | 188/209 | |
Neuronal_Ceroid_Lipofuscinosis.yaml |
90.0% | 90.4% | 206/229 | |
Ataxia_With_Oculomotor_Apraxia_Type_2.yaml |
90.0% | 90.2% | 269/299 | |
PRKAG2_Cardiac_Syndrome.yaml |
90.0% | 91.2% | 269/299 | |
Brachydactyly_Type_C.yaml |
90.0% | 91.2% | 81/90 | |
Czech_Dysplasia.yaml |
90.0% | 92.8% | 63/70 | |
Dyslexia.yaml |
90.0% | 91.5% | 54/60 | |
Hereditary_Hemorrhagic_Telangiectasia.yaml |
90.0% | 91.1% | 189/210 | |
Huppke-Brendel_syndrome.yaml |
90.0% | 91.3% | 99/110 | |
Hypercatabolic_Hypoproteinemia.yaml |
90.0% | 89.4% | 117/130 | 1 |
Isolated_Pierre_Robin_Syndrome.yaml |
90.0% | 91.4% | 54/60 | 1 |
Medulloblastoma_SHH_Activated.yaml |
90.0% | 92.3% | 81/90 | |
Neurodevelopmental_Disorder_with_Poor_Growth_Spastic_Tetraplegia_and_Hearing_Loss.yaml |
90.0% | 91.4% | 171/190 | |
Thomsen_and_Becker_disease.yaml |
90.0% | 90.7% | 126/140 | 1 |
Triglyceride_Storage_Disease_Type_2.yaml |
90.0% | 92.6% | 45/50 | |
Spinocerebellar_Ataxia_48.yaml |
90.0% | 90.1% | 253/281 | |
Hashimotos_Thyroiditis.yaml |
90.0% | 90.3% | 217/241 | |
Hypomyelinating_Leukodystrophy_14.yaml |
90.0% | 90.7% | 217/241 | |
Estrogen_Resistance_Syndrome.yaml |
90.0% | 90.4% | 190/211 | |
Large_Cell_Neuroendocrine_Carcinoma.yaml |
90.1% | 90.7% | 172/191 | |
DPAGT1-Congenital_Disorder_of_Glycosylation.yaml |
90.1% | 90.6% | 154/171 | |
PACS2-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
90.1% | 91.7% | 145/161 | |
Pachyonychia_Congenita.yaml |
90.1% | 90.9% | 272/302 | |
Eosinophilic_Esophagitis.yaml |
90.1% | 90.6% | 127/141 | |
Charcot-Marie-Tooth_Disease_Type_4B3.yaml |
90.1% | 89.8% | 236/262 | 1 |
Cystic_Fibrosis.yaml |
90.1% | 90.1% | 572/635 | 1 |
Blepharophimosis_Ptosis_and_Epicanthus_Inversus_Syndrome.yaml |
90.1% | 91.6% | 109/121 | |
Cat-Scratch_Disease.yaml |
90.1% | 90.5% | 109/121 | 1 |
Benign_Familial_Infantile_Epilepsy.yaml |
90.1% | 89.4% | 191/212 | 2 |
Roberts_Syndrome.yaml |
90.1% | 90.2% | 447/496 | |
CNGB1-Related_Retinopathy.yaml |
90.1% | 90.3% | 210/233 | |
Kabuki_Syndrome.yaml |
90.1% | 90.4% | 274/304 | |
Erb_Palsy.yaml |
90.1% | 90.6% | 128/142 | |
Mucoepidermoid_Carcinoma.yaml |
90.1% | 91.0% | 64/71 | |
Brachydactyly_Type_A2.yaml |
90.2% | 91.1% | 119/132 | |
Erythropoietic_Protoporphyria.yaml |
90.2% | 91.6% | 119/132 | |
Ulceroglandular_Tularemia.yaml |
90.2% | 92.1% | 55/61 | |
Danon_disease.yaml |
90.2% | 91.0% | 156/173 | |
Mal_De_Debarquement.yaml |
90.2% | 90.7% | 101/112 | |
Early-Onset_Autosomal_Dominant_Alzheimer_Disease.yaml |
90.2% | 90.9% | 239/265 | |
Microcytic_Anemia_With_Liver_Iron_Overload.yaml |
90.2% | 91.1% | 92/102 | 1 |
Paget_Disease_of_Bone.yaml |
90.2% | 91.5% | 138/153 | |
Migraine_with_Aura.yaml |
90.2% | 90.7% | 120/133 | |
ARHGDIA-Related_Steroid-Resistant_Nephrotic_Syndrome.yaml |
90.2% | 90.6% | 231/256 | |
Dextro_Transposition_of_the_Great_Arteries.yaml |
90.2% | 91.6% | 74/82 | |
Glycogen_Storage_Disease_Type_VI.yaml |
90.2% | 91.6% | 111/123 | |
Malignant_Peritoneal_Mesothelioma.yaml |
90.2% | 91.4% | 111/123 | |
Neuronal_Ceroid_Lipofuscinosis_3.yaml |
90.2% | 91.8% | 148/164 | |
Primary_Polyarteritis_Nodosa.yaml |
90.2% | 88.4% | 74/82 | 3 |
SYCE1_Related_Gametogenic_Failure.yaml |
90.2% | 91.9% | 74/82 | |
TANGO2_Deficiency_Disorder.yaml |
90.3% | 90.6% | 343/380 | |
Diabetic_Retinopathy.yaml |
90.3% | 90.7% | 102/113 | |
Far_East_Scarlet_Like_Fever.yaml |
90.3% | 91.5% | 102/113 | |
Lichtenstein-Knorr_Syndrome.yaml |
90.3% | 91.2% | 65/72 | 1 |
Pilarowski-Bjornsson_syndrome.yaml |
90.3% | 91.8% | 93/103 | |
Polymyalgia_Rheumatica.yaml |
90.3% | 91.2% | 93/103 | |
Cyanide_Poisoning.yaml |
90.3% | 90.4% | 242/268 | |
Hearing_Loss_Autosomal_Recessive_120.yaml |
90.3% | 90.5% | 121/134 | |
Corpus_Callosum_Agenesis-Intellectual_Disability-Coloboma-Micrognathia_Syndrome.yaml |
90.3% | 91.4% | 112/124 | |
Developmental_Malformations-Deafness-Dystonia_Syndrome.yaml |
90.3% | 91.7% | 112/124 | |
Spondylo-ocular_Syndrome.yaml |
90.3% | 90.9% | 168/186 | |
Glomerulonephritis.yaml |
90.3% | 91.4% | 243/269 | |
Hypogonadotropic_Hypogonadism_18_With_Or_Without_Anosmia.yaml |
90.3% | 90.9% | 131/145 | |
Chronic_Recurrent_Multifocal_Osteomyelitis.yaml |
90.4% | 91.4% | 75/83 | 1 |
Dilated_Cardiomyopathy_2A.yaml |
90.4% | 91.7% | 150/166 | |
Enhanced_S-Cone_Syndrome.yaml |
90.4% | 92.5% | 75/83 | |
Psoriatic_Arthritis.yaml |
90.4% | 89.7% | 75/83 | 1 |
SYCP2-related_spermatogenic_failure.yaml |
90.4% | 92.5% | 75/83 | |
TUBG1-related_Tubulinopathy.yaml |
90.4% | 90.8% | 150/166 | |
Pre-descemet_Corneal_Dystrophy.yaml |
90.4% | 89.9% | 122/135 | 1 |
Mucopolysaccharidosis_type_X.yaml |
90.4% | 92.0% | 169/187 | |
Obsessive-Compulsive_Disorder.yaml |
90.4% | 90.6% | 169/187 | |
Rapadilino_Syndrome.yaml |
90.4% | 90.9% | 169/187 | |
Developmental_And_Epileptic_Encephalopathy_82.yaml |
90.4% | 91.0% | 235/260 | 1 |
Ciguatera_Fish_Poisoning.yaml |
90.4% | 90.5% | 273/302 | 1 |
Brachydactyly_Type_D.yaml |
90.4% | 91.6% | 66/73 | |
High_Altitude_Pulmonary_Edema.yaml |
90.4% | 91.5% | 132/146 | 1 |
Isolated_Sedoheptulokinase_Deficiency.yaml |
90.4% | 92.4% | 66/73 | |
Sialuria.yaml |
90.4% | 90.1% | 132/146 | 1 |
ACTA1-Related_Nemaline_Myopathy.yaml |
90.4% | 90.7% | 217/240 | |
Neuropathy_Hereditary_Motor_And_Sensory_Type_VIc_With_Optic_Atrophy.yaml |
90.4% | 91.0% | 151/167 | 1 |
Cerebral_Cavernous_Malformation.yaml |
90.4% | 91.9% | 85/94 | 1 |
WFS1-Related_Disorder.yaml |
90.4% | 90.8% | 170/188 | |
Congenital_Myasthenic_Syndrome.yaml |
90.4% | 91.3% | 369/408 | |
Ergotism.yaml |
90.4% | 90.3% | 246/272 | |
CTNNB1_Neurodevelopmental_Disorder.yaml |
90.5% | 91.2% | 379/419 | |
Spondyloenchondrodysplasia.yaml |
90.5% | 91.0% | 199/220 | |
Ataxia_With_Oculomotor_Apraxia_Type_1.yaml |
90.5% | 91.9% | 133/147 | |
Creatine_Transporter_Deficiency.yaml |
90.5% | 92.7% | 57/63 | |
Spondylocostal_Dysostosis.yaml |
90.5% | 92.1% | 95/105 | |
Striate_Palmoplantar_Keratoderma_Type_2.yaml |
90.5% | 90.5% | 171/189 | 1 |
Angelman_Syndrome.yaml |
90.5% | 90.5% | 504/557 | |
Schizophrenia.yaml |
90.5% | 89.6% | 333/368 | 1 |
Wilms_Tumor.yaml |
90.5% | 90.8% | 257/284 | 1 |
Meier-Gorlin_Syndrome.yaml |
90.5% | 91.5% | 362/400 | |
Cardiomyopathy_Dilated_100.yaml |
90.5% | 90.4% | 124/137 | |
Sengers_syndrome.yaml |
90.5% | 91.5% | 124/137 | |
Hearing_Loss_Autosomal_Dominant_82.yaml |
90.5% | 90.9% | 105/116 | |
Pyrimidine_5_Nucleotidase_Deficiency.yaml |
90.5% | 91.3% | 105/116 | |
Quebec_Platelet_Disorder.yaml |
90.5% | 90.4% | 105/116 | |
Cleft_Palate_Proliferative_Retinopathy_And_Developmental_Delay.yaml |
90.5% | 91.8% | 172/190 | |
Immunodeficiency_127.yaml |
90.5% | 92.1% | 86/95 | 1 |
Stickler_Syndrome_Type_6.yaml |
90.5% | 91.3% | 153/169 | |
Transitional_Cell_Carcinoma.yaml |
90.6% | 91.9% | 115/127 | |
MEND_Syndrome.yaml |
90.6% | 91.7% | 125/138 | |
Lymphatic_Malformation_6.yaml |
90.6% | 91.2% | 154/170 | |
Multiple_Endocrine_Neoplasia_Type_1.yaml |
90.6% | 91.8% | 77/85 | |
Developmental_And_Epileptic_Encephalopathy_14.yaml |
90.6% | 89.8% | 260/287 | 1 |
Kennedy_Disease.yaml |
90.6% | 92.5% | 106/117 | |
Brucellosis.yaml |
90.6% | 90.0% | 270/298 | 2 |
Acute_Erythroid_Leukemia.yaml |
90.6% | 90.8% | 203/224 | |
CDH1-Related_Hereditary_Diffuse_Gastric_Cancer.yaml |
90.6% | 91.8% | 58/64 | |
DPM2-congenital_disorder_of_glycosylation.yaml |
90.6% | 92.3% | 232/256 | |
Dilated_Cardiomyopathy_1CC.yaml |
90.6% | 91.9% | 174/192 | |
Hantavirus_Pulmonary_Syndrome.yaml |
90.6% | 91.6% | 116/128 | |
Hearing_Loss_Autosomal_Recessive_116.yaml |
90.6% | 90.9% | 145/160 | |
MUTYH-Associated_Polyposis.yaml |
90.6% | 92.0% | 58/64 | |
Phelan-McDermid_Syndrome.yaml |
90.6% | 91.1% | 87/96 | |
Nephronophthisis.yaml |
90.6% | 90.2% | 378/417 | |
Congenital_Chloride_Diarrhea.yaml |
90.7% | 92.3% | 68/75 | |
Encephalocraniocutaneous_Lipomatosis.yaml |
90.7% | 91.6% | 68/75 | |
Glycogen_Storage_Disease_Due_To_Phosphoglycerate_Mutase_Deficiency.yaml |
90.7% | 91.3% | 146/161 | |
Hereditary_Multiple_Osteochondromas.yaml |
90.7% | 90.4% | 302/333 | |
Congenital_Disorder_Of_Glycosylation_Type_ICC.yaml |
90.7% | 92.2% | 117/129 | |
Hearing_Loss_Autosomal_Dominant_76.yaml |
90.7% | 91.2% | 117/129 | |
RAB5C-Related_Neurodevelopmental_Disorder_with_Macrocephaly.yaml |
90.7% | 93.5% | 39/43 | |
Gestational_Trophoblastic_Neoplasm.yaml |
90.7% | 93.6% | 88/97 | |
Hereditary_Spastic_Paraplegia_49.yaml |
90.7% | 91.1% | 176/194 | |
Brachyolmia-Amelogenesis_Imperfecta_Syndrome.yaml |
90.7% | 91.4% | 245/270 | |
NELABA.yaml |
90.8% | 91.7% | 157/173 | |
Cole-Carpenter_Syndrome.yaml |
90.8% | 92.3% | 108/119 | |
Immunodeficiency_131.yaml |
90.8% | 91.8% | 108/119 | |
Adult_Granulosa_Cell_Tumor_of_Ovary.yaml |
90.8% | 92.0% | 118/130 | |
Hypertrophic_Cardiomyopathy_4.yaml |
90.8% | 91.4% | 256/282 | 2 |
Immunodeficiency_76.yaml |
90.8% | 91.9% | 128/141 | |
Carney_Complex.yaml |
90.8% | 92.1% | 69/76 | |
Familial_Expansile_Osteolysis.yaml |
90.8% | 90.9% | 276/304 | |
Isolated_Thyroid-stimulating_Hormone_Deficiency.yaml |
90.8% | 91.1% | 148/163 | |
Charcot-Marie-Tooth_Disease_Type_4.yaml |
90.8% | 92.2% | 168/185 | |
SMAD6-related_Craniosynostosis.yaml |
90.8% | 91.6% | 89/98 | |
Erysipelas.yaml |
90.8% | 90.6% | 99/109 | 1 |
Thyroid_Follicular_Carcinoma.yaml |
90.8% | 92.8% | 109/120 | |
Narcolepsy.yaml |
90.8% | 91.0% | 119/131 | |
Cerebral_Amyloid_Angiopathy.yaml |
90.8% | 91.2% | 129/142 | |
Epidermolysis_Bullosa_Simplex.yaml |
90.9% | 91.2% | 288/317 | |
Non-Small_Cell_Lung_Cancer.yaml |
90.9% | 89.9% | 298/328 | 3 |
Leukocyte_Adhesion_Deficiency_1.yaml |
90.9% | 91.3% | 169/186 | |
Labyrinthitis.yaml |
90.9% | 90.9% | 209/230 | 1 |
Lateral_Meningocele_Syndrome.yaml |
90.9% | 91.9% | 219/241 | |
Cholera.yaml |
90.9% | 89.3% | 299/329 | 1 |
Dental_Fluorosis.yaml |
90.9% | 93.2% | 50/55 | |
Galactosialidosis.yaml |
90.9% | 92.4% | 90/99 | |
Hereditary_Sensory_Neuropathy_Type_1D.yaml |
90.9% | 91.7% | 80/88 | |
Pancytopenia-Developmental_Delay_Syndrome.yaml |
90.9% | 91.5% | 150/165 | |
Proliferative_Vitreoretinopathy.yaml |
90.9% | 91.8% | 60/66 | |
SLC13A5_Citrate_Transporter_Disorder.yaml |
90.9% | 92.8% | 100/110 | |
Lissencephaly_Spectrum_Disorders.yaml |
90.9% | 91.9% | 281/309 | 2 |
Benign_Neonatal_Seizures.yaml |
90.9% | 90.6% | 221/243 | 2 |
Kindler_Epidermolysis_Bullosa.yaml |
91.0% | 91.5% | 161/177 | |
Deafness-Lymphedema-Leukemia_Syndrome.yaml |
91.0% | 91.6% | 131/144 | |
Immunodeficiency_64.yaml |
91.0% | 92.0% | 131/144 | |
BRCA_Mutant_Prostate_Cancer.yaml |
91.0% | 90.8% | 202/222 | 1 |
IFT140-related_Recessive_Ciliopathy.yaml |
91.0% | 92.3% | 101/111 | |
Woodhouse-Sakati_Syndrome.yaml |
91.0% | 91.5% | 192/211 | |
Ethmoid_Sinus_Adenocarcinoma.yaml |
91.0% | 92.3% | 91/100 | |
Hatipoglu_Immunodeficiency_Syndrome.yaml |
91.0% | 91.9% | 172/189 | |
Photosensitive_Epilepsy.yaml |
91.0% | 91.3% | 162/178 | 1 |
Fibrodysplasia_Ossificans_Progressiva.yaml |
91.0% | 91.7% | 142/156 | |
Progressive_Familial_Heart_Block.yaml |
91.0% | 94.3% | 71/78 | |
Autosomal_Dominant_Non-Syndromic_Intellectual_Disability.yaml |
91.0% | 91.8% | 406/446 | |
Neurodevelopmental_Disorder_with_Central_Hypotonia_and_Dysmorphic_Facies.yaml |
91.0% | 92.7% | 264/290 | |
NDP_Related_Vitreoretinopathy.yaml |
91.0% | 93.0% | 61/67 | |
Inherited_Porphyria.yaml |
91.1% | 91.9% | 275/302 | |
Mendelian_Susceptibility_To_Mycobacterial_Diseases_Due_To_Complete_ISG15_Deficiency.yaml |
91.1% | 91.5% | 163/179 | |
Ricin_Poisoning.yaml |
91.1% | 91.1% | 377/414 | |
Mosaic_Variegated_Aneuploidy_Syndrome.yaml |
91.1% | 91.6% | 265/291 | |
Polycystic_Kidney_Disease.yaml |
91.1% | 91.0% | 316/347 | 1 |
Autosomal_Dominant_Hyper-IgE_Syndrome.yaml |
91.1% | 91.9% | 153/168 | |
Cerebral_Proliferative_Angiopathy.yaml |
91.1% | 91.7% | 51/56 | 1 |
Coronary_Vasospasm.yaml |
91.1% | 92.3% | 102/112 | |
Hypokalemic_Periodic_Paralysis.yaml |
91.1% | 93.2% | 102/112 | |
Bejel.yaml |
91.1% | 91.8% | 143/157 | |
Polymyositis.yaml |
91.1% | 91.7% | 143/157 | |
MCM9-related_gametogenic_failure.yaml |
91.1% | 92.2% | 92/101 | |
Sheehan_Syndrome.yaml |
91.1% | 91.8% | 225/247 | |
Hereditary_Hemorrhagic_Telangiectasia_5.yaml |
91.1% | 92.1% | 195/214 | |
Proteasome_Associated_Autoinflammatory_Syndrome.yaml |
91.1% | 91.7% | 154/169 | |
Holoprosencephaly_9.yaml |
91.1% | 92.0% | 267/293 | |
Anal_Canal_Carcinoma.yaml |
91.1% | 93.0% | 113/124 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_22.yaml |
91.1% | 91.3% | 113/124 | 1 |
Microphthalmia_with_Coloboma.yaml |
91.1% | 91.9% | 226/248 | |
Bainbridge-Ropers_Syndrome.yaml |
91.1% | 92.7% | 288/316 | 1 |
Spinocerebellar_Ataxia_Type_2.yaml |
91.1% | 92.3% | 144/158 | |
RYR2_CPVT.yaml |
91.1% | 92.0% | 247/271 | |
Dandy-Walker_Syndrome.yaml |
91.1% | 91.3% | 175/192 | 1 |
Factor_XIII_A_Subunit_Deficiency.yaml |
91.2% | 89.5% | 268/294 | 3 |
Ferguson-Bonni_Neurodevelopmental_Syndrome.yaml |
91.2% | 92.4% | 134/147 | |
TRMU-Related_Acute_Infantile_Liver_Failure.yaml |
91.2% | 91.7% | 165/181 | |
Esophageal_Adenocarcinoma.yaml |
91.2% | 92.6% | 124/136 | |
Legionnaires_Disease.yaml |
91.2% | 92.6% | 93/102 | |
Schistosomiasis.yaml |
91.2% | 90.7% | 93/102 | |
Multiple_Sclerosis.yaml |
91.2% | 91.1% | 414/454 | 2 |
Microcephaly-Capillary_Malformation_Syndrome.yaml |
91.2% | 92.6% | 321/352 | |
Intellectual_Developmental_Disorder_X-Linked_Syndromic_37.yaml |
91.2% | 92.5% | 259/284 | |
Primary_Aldosteronism.yaml |
91.2% | 92.4% | 228/250 | |
COA5-Related_Fatal_Infantile_Cardioencephalomyopathy.yaml |
91.2% | 91.5% | 156/171 | |
Idiopathic_Hypereosinophilic_Syndrome.yaml |
91.2% | 91.6% | 229/251 | |
Chronic_Lymphocytic_Inflammation_With_Pontine_Perivascular_Enhancement_Responsive_To_Steroids.yaml |
91.2% | 91.8% | 125/137 | |
Lenz-Majewski_hyperostotic_dwarfism.yaml |
91.2% | 92.7% | 125/137 | |
Intellectual_Disability_X-linked_Syndromic_35.yaml |
91.2% | 92.5% | 198/217 | |
Neuronal_Intranuclear_Inclusion_Disease.yaml |
91.3% | 92.0% | 167/183 | |
Charcot-Marie-Tooth_Disease_Type_1.yaml |
91.3% | 92.5% | 115/126 | |
Pancreatic_Neuroendocrine_Tumor.yaml |
91.3% | 93.3% | 115/126 | |
UGGT1-congenital_disorder_of_glycosylation.yaml |
91.3% | 92.1% | 115/126 | |
Dilated_Cardiomyopathy_1II.yaml |
91.3% | 92.3% | 157/172 | |
Autosomal_Recessive_Cutis_Laxa_Type_2A.yaml |
91.3% | 92.3% | 178/195 | |
Combined_Oxidative_Phosphorylation_Deficiency_48.yaml |
91.3% | 91.6% | 178/195 | |
RYR1-Related_Myopathy.yaml |
91.3% | 92.7% | 199/218 | 1 |
Wiedemann-Rautenstrauch_Syndrome.yaml |
91.3% | 91.5% | 451/494 | |
Developmental_And_Epileptic_Encephalopathy_40.yaml |
91.3% | 93.1% | 84/92 | |
Guillain_Barre_Syndrome.yaml |
91.3% | 91.5% | 105/115 | |
IHH-Related_Polysyndactyly.yaml |
91.3% | 94.4% | 63/69 | |
Peroxisomal_Acyl-CoA_Oxidase_Deficiency.yaml |
91.3% | 92.1% | 168/184 | |
Moyamoya_Disease.yaml |
91.3% | 91.8% | 137/150 | 1 |
Inclusion_Body_Myositis.yaml |
91.3% | 92.2% | 285/312 | |
Arginase_Deficiency.yaml |
91.4% | 91.4% | 317/347 | |
Kidney_Sarcoma.yaml |
91.4% | 92.0% | 148/162 | |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_41.yaml |
91.4% | 91.2% | 159/174 | |
Familial_Vesicoureteral_Reflux.yaml |
91.4% | 92.7% | 297/325 | |
Congenital_Myasthenic_Syndrome_15.yaml |
91.4% | 92.8% | 85/93 | |
Rabson-Mendenhall_Syndrome.yaml |
91.4% | 92.4% | 202/221 | |
Dent_Disease.yaml |
91.4% | 91.1% | 319/349 | 1 |
Hodgkin_Lymphoma.yaml |
91.4% | 92.7% | 117/128 | |
adrenoleukodystrophy.yaml |
91.4% | 92.0% | 234/256 | |
MBD5_Haploinsufficiency_Syndrome.yaml |
91.4% | 92.3% | 149/163 | |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_7.yaml |
91.4% | 90.0% | 160/175 | 1 |
Endometrial_Endometrioid_Adenocarcinoma.yaml |
91.4% | 92.5% | 128/140 | |
GJB2-GJB6_Digenic_Nonsyndromic_Hearing_Loss.yaml |
91.4% | 94.3% | 32/35 | |
VPS53-Related_Pontocerebellar_Hypoplasia_Type_2E.yaml |
91.4% | 93.2% | 96/105 | |
Arrhythmogenic_Right_Ventricular_Cardiomyopathy.yaml |
91.4% | 91.2% | 299/327 | 2 |
ODonnell-Luria-Rodan_Syndrome.yaml |
91.5% | 91.9% | 289/316 | |
Congenital_Bilateral_Absence_of_Vas_Deferens.yaml |
91.5% | 92.0% | 150/164 | |
Marfanoid_Progeroid_Lipodystrophy_Syndrome.yaml |
91.5% | 92.2% | 279/305 | |
Childhood-Onset_Striatonigral_Degeneration.yaml |
91.5% | 92.5% | 161/176 | |
Double_Outlet_Right_Ventricle.yaml |
91.5% | 91.8% | 322/352 | |
GRIN2A-Related_Epileptic_Encephalopathy_and_Intellectual_Disability.yaml |
91.5% | 92.7% | 290/317 | |
GFI1B-related_Platelet-type_Bleeding_Disorder.yaml |
91.5% | 92.4% | 86/94 | 1 |
Chromoblastomycosis.yaml |
91.5% | 92.7% | 54/59 | |
Cushings_Syndrome.yaml |
91.5% | 92.5% | 54/59 | |
Autosomal_Recessive_Hypercholesterolemia.yaml |
91.5% | 91.5% | 227/248 | |
Frontotemporal_Dementia_And_Or_Amyotrophic_Lateral_Sclerosis_2.yaml |
91.5% | 91.5% | 238/260 | 1 |
Hereditary_von_Willebrand_Disease.yaml |
91.5% | 91.5% | 119/130 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_23.yaml |
91.5% | 91.9% | 119/130 | |
Primary_Hyperoxaluria_Type_3.yaml |
91.5% | 93.1% | 65/71 | |
Autosomal_Recessive_Limb-Girdle_Muscular_Dystrophy.yaml |
91.6% | 92.6% | 228/249 | |
MET_Exon_14_Skipping_NSCLC.yaml |
91.6% | 94.0% | 76/83 | |
Neurodegeneration_Childhood-onset_With_Cerebellar_Atrophy.yaml |
91.6% | 92.3% | 380/415 | |
Neurofibromatosis-Noonan_Syndrome.yaml |
91.6% | 93.7% | 76/83 | |
Dermatitis_Herpetiformis.yaml |
91.6% | 92.6% | 98/107 | |
SLC35A2-CDG.yaml |
91.6% | 92.6% | 98/107 | |
Malignant_Peripheral_Nerve_Sheath_Tumor.yaml |
91.6% | 91.8% | 120/131 | |
Hepatitis_B.yaml |
91.6% | 90.5% | 251/274 | |
Familial_Digital_Arthropathy-Brachydactyly.yaml |
91.6% | 92.2% | 142/155 | |
Serotonin_Syndrome.yaml |
91.6% | 92.0% | 153/167 | |
Duane_Retraction_Syndrome_3_With_Or_Without_Deafness.yaml |
91.6% | 92.3% | 175/191 | |
AICA-ribosiduria.yaml |
91.6% | 92.2% | 219/239 | |
Hypertrophic_Cardiomyopathy_21.yaml |
91.7% | 93.2% | 77/84 | |
Intellectual_Disability_Autosomal_Dominant_11.yaml |
91.7% | 92.9% | 55/60 | |
MOGAD.yaml |
91.7% | 92.0% | 132/144 | |
Multisystemic_Smooth_Muscle_Dysfunction_Syndrome.yaml |
91.7% | 93.1% | 66/72 | 2 |
Osteogenesis_Imperfecta_Type_VI.yaml |
91.7% | 93.3% | 77/84 | |
Social_Anxiety_Disorder.yaml |
91.7% | 89.0% | 132/144 | 3 |
Sterol_Carrier_Protein_2_Deficiency.yaml |
91.7% | 92.4% | 177/193 | |
Leprosy.yaml |
91.7% | 91.9% | 155/169 | |
Neuronal_Ceroid_Lipofuscinosis_7.yaml |
91.7% | 92.3% | 144/157 | 1 |
Rasmussen_Encephalitis.yaml |
91.7% | 92.4% | 144/157 | |
Spinocerebellar_Ataxia_Type_23.yaml |
91.7% | 93.0% | 144/157 | |
Mendelian_Susceptibility_To_Mycobacterial_Diseases_Due_To_Complete_IL12RB1_Deficiency.yaml |
91.7% | 92.1% | 111/121 | 1 |
Myelodysplastic_Syndrome.yaml |
91.7% | 93.3% | 100/109 | |
Carney-Stratakis_Syndrome.yaml |
91.8% | 92.6% | 89/97 | |
Eisenmenger_Syndrome.yaml |
91.8% | 91.8% | 234/255 | |
Chung-Jansen_Syndrome.yaml |
91.8% | 92.2% | 324/353 | 1 |
Aspirin-Exacerbated_Respiratory_Disease.yaml |
91.8% | 91.6% | 380/414 | |
3-Methylglutaconic_Aciduria_Type_I.yaml |
91.8% | 92.3% | 168/183 | |
Chondrosarcoma.yaml |
91.8% | 92.7% | 168/183 | |
Dilated_Cardiomyopathy_1JJ.yaml |
91.8% | 92.7% | 168/183 | |
SADDAN.yaml |
91.8% | 93.9% | 56/61 | |
Autosomal_Recessive_Spondylometaphyseal_Dysplasia_Megarbane_Type.yaml |
91.8% | 91.7% | 325/354 | 1 |
Deafness_Congenital_Heart_Defects_And_Posterior_Embryotoxon.yaml |
91.8% | 93.3% | 213/232 | |
Barth_Syndrome.yaml |
91.8% | 91.9% | 157/171 | |
Intellectual_Disability_Autosomal_Recessive_65.yaml |
91.8% | 92.6% | 146/159 | |
Progressive_Supranuclear_Palsy.yaml |
91.8% | 92.8% | 146/159 | |
Inflammatory_Myofibroblastic_Tumor.yaml |
91.8% | 92.6% | 90/98 | |
Sinoatrial_Node_Dysfunction_and_Deafness.yaml |
91.8% | 92.9% | 180/196 | |
Taurine_Transporter_Deficiency.yaml |
91.8% | 93.1% | 180/196 | |
Warsaw_breakage_syndrome.yaml |
91.9% | 92.4% | 203/221 | |
Myeloperoxidase_Deficiency.yaml |
91.9% | 92.9% | 113/123 | |
PUM1-Associated_Developmental_Disability_Ataxia_Seizure_Syndrome.yaml |
91.9% | 92.7% | 181/197 | |
Peroxisome_Biogenesis_Disorder_4A_Zellweger.yaml |
91.9% | 92.8% | 136/148 | |
ARPC1B_Deficiency.yaml |
91.9% | 93.0% | 148/161 | |
Carbon_Monoxide_Poisoning.yaml |
91.9% | 92.4% | 171/186 | |
Adult_Refsum_Disease.yaml |
92.0% | 91.7% | 240/261 | |
Non-functional_Pancreatic_Neuroendocrine_Tumor.yaml |
92.0% | 93.6% | 80/87 | |
Pacak-Zhuang_syndrome.yaml |
92.0% | 93.1% | 80/87 | |
Disorder_of_Catecholamine_Synthesis.yaml |
92.0% | 92.6% | 207/225 | |
Incontinentia_Pigmenti.yaml |
92.0% | 93.3% | 138/150 | |
Mercury_Poisoning.yaml |
92.0% | 94.8% | 46/50 | |
Peripheral_T_Cell_Lymphoma.yaml |
92.0% | 92.4% | 161/175 | |
Spastic_Paraplegia_90A_Autosomal_Dominant.yaml |
92.0% | 92.9% | 138/150 | |
Whipple_Disease.yaml |
92.0% | 93.0% | 115/125 | |
Syndromic_X-linked_Intellectual_Disability_94.yaml |
92.0% | 92.6% | 288/313 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_2.yaml |
92.0% | 92.5% | 208/226 | |
PAX3_Waardenburg_Spectrum.yaml |
92.0% | 92.1% | 104/113 | 1 |
Chromosome_3q29_Microdeletion_Syndrome.yaml |
92.0% | 92.9% | 185/201 | |
CN_Related_DEE.yaml |
92.1% | 92.9% | 116/126 | 1 |
Craniometadiaphyseal_Osteosclerosis_With_Hip_Dysplasia.yaml |
92.1% | 92.9% | 116/126 | |
Dominant_Deafness-Onychodystrophy_Syndrome.yaml |
92.1% | 93.1% | 174/189 | 1 |
Fibrocartilaginous_Embolism.yaml |
92.1% | 92.5% | 58/63 | 1 |
Osteogenesis_Imperfecta_Type_VIII.yaml |
92.1% | 94.2% | 58/63 | |
Parenti-Mignot_Neurodevelopmental_Syndrome.yaml |
92.1% | 93.7% | 93/101 | |
Pelger-Huet_Anomaly.yaml |
92.1% | 90.6% | 128/139 | 1 |
Aortitis.yaml |
92.1% | 91.7% | 198/215 | 2 |
Congenital_Glaucoma.yaml |
92.1% | 92.4% | 303/329 | |
Neonatal_Lupus_Erythematosus.yaml |
92.1% | 93.3% | 117/127 | |
46_XY_Sex_Reversal_11.yaml |
92.1% | 92.1% | 328/356 | |
Cooks_Syndrome.yaml |
92.1% | 93.0% | 82/89 | |
Congenital_Isolated_Hyperinsulinism.yaml |
92.1% | 93.0% | 211/229 | |
Charlevoix-Saguenay_spastic_ataxia.yaml |
92.2% | 93.2% | 141/153 | |
Cutaneous_Collagenous_Vasculopathy.yaml |
92.2% | 91.4% | 47/51 | 2 |
Renal_Coloboma_Syndrome.yaml |
92.2% | 92.6% | 235/255 | |
Myopathy_Lactic_Acidosis_and_Sideroblastic_Anemia.yaml |
92.2% | 92.6% | 247/268 | |
Zlotogora-Ogur_Syndrome.yaml |
92.2% | 93.4% | 106/115 | |
Gaucher_Disease.yaml |
92.2% | 91.2% | 436/473 | 2 |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_98.yaml |
92.2% | 92.9% | 142/154 | |
Preeclampsia.yaml |
92.2% | 92.9% | 284/308 | |
Ocular_Melanoma.yaml |
92.2% | 93.2% | 308/334 | |
Brachydactyly_Type_A1.yaml |
92.2% | 92.9% | 166/180 | |
Satoyoshi_Syndrome.yaml |
92.2% | 92.6% | 166/180 | 1 |
Acrocapitofemoral_Dysplasia.yaml |
92.2% | 92.4% | 273/296 | |
Unverricht-Lundborg_Disease.yaml |
92.2% | 92.6% | 190/206 | 2 |
Embryonal_Rhabdomyosarcoma.yaml |
92.2% | 92.9% | 119/129 | |
Rosacea.yaml |
92.2% | 92.2% | 476/516 | 1 |
Tuberculosis.yaml |
92.3% | 92.3% | 274/297 | |
Pfeiffer_Syndrome.yaml |
92.3% | 93.0% | 143/155 | |
Growth_Hormone_Insensitivity_Syndrome.yaml |
92.3% | 93.2% | 167/181 | |
Brugada_Syndrome.yaml |
92.3% | 91.5% | 251/272 | 4 |
Pyoderma_Gangrenosum.yaml |
92.3% | 92.1% | 311/337 | 1 |
EVEN-PLUS_Syndrome.yaml |
92.3% | 93.4% | 120/130 | |
Greig_Cephalopolysyndactyly.yaml |
92.3% | 93.6% | 84/91 | |
Intellectual_Disability_Autosomal_Recessive_43.yaml |
92.3% | 92.9% | 192/208 | 1 |
MITF_Waardenburg_Tietz_Spectrum.yaml |
92.3% | 93.0% | 84/91 | |
Shprintzen-Goldberg_Syndrome.yaml |
92.3% | 92.3% | 72/78 | |
Oculocutaneous_Albinism.yaml |
92.3% | 93.4% | 193/209 | |
Immunodeficiency_101_Varicella_Zoster_Virus-specific.yaml |
92.3% | 93.1% | 181/196 | |
Empty_Nose_Syndrome.yaml |
92.4% | 92.1% | 145/157 | 1 |
Anencephaly.yaml |
92.4% | 92.9% | 133/144 | 1 |
Eosinophilic_Fasciitis.yaml |
92.4% | 93.1% | 109/118 | |
WAPL-Related_Developmental_Disorder.yaml |
92.4% | 93.3% | 218/236 | |
Autoimmune_Pulmonary_Alveolar_Proteinosis.yaml |
92.4% | 92.6% | 292/316 | 1 |
Rienhoff_Syndrome.yaml |
92.4% | 93.5% | 219/237 | |
CPLX1-Related_DEE.yaml |
92.4% | 92.4% | 256/277 | 2 |
Allopurinol_Induced_SJS_TEN.yaml |
92.4% | 93.0% | 110/119 | 1 |
Hyperlipidemia.yaml |
92.4% | 92.6% | 220/238 | 1 |
Hypersensitivity_Pneumonitis.yaml |
92.4% | 92.3% | 110/119 | 1 |
Mycosis_Fungoides.yaml |
92.4% | 92.4% | 110/119 | 1 |
Sorbitol_Dehydrogenase_Deficiency.yaml |
92.4% | 93.0% | 220/238 | 1 |
ATTR_Amyloidosis.yaml |
92.4% | 92.7% | 257/278 | |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_11.yaml |
92.5% | 91.9% | 98/106 | 1 |
Methylmalonate_Semialdehyde_Dehydrogenase_Deficiency.yaml |
92.5% | 92.7% | 147/159 | 1 |
Scabies.yaml |
92.5% | 91.7% | 49/53 | |
Yunis-Varon_Syndrome.yaml |
92.5% | 93.0% | 282/305 | |
Squamous_Cell_Carcinoma_of_Penis.yaml |
92.5% | 93.8% | 86/93 | |
5-Oxoprolinase_Deficiency.yaml |
92.5% | 93.5% | 123/133 | |
Hereditary_Sensory_and_Autonomic_Neuropathy_Type_6.yaml |
92.5% | 93.0% | 160/173 | |
Hypotrichosis_4.yaml |
92.5% | 92.8% | 148/160 | |
Lipoyl_Transferase_1_Deficiency.yaml |
92.5% | 93.2% | 111/120 | |
Primary_Hypertrophic_Osteoarthropathy.yaml |
92.5% | 93.9% | 111/120 | |
Hypobetalipoproteinemia.yaml |
92.5% | 93.2% | 247/267 | |
Severe_Combined_Immunodeficiency.yaml |
92.5% | 93.0% | 371/401 | |
Canavan_Disease.yaml |
92.5% | 92.7% | 297/321 | |
HSD10_Mitochondrial_Disease.yaml |
92.5% | 93.9% | 99/107 | |
Pilocytic_Astrocytoma.yaml |
92.5% | 93.0% | 99/107 | |
Hereditary_Spastic_Paraplegia_3A.yaml |
92.5% | 92.5% | 384/415 | 1 |
SCN2A-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
92.5% | 93.9% | 124/134 | |
Myofibrillar_Myopathy.yaml |
92.5% | 93.4% | 360/389 | |
Essential_Hypertension.yaml |
92.6% | 92.5% | 87/94 | |
VEXAS_Syndrome.yaml |
92.6% | 92.7% | 174/188 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_32.yaml |
92.6% | 93.3% | 199/215 | |
Lathyrism.yaml |
92.6% | 93.9% | 137/148 | |
Hereditary_Hemorrhagic_Telangiectasia_Type_2.yaml |
92.6% | 92.7% | 287/310 | |
CDK19-Related_Disorder.yaml |
92.6% | 93.1% | 362/391 | |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_37.yaml |
92.6% | 93.1% | 100/108 | |
Lymphomatoid_Granulomatosis.yaml |
92.6% | 93.4% | 125/135 | |
Niemann-Pick_Disease_Type_E.yaml |
92.6% | 96.2% | 25/27 | |
Paralytic_Poliomyelitis.yaml |
92.6% | 93.4% | 100/108 | 1 |
Pick_Disease.yaml |
92.6% | 93.6% | 138/149 | |
Shwachman-Diamond_Syndrome.yaml |
92.6% | 92.9% | 276/298 | |
Acute_Alcohol_Sensitivity.yaml |
92.6% | 92.9% | 113/122 | |
Lowe_Syndrome.yaml |
92.6% | 93.7% | 113/122 | |
Duane_Retraction_Syndrome.yaml |
92.6% | 94.2% | 88/95 | |
IgG4-Related_Sclerosing_Cholangitis.yaml |
92.6% | 93.4% | 88/95 | 1 |
Bullous_Pemphigoid.yaml |
92.7% | 94.3% | 101/109 | |
Mitochondrial_DNA_Depletion_Syndrome_14B.yaml |
92.7% | 93.3% | 215/232 | 1 |
COA6-Related_Fatal_Infantile_Cardioencephalomyopathy.yaml |
92.7% | 92.8% | 152/164 | |
Primary_Biliary_Cholangitis.yaml |
92.7% | 92.9% | 114/123 | |
Subcutaneous_Panniculitis-like_T-cell_Lymphoma.yaml |
92.7% | 93.4% | 152/164 | |
3-Hydroxy-3-Methylglutaric_Aciduria.yaml |
92.7% | 93.2% | 241/260 | |
Choroiditis.yaml |
92.7% | 93.1% | 368/397 | |
Atrial_Fibrillation.yaml |
92.7% | 92.5% | 254/274 | |
Plasma_Cell_Neoplasm.yaml |
92.7% | 94.1% | 127/137 | |
Cutis_Laxa_Autosomal_Recessive_Type_2E.yaml |
92.7% | 93.3% | 305/329 | |
Uveal_Coloboma-Cleft_Lip_and_Palate-Intellectual_Disability_Syndrome.yaml |
92.7% | 93.5% | 178/192 | |
Isolated_Sulfite_Oxidase_Deficiency.yaml |
92.7% | 94.0% | 242/261 | |
Junctional_Epidermolysis_Bullosa.yaml |
92.7% | 93.0% | 255/275 | |
Meningeal_Melanocytoma.yaml |
92.7% | 93.7% | 102/110 | 1 |
Medullary_Sponge_Kidney.yaml |
92.7% | 93.5% | 115/124 | |
GOLGA2-Related_Golgin_A2_Deficiency.yaml |
92.8% | 94.8% | 64/69 | |
Pouchitis.yaml |
92.8% | 93.3% | 64/69 | |
Sneddon_syndrome.yaml |
92.8% | 94.4% | 64/69 | |
Immunodeficiency_63_with_Lymphoproliferation_and_Autoimmunity.yaml |
92.8% | 93.6% | 154/166 | |
BRPF1-Related_Intellectual_Disability.yaml |
92.8% | 92.7% | 706/761 | 1 |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_6.yaml |
92.8% | 93.4% | 167/180 | |
Capillary_Malformation-Arteriovenous_Malformation_Syndrome.yaml |
92.8% | 94.2% | 90/97 | |
Measles.yaml |
92.8% | 93.6% | 90/97 | |
Bronchiectasis.yaml |
92.8% | 93.1% | 193/208 | |
RTN4IP1-Related_Optic_Atrophy.yaml |
92.8% | 93.8% | 103/111 | |
WHIM_Syndrome_1.yaml |
92.8% | 93.8% | 206/222 | |
Spondyloepimetaphyseal_Dysplasia_Faden-Alkuraya_Type.yaml |
92.8% | 94.3% | 271/292 | |
Camurati-Engelmann_Disease.yaml |
92.8% | 93.9% | 142/153 | |
Cerebellar_Ataxia-Hypogonadism_Syndrome.yaml |
92.8% | 94.0% | 155/167 | |
Catatonia.yaml |
92.9% | 93.5% | 208/224 | |
Immunodeficiency_32B.yaml |
92.9% | 94.2% | 117/126 | |
Jacobsen_Syndrome.yaml |
92.9% | 94.2% | 91/98 | |
Juvenile_Open_Angle_Glaucoma.yaml |
92.9% | 94.1% | 104/112 | |
Nonimmune_Chronic_Idiopathic_Neutropenia_of_Adults.yaml |
92.9% | 93.2% | 91/98 | 1 |
ROS1_Rearranged_NSCLC.yaml |
92.9% | 93.4% | 169/182 | |
Renpenning_syndrome.yaml |
92.9% | 94.7% | 65/70 | |
THOC6-Related_Developmental_Delay-Microcephaly-Facial_Dysmorphism_Syndrome.yaml |
92.9% | 94.0% | 156/168 | 1 |
CDK8-Related_Disorder.yaml |
92.9% | 93.5% | 444/478 | |
Isolated_Glycerol_Kinase_Deficiency.yaml |
92.9% | 93.1% | 131/141 | 1 |
Klippel-Feil_Syndrome.yaml |
92.9% | 93.8% | 131/141 | |
Rhizomelic_Chondrodysplasia_Punctata_Plasmalogen_Synthesis_Defect.yaml |
92.9% | 94.0% | 131/141 | |
Osteootohepatoenteric_Syndrome.yaml |
92.9% | 93.5% | 118/127 | 1 |
Immune_Thrombocytopenia.yaml |
92.9% | 93.3% | 79/85 | |
Pulmonary_Alveolar_Proteinosis_With_Hypogammaglobulinemia.yaml |
92.9% | 93.9% | 158/170 | |
Segmental_Arterial_Mediolysis.yaml |
92.9% | 93.3% | 79/85 | 1 |
Ablepharon_Macrostomia_Syndrome.yaml |
92.9% | 92.9% | 382/411 | |
22q11.2_Deletion_Syndrome.yaml |
93.0% | 93.5% | 211/227 | |
Metabolic_Dysfunction-Associated_Steatotic_Liver_Disease.yaml |
93.0% | 93.1% | 330/355 | 3 |
Pleuropulmonary_Blastoma.yaml |
93.0% | 93.5% | 132/142 | |
Skraban-Deardorff_Syndrome.yaml |
93.0% | 94.4% | 132/142 | |
Bardet-Biedl_Syndrome.yaml |
93.0% | 93.3% | 291/313 | |
Cannabis_Hyperemesis_Syndrome.yaml |
93.0% | 93.2% | 106/114 | |
Gaucher_Disease_Due_To_Saposin_C_Deficiency.yaml |
93.0% | 94.7% | 53/57 | |
Lung_Carcinoma.yaml |
93.0% | 92.9% | 53/57 | 1 |
Bilateral_Striopallidodentate_Calcinosis.yaml |
93.0% | 94.1% | 146/157 | |
Congenital_Myasthenic_Syndrome_18.yaml |
93.0% | 94.3% | 146/157 | |
FOXP1_Syndrome.yaml |
93.0% | 93.5% | 399/429 | 1 |
Fanconi_Renotubular_Syndrome.yaml |
93.0% | 94.2% | 133/143 | |
Primary_Ciliary_Dyskinesia.yaml |
93.0% | 93.2% | 705/758 | |
Dilated_Cardiomyopathy.yaml |
93.0% | 93.4% | 386/415 | |
Brucella_Melitensis_Brucellosis.yaml |
93.0% | 93.0% | 160/172 | 1 |
Carvajal_Syndrome.yaml |
93.0% | 94.2% | 120/129 | |
Endometrial_Carcinoma.yaml |
93.0% | 93.9% | 200/215 | |
X-linked_Reticulate_Pigmentary_Disorder.yaml |
93.0% | 93.5% | 200/215 | |
Pelvic_Inflammatory_Disease.yaml |
93.0% | 93.3% | 227/244 | 1 |
Peters_Plus_Syndrome.yaml |
93.0% | 93.9% | 227/244 | |
Congenital_Insensitivity_to_Pain.yaml |
93.0% | 94.2% | 147/158 | |
Nijmegen_breakage_syndrome.yaml |
93.0% | 93.8% | 107/115 | |
Keipert_syndrome.yaml |
93.1% | 94.8% | 67/72 | |
Progressive_Bulbar_Palsy.yaml |
93.1% | 95.1% | 67/72 | |
Cryoglobulinemic_Vasculitis.yaml |
93.1% | 93.1% | 94/101 | 2 |
Hepatic_Veno-occlusive_Disease-Immunodeficiency_Syndrome.yaml |
93.1% | 94.6% | 94/101 | |
Menieres_Disease.yaml |
93.1% | 93.0% | 94/101 | |
Neurodevelopmental_Disorder_with_Microcephaly_Impaired_Language_and_Gait_Abnormalities.yaml |
93.1% | 94.0% | 242/260 | |
Ventricular_Septal_Defect.yaml |
93.1% | 93.6% | 202/217 | |
Familial_Hyperaldosteronism.yaml |
93.1% | 94.3% | 135/145 | |
Keratoderma_Hereditarium_Mutilans.yaml |
93.1% | 92.9% | 108/116 | 1 |
Multiple_Mitochondrial_Dysfunctions_Syndrome_4.yaml |
93.1% | 92.6% | 108/116 | 1 |
Rheumatoid_Vasculitis.yaml |
93.1% | 93.9% | 108/116 | 2 |
Waardenburg_Syndrome_Type_2F.yaml |
93.1% | 93.8% | 135/145 | |
PUS7-Related_Neurodevelopmental_Disorder.yaml |
93.1% | 94.5% | 284/305 | |
Left_Ventricular_Noncompaction.yaml |
93.1% | 93.5% | 149/160 | |
Adult_Onset_Foveomacular_Vitelliform_Dystrophy.yaml |
93.1% | 94.5% | 95/102 | |
Immunodeficiency_98_With_Autoinflammation.yaml |
93.1% | 93.8% | 163/175 | |
Townes-Brocks_Syndrome_1.yaml |
93.2% | 93.9% | 313/336 | |
Pulmonary_Hemosiderosis.yaml |
93.2% | 94.3% | 177/190 | |
Panic_Disorder.yaml |
93.2% | 93.4% | 109/117 | |
Spinocerebellar_Ataxia_43.yaml |
93.2% | 94.4% | 109/117 | 1 |
Scorpion_Envenomation.yaml |
93.2% | 93.4% | 273/293 | |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_47.yaml |
93.2% | 95.2% | 41/44 | |
Infantile_Myofibromatosis.yaml |
93.2% | 95.3% | 41/44 | |
Sjogrens_Syndrome.yaml |
93.2% | 93.9% | 178/191 | |
Visceral_Heterotaxy.yaml |
93.2% | 94.2% | 96/103 | |
Autoimmune_Encephalitis.yaml |
93.2% | 93.3% | 206/221 | |
Crouzon_Syndrome.yaml |
93.2% | 94.5% | 110/118 | |
GAPO_Syndrome.yaml |
93.2% | 93.7% | 165/177 | 1 |
Splenic_Artery_Aneurysm.yaml |
93.2% | 93.7% | 110/118 | 1 |
Mumps.yaml |
93.2% | 93.8% | 69/74 | |
Multiple_Epiphyseal_Dysplasia.yaml |
93.3% | 94.4% | 166/178 | |
Citrin_Deficiency.yaml |
93.3% | 93.6% | 236/253 | 1 |
Granulomatosis_with_Polyangiitis.yaml |
93.3% | 94.1% | 292/313 | |
Fowler_Syndrome.yaml |
93.3% | 94.0% | 195/209 | 1 |
Hypertensive_Retinopathy.yaml |
93.3% | 94.6% | 84/90 | |
Hypochondrogenesis.yaml |
93.3% | 94.1% | 168/180 | |
Specific_Antibody_Deficiency.yaml |
93.3% | 94.3% | 112/120 | |
ZNF341_Deficiency.yaml |
93.3% | 93.9% | 252/270 | |
ATP6V0C-Related_Epilepsy.yaml |
93.4% | 93.7% | 239/256 | |
Baller-Gerold_Syndrome.yaml |
93.4% | 93.9% | 169/181 | |
Multiminicore_Disease.yaml |
93.4% | 94.4% | 155/166 | |
KCNH1_Associated_Disorder.yaml |
93.4% | 94.7% | 212/227 | |
Brittle_Cornea_Syndrome.yaml |
93.4% | 94.7% | 99/106 | |
Hearing_Loss_Autosomal_Recessive_106.yaml |
93.4% | 93.3% | 85/91 | 1 |
Chemotherapy_Induced_Nausea_and_Vomiting.yaml |
93.4% | 94.8% | 71/76 | |
Naxos_disease.yaml |
93.4% | 94.7% | 142/152 | |
Methylcobalamin_Deficiency_Type_cblE.yaml |
93.4% | 93.8% | 199/213 | |
CYFIP2-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
93.4% | 93.4% | 256/274 | |
Rhizomelic_Chondrodysplasia_Punctata_Type_1.yaml |
93.4% | 94.3% | 128/137 | |
Diaphyseal_Medullary_Stenosis_With_Malignant_Fibrous_Histiocytoma.yaml |
93.4% | 94.4% | 114/122 | |
Wilsons_Disease.yaml |
93.4% | 93.1% | 713/763 | 3 |
Classic_Hodgkin_Lymphoma.yaml |
93.5% | 93.7% | 157/168 | |
Immunodeficiency_57.yaml |
93.5% | 93.6% | 157/168 | |
Mucopolysaccharidosis.yaml |
93.5% | 93.5% | 157/168 | |
Mitochondrial_Trifunctional_Protein_Deficiency.yaml |
93.5% | 93.6% | 286/306 | 1 |
Choroid_Plexus_Neoplasm.yaml |
93.5% | 94.0% | 329/352 | |
ADan_amyloidosis.yaml |
93.5% | 93.7% | 229/245 | |
Congestive_Splenomegaly.yaml |
93.5% | 94.9% | 86/92 | |
Shigellosis.yaml |
93.5% | 94.0% | 115/123 | |
Sepsis.yaml |
93.5% | 94.3% | 159/170 | |
Hereditary_Neuropathy_with_Liability_to_Pressure_Palsies.yaml |
93.5% | 94.1% | 87/93 | |
Idiopathic_Pulmonary_Arterial_Hypertension.yaml |
93.5% | 93.3% | 261/279 | 1 |
Malignant_Sertoli-Leydig_Cell_Tumor_of_Ovary.yaml |
93.5% | 94.7% | 116/124 | |
Mitochondrial_DNA_Depletion_Syndrome_7.yaml |
93.5% | 95.2% | 87/93 | |
Osteogenesis_Imperfecta_Type_XVIII.yaml |
93.5% | 95.6% | 58/62 | |
Osteogenesis_Imperfecta_Type_XXII.yaml |
93.5% | 95.6% | 58/62 | |
Malonic_Aciduria.yaml |
93.6% | 94.7% | 160/171 | |
Spinocerebellar_Ataxia_Type_36.yaml |
93.6% | 93.6% | 277/296 | |
Hurler_syndrome.yaml |
93.6% | 94.8% | 175/187 | |
Birt-Hogg-Dube_Syndrome.yaml |
93.6% | 94.7% | 73/78 | |
Primary_Erythermalgia.yaml |
93.6% | 94.7% | 73/78 | |
TUBGCP4-related_Microcephaly_and_Chorioretinopathy.yaml |
93.6% | 94.7% | 73/78 | |
Krabbe_Disease.yaml |
93.6% | 94.0% | 190/203 | 1 |
Ovarian_Hyperstimulation_Syndrome.yaml |
93.6% | 93.7% | 322/344 | |
Developmental_And_Epileptic_Encephalopathy_89.yaml |
93.6% | 94.4% | 366/391 | |
Carotid_Web.yaml |
93.6% | 95.3% | 44/47 | 1 |
North_Carolina_Macular_Dystrophy.yaml |
93.6% | 95.1% | 88/94 | |
RP1-Related_Retinopathy.yaml |
93.6% | 95.1% | 88/94 | |
Thymoma.yaml |
93.6% | 94.6% | 191/204 | |
MRPL44_Deficiency.yaml |
93.7% | 93.6% | 369/394 | 2 |
Idiopathic_Interstitial_Pneumonia.yaml |
93.7% | 94.2% | 148/158 | |
oligoastrocytoma.yaml |
93.7% | 95.2% | 74/79 | |
Usmani-Riazuddin_Syndrome_Autosomal_Dominant.yaml |
93.7% | 94.1% | 193/206 | |
Cytomegalovirus_Retinitis.yaml |
93.7% | 94.7% | 119/127 | |
Graves_Disease.yaml |
93.7% | 93.7% | 268/286 | 1 |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_88.yaml |
93.7% | 94.2% | 164/175 | |
CHEK2-related_Cancer_Predisposition.yaml |
93.7% | 93.6% | 179/191 | |
Familial_Hypercholesterolemia.yaml |
93.7% | 93.6% | 449/479 | 2 |
Autosomal_Dominant_Osteosclerosis_Worth_Type.yaml |
93.8% | 94.0% | 225/240 | |
Leber_Hereditary_Optic_Neuropathy.yaml |
93.8% | 93.9% | 285/304 | 1 |
Lupus_Nephritis.yaml |
93.8% | 94.7% | 180/192 | |
Osteogenesis_Imperfecta_Type_XII.yaml |
93.8% | 95.7% | 60/64 | |
Sinonasal_Undifferentiated_Carcinoma.yaml |
93.8% | 94.9% | 105/112 | |
TTC19-related_Mitochondrial_Complex_III_Deficiency.yaml |
93.8% | 95.6% | 90/96 | |
Long_COVID.yaml |
93.8% | 93.5% | 526/561 | 3 |
COX4I2-Related_Pancreatic_Insufficiency-Anemia-Hyperostosis_Syndrome.yaml |
93.8% | 93.5% | 226/241 | 1 |
Vulvar_Adenocarcinoma.yaml |
93.8% | 93.8% | 226/241 | |
Blastic_Plasmacytoid_Dendritic_Cell_Neoplasm.yaml |
93.8% | 93.8% | 437/466 | 1 |
GPD1_Deficiency.yaml |
93.8% | 94.1% | 196/209 | |
Yolk_Sac_Tumor.yaml |
93.8% | 93.7% | 196/209 | |
Metachromatic_Leukodystrophy.yaml |
93.8% | 93.6% | 136/145 | 1 |
LDLR-Related_Familial_Hypercholesterolemia.yaml |
93.8% | 93.9% | 348/371 | |
Kosaki_Overgrowth_Syndrome.yaml |
93.8% | 95.0% | 91/97 | |
Spinocerebellar_Ataxia_Type_31.yaml |
93.8% | 94.8% | 167/178 | |
Feingold_Syndrome.yaml |
93.8% | 94.8% | 137/146 | |
X-Linked_Hypophosphatemia.yaml |
93.8% | 94.0% | 244/260 | |
Heme_Oxygenase_1_Deficiency.yaml |
93.9% | 93.9% | 397/423 | 1 |
Liddle_Syndrome.yaml |
93.9% | 94.5% | 168/179 | |
BMP2-Related_Short_Stature-Facial_Dysmorphism-Skeletal_Anomalies_Syndrome.yaml |
93.9% | 94.4% | 382/407 | |
TUBB2A_TUBB2B-related_Cortical_Malformation.yaml |
93.9% | 94.3% | 199/212 | 2 |
Charcot-Marie-Tooth_Disease_Type_2.yaml |
93.9% | 94.6% | 490/522 | |
Chediak-Higashi_Syndrome.yaml |
93.9% | 95.0% | 138/147 | |
Psittacosis.yaml |
93.9% | 94.0% | 46/49 | |
Premenstrual_Dysphoric_Disorder.yaml |
93.9% | 94.2% | 154/164 | |
Cardiac_Facial_And_Digital_Anomalies_With_Developmental_Delay.yaml |
93.9% | 94.6% | 309/329 | |
Ornithine_Carbamoyltransferase_Deficiency.yaml |
93.9% | 94.4% | 201/214 | |
Amelogenesis_Imperfecta.yaml |
93.9% | 94.2% | 232/247 | |
Juvenile-Onset_Diabetes_Mellitus_with_Central_and_Peripheral_Neurodegeneration.yaml |
93.9% | 94.6% | 232/247 | |
Aland_Island_Eye_Disease.yaml |
93.9% | 94.6% | 124/132 | |
Burkitt_Lymphoma.yaml |
93.9% | 94.7% | 124/132 | |
Cardiac_Sarcoidosis.yaml |
93.9% | 94.1% | 248/264 | |
Chickenpox.yaml |
93.9% | 93.1% | 155/165 | 1 |
Garg-Mishra_Progeroid_Syndrome.yaml |
93.9% | 94.5% | 217/231 | |
Hereditary_Spastic_Paraplegia_11.yaml |
93.9% | 95.2% | 93/99 | 1 |
Immunodeficiency_96.yaml |
93.9% | 94.4% | 217/231 | |
PTCH1-related_Nevoid_Basal_Cell_Carcinoma_Syndrome.yaml |
93.9% | 94.7% | 93/99 | |
TMEM199-CDG.yaml |
93.9% | 94.6% | 155/165 | |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_2A.yaml |
94.0% | 93.7% | 202/215 | 1 |
Dermatomyositis.yaml |
94.0% | 94.6% | 249/265 | |
Acute_Hypotension.yaml |
94.0% | 94.5% | 78/83 | |
Aminoacylase_1_Deficiency.yaml |
94.0% | 95.1% | 156/166 | |
Palmoplantar_Keratoderma-Deafness_Syndrome.yaml |
94.0% | 95.2% | 78/83 | |
Craniopharyngioma.yaml |
94.0% | 94.9% | 172/183 | |
SEPSECS_Deficiency.yaml |
94.0% | 96.3% | 47/50 | |
Weaver_Syndrome.yaml |
94.0% | 94.8% | 188/200 | 1 |
AFG2A-Related_Encephalopathy.yaml |
94.0% | 93.9% | 220/234 | 1 |
Warburg_Cinotti_Syndrome.yaml |
94.0% | 95.0% | 110/117 | |
Immunodeficiency_128.yaml |
94.0% | 95.5% | 126/134 | |
Osteogenesis_Imperfecta_Type_X.yaml |
94.0% | 95.9% | 63/67 | |
Osteogenesis_Imperfecta_Type_XX.yaml |
94.0% | 95.9% | 63/67 | |
PET100-Related_COX_Deficiency.yaml |
94.0% | 94.9% | 126/134 | |
Riley-Day_Syndrome.yaml |
94.0% | 94.2% | 316/336 | 1 |
Iron_Poisoning.yaml |
94.1% | 94.9% | 269/286 | |
Immunodeficiency_102.yaml |
94.1% | 95.1% | 190/202 | |
Platelet-Type_von_Willebrand_Disease.yaml |
94.1% | 95.4% | 95/101 | |
Waldenstrom_Macroglobulinemia.yaml |
94.1% | 94.5% | 95/101 | |
Auditory_Neuropathy.yaml |
94.1% | 94.1% | 206/219 | 1 |
Cernunnos-XLF_deficiency.yaml |
94.1% | 95.1% | 111/118 | |
Ichthyotic_Keratoderma_Spasticity_Hypomyelination_And_Dysmorphic_Facial_Features.yaml |
94.1% | 95.2% | 111/118 | |
Short-Rib_Thoracic_Dysplasia_6_With_Or_Without_Polydactyly.yaml |
94.1% | 94.7% | 111/118 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_103.yaml |
94.1% | 94.7% | 127/135 | |
Gilberts_Syndrome.yaml |
94.1% | 93.9% | 207/220 | 1 |
Lymphoma.yaml |
94.1% | 93.5% | 32/34 | 1 |
MT-ATP6_MT-ATP8-Related_Infantile_Hypertrophic_Cardiomyopathy.yaml |
94.1% | 95.0% | 176/187 | |
Malnutrition-related_Diabetes_Mellitus.yaml |
94.1% | 100.0% | 16/17 | |
Okur_Chung_neurodevelopmental_syndrome.yaml |
94.1% | 95.1% | 96/102 | |
Osteogenesis_Imperfecta_Type_XI.yaml |
94.1% | 96.1% | 64/68 | |
Osteogenesis_Imperfecta_Type_XVI.yaml |
94.1% | 95.9% | 64/68 | |
Thromboangiitis_Obliterans.yaml |
94.1% | 95.4% | 112/119 | |
Splenic_Marginal_Zone_Lymphoma.yaml |
94.2% | 94.5% | 161/171 | |
Congenital_Aural_Atresia.yaml |
94.2% | 95.0% | 97/103 | |
Glutathione_Synthetase_Deficiency.yaml |
94.2% | 95.3% | 97/103 | |
Pancreatic_Mucinous_Cystadenoma.yaml |
94.2% | 94.5% | 97/103 | |
Lymphatic_Filariasis.yaml |
94.2% | 94.0% | 81/86 | |
Vitamin_D-Dependent_Rickets_Type_3.yaml |
94.2% | 94.2% | 260/276 | 2 |
Optic_Neuritis.yaml |
94.2% | 94.1% | 212/225 | |
Brachyphalangy_Polydactyly_Tibial_Aplasia_Syndrome.yaml |
94.2% | 95.2% | 98/104 | |
Autoimmune_Enteropathy.yaml |
94.2% | 94.5% | 131/139 | |
RP2-Related_Retinopathy.yaml |
94.3% | 95.8% | 82/87 | |
Familial_Mediterranean_Fever.yaml |
94.3% | 94.0% | 148/157 | 2 |
ADGRG1_Bilateral_Frontoparietal_Polymicrogyria.yaml |
94.3% | 94.4% | 247/262 | 3 |
Cold_Agglutinin_Disease.yaml |
94.3% | 94.2% | 297/315 | |
Osteogenesis_Imperfecta_Type_XVII.yaml |
94.3% | 96.2% | 66/70 | |
Pallister-Hall_Syndrome.yaml |
94.3% | 95.2% | 99/105 | |
Penile_Cancer.yaml |
94.3% | 94.5% | 99/105 | |
Fibrochondrogenesis.yaml |
94.3% | 95.0% | 149/158 | |
Beck-Fahrner_Syndrome.yaml |
94.3% | 95.9% | 83/88 | |
Undetermined_Early_Onset_Epileptic_Encephalopathy.yaml |
94.3% | 95.2% | 133/141 | |
Barber-Say_Syndrome.yaml |
94.3% | 94.4% | 383/406 | |
Acute_Macular_Neuroretinopathy.yaml |
94.3% | 94.5% | 50/53 | |
Familial_Isolated_Vitamin_E_Deficiency.yaml |
94.3% | 95.7% | 100/106 | |
Intellectual_Developmental_Disorder_Autosomal_Dominant_72.yaml |
94.3% | 95.1% | 250/265 | |
ALG11-Congenital_Disorder_of_Glycosylation.yaml |
94.4% | 95.2% | 284/301 | |
Irritable_Bowel_Syndrome.yaml |
94.4% | 94.3% | 117/124 | |
Stickler_Syndrome_Type_2.yaml |
94.4% | 94.7% | 184/195 | |
Congenital_Renal_Artery_Stenosis.yaml |
94.4% | 95.9% | 67/71 | |
Osteogenesis_Imperfecta_Type_XIX.yaml |
94.4% | 96.2% | 67/71 | |
Sagittal_Sinus_Thrombosis.yaml |
94.4% | 96.2% | 67/71 | |
Travelers_Diarrhea.yaml |
94.4% | 94.5% | 285/302 | |
Posterior_Polymorphous_Corneal_Dystrophy.yaml |
94.4% | 95.8% | 84/89 | |
Visual_Snow_Syndrome.yaml |
94.4% | 94.3% | 168/178 | 2 |
12p12.1_Microdeletion_Syndrome.yaml |
94.4% | 95.2% | 101/107 | |
Juvenile_Neuronal_Ceroid_Lipofuscinosis.yaml |
94.4% | 95.1% | 219/232 | |
COQ6-Related_Steroid-Resistant_Nephrotic_Syndrome.yaml |
94.4% | 94.5% | 270/286 | |
Diffuse_Nonepidermolytic_Palmoplantar_Keratoderma.yaml |
94.4% | 94.8% | 135/143 | 1 |
SCUBE3-Related_Short_Stature_Syndrome.yaml |
94.4% | 94.1% | 152/161 | |
MPI-Congenital_Disorder_of_Glycosylation.yaml |
94.4% | 94.5% | 355/376 | |
Leber-like_Hereditary_Optic_Neuropathy_Autosomal_Recessive_1.yaml |
94.4% | 95.2% | 186/197 | |
Malaria.yaml |
94.4% | 94.2% | 186/197 | 1 |
Isobutyryl-CoA_Dehydrogenase_Deficiency.yaml |
94.4% | 94.4% | 203/215 | 1 |
AR_Cerebellar_Ataxia-Saccadic_Intrusion_Syndrome.yaml |
94.4% | 95.0% | 136/144 | |
Dentatorubral-Pallidoluysian_Atrophy.yaml |
94.4% | 95.0% | 119/126 | |
Hermansky_Pudlak_Syndrome.yaml |
94.4% | 95.0% | 255/270 | |
Otomycosis.yaml |
94.4% | 93.8% | 187/198 | 2 |
Pemphigus_Vulgaris.yaml |
94.4% | 94.8% | 136/144 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_17.yaml |
94.5% | 94.6% | 188/199 | |
Hirschsprung_Disease.yaml |
94.5% | 94.1% | 137/145 | |
Ayme-Gripp_Syndrome.yaml |
94.5% | 94.2% | 120/127 | |
Lipoic_Acid_Synthetase_Deficiency.yaml |
94.5% | 95.3% | 120/127 | |
X-Linked_Nephrogenic_Diabetes_Insipidus.yaml |
94.5% | 94.7% | 309/327 | |
USP9X_Female-Restricted_Syndromic_Intellectual_Disability.yaml |
94.5% | 95.2% | 395/418 | |
CHILD_Syndrome.yaml |
94.5% | 93.6% | 361/382 | 2 |
You-Hoover-Fong_Syndrome.yaml |
94.5% | 96.5% | 86/91 | |
COX6B1-Related_COX_Deficiency.yaml |
94.5% | 94.1% | 310/328 | |
FOLR1-Related_Cerebral_Folate_Transport_Deficiency.yaml |
94.5% | 95.6% | 121/128 | |
Trichothiodystrophy.yaml |
94.5% | 94.7% | 537/568 | 1 |
AA_Amyloidosis.yaml |
94.5% | 94.7% | 364/385 | |
Dyssegmental_Dysplasia.yaml |
94.5% | 95.6% | 156/165 | |
Familial_Renal_Glucosuria.yaml |
94.5% | 96.4% | 52/55 | |
TUBB1-related_Macrothrombocytopenia.yaml |
94.5% | 95.3% | 104/110 | |
Oppositional_Defiant_Disorder.yaml |
94.6% | 94.7% | 122/129 | |
pseudotumor_cerebri.yaml |
94.6% | 94.7% | 244/258 | 1 |
Hereditary_Hyperferritinemia_With_Congenital_Cataracts.yaml |
94.6% | 94.6% | 175/185 | |
Osteogenesis_Imperfecta_Type_XIII.yaml |
94.6% | 96.3% | 70/74 | |
Renal_Artery_Obstruction.yaml |
94.6% | 95.7% | 105/111 | |
TCF20-Associated_Neurodevelopmental_Disorder.yaml |
94.6% | 95.4% | 140/148 | |
Cerebrocostomandibular_Syndrome.yaml |
94.6% | 95.2% | 193/204 | |
Acromesomelic_Dysplasia_PRKG2_Type.yaml |
94.6% | 95.5% | 158/167 | |
Noonan_Syndrome_with_Multiple_Lentigines.yaml |
94.6% | 95.3% | 123/130 | |
16p11.2_Deletion_Syndrome.yaml |
94.6% | 95.1% | 211/223 | |
Hereditary_Spastic_Paraplegia_7.yaml |
94.6% | 96.1% | 88/93 | |
Schindler_Disease.yaml |
94.6% | 96.7% | 53/56 | |
Schwartz-Jampel_Syndrome.yaml |
94.6% | 95.5% | 265/280 | |
Glycogen_Storage_Disease_Type_IX.yaml |
94.7% | 95.3% | 249/263 | |
Hypomyelinating_Leukodystrophy_7.yaml |
94.7% | 96.0% | 89/94 | |
Punctate_Palmoplantar_Keratoderma.yaml |
94.7% | 95.5% | 107/113 | |
Pancreatic_Agenesis.yaml |
94.7% | 95.7% | 143/151 | |
Blue_Cone_Monochromacy.yaml |
94.7% | 95.1% | 215/227 | |
Androgen_Insensitivity_Syndrome.yaml |
94.7% | 94.8% | 521/550 | |
Achondrogenesis_Type_IA.yaml |
94.7% | 95.0% | 306/323 | |
Humeroradial_Synostosis.yaml |
94.7% | 95.9% | 108/114 | |
Lone_Star_Virus_Infection.yaml |
94.7% | 100.0% | 18/19 | |
Triglyceride_Storage_Disease_Type_1.yaml |
94.7% | 95.9% | 90/95 | |
Fructose-1,6-Bisphosphatase_Deficiency.yaml |
94.8% | 96.0% | 163/172 | |
Frasier_Syndrome.yaml |
94.8% | 95.2% | 145/153 | |
IPEX_Syndrome.yaml |
94.8% | 95.8% | 145/153 | |
Li-Ghorbani-Weisz-Hubshman_Syndrome.yaml |
94.8% | 95.6% | 109/115 | |
Congenital_Myasthenic_Syndrome_6.yaml |
94.8% | 96.1% | 91/96 | |
TTN_Related_Myopathy_Dominant_Negative_TTNsv.yaml |
94.8% | 96.0% | 91/96 | |
46_XY_DSD_Due_to_5_Alpha_Reductase_2_Deficiency.yaml |
94.8% | 95.3% | 164/173 | |
Hypertrophic_Cardiomyopathy.yaml |
94.8% | 94.3% | 310/327 | 2 |
EDEM3-Congenital_Disorder_of_Glycosylation.yaml |
94.8% | 95.5% | 128/135 | |
Adams-Oliver_Syndrome.yaml |
94.8% | 95.0% | 311/328 | |
Microcephaly_Short_Stature_and_Impaired_Glucose_Metabolism_1.yaml |
94.8% | 95.3% | 311/328 | |
Acute_Respiratory_Distress_Syndrome.yaml |
94.8% | 95.4% | 220/232 | |
Glycogen_Storage_Disease_Due_To_Aldolase_A_Deficiency.yaml |
94.8% | 95.3% | 147/155 | 1 |
Carboxypeptidase_N_Deficiency.yaml |
94.8% | 95.0% | 184/194 | |
Dopa_Responsive_Dystonia.yaml |
94.8% | 95.9% | 92/97 | |
PRMT7-Related_Short_Stature-Brachydactyly_Syndrome.yaml |
94.8% | 96.2% | 92/97 | |
TARP_syndrome.yaml |
94.8% | 96.2% | 92/97 | |
Familial_Defective_Apolipoprotein_B-100.yaml |
94.9% | 95.1% | 258/272 | |
Cutaneous_Larva_Migrans.yaml |
94.9% | 95.5% | 111/117 | |
Juvenile_Sialidosis_Type_2.yaml |
94.9% | 96.5% | 74/78 | |
VPS51-Related_Pontocerebellar_Hypoplasia-CDG.yaml |
94.9% | 96.5% | 74/78 | |
Autosomal_Dominant_Cutis_Laxa_1.yaml |
94.9% | 95.0% | 408/430 | |
Legius_Syndrome.yaml |
94.9% | 95.7% | 130/137 | 2 |
Aquarium_Granuloma.yaml |
94.9% | 94.6% | 112/118 | 2 |
IFNAR1_Deficiency.yaml |
94.9% | 94.9% | 112/118 | 1 |
Immunodeficiency_61.yaml |
94.9% | 96.1% | 112/118 | |
Asherman_Syndrome.yaml |
94.9% | 93.9% | 318/335 | 3 |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_53.yaml |
94.9% | 96.2% | 75/79 | |
Neuromyelitis_Optica_Spectrum_Disorder.yaml |
94.9% | 94.2% | 75/79 | 1 |
POEMS_Syndrome.yaml |
94.9% | 96.2% | 75/79 | |
Spasmodic_Dysphonia.yaml |
94.9% | 96.4% | 75/79 | |
Steel_Syndrome.yaml |
94.9% | 95.5% | 244/257 | |
Developmental_And_Epileptic_Encephalopathy_50.yaml |
94.9% | 95.9% | 169/178 | |
Essential_Thrombocythemia.yaml |
94.9% | 96.3% | 169/178 | |
OPTN-related_Open_Angle_Glaucoma.yaml |
95.0% | 95.1% | 207/218 | |
Autosomal_Recessive_Hypophosphatemic_Rickets_1.yaml |
95.0% | 95.3% | 358/377 | |
Central_Nervous_System_Teratoma.yaml |
95.0% | 95.1% | 132/139 | 1 |
Anterior_Spinal_Artery_Syndrome.yaml |
95.0% | 95.2% | 151/159 | 1 |
Congenital_Vertebral-Cardiac-Renal_Anomalies_Syndrome.yaml |
95.0% | 95.1% | 285/300 | |
Immunodeficiency_25.yaml |
95.0% | 94.8% | 114/120 | 1 |
Intellectual_Disability_Autosomal_Dominant_48.yaml |
95.0% | 95.4% | 190/200 | 1 |
MERTK-Related_Retinopathy.yaml |
95.0% | 96.3% | 95/100 | |
Mitochondrial_Complex_I_Deficiency_Nuclear_Type_19.yaml |
95.0% | 95.9% | 114/120 | |
SYCP3-related_spermatogenic_failure.yaml |
95.0% | 96.9% | 57/60 | |
Transketolase_Deficiency.yaml |
95.0% | 96.7% | 57/60 | |
Carbamoyl_Phosphate_Synthetase_I_Deficiency.yaml |
95.0% | 95.6% | 230/242 | |
Congenital_Merosin-deficient_Muscular_Dystrophy_1A.yaml |
95.0% | 95.0% | 518/545 | |
Autoimmune_Polyendocrinopathy.yaml |
95.1% | 95.2% | 231/243 | 1 |
Osteogenesis_Imperfecta_Type_XIV.yaml |
95.1% | 96.7% | 77/81 | |
Osteogenesis_Imperfecta_Type_XV.yaml |
95.1% | 96.7% | 77/81 | |
Noonan_Syndrome.yaml |
95.1% | 95.2% | 674/709 | |
Immunodeficiency_74_COVID-19-related_X-linked.yaml |
95.1% | 95.8% | 174/183 | 2 |
Meckel_Diverticulum.yaml |
95.1% | 96.2% | 58/61 | |
Bryant-Li-Bhoj_Neurodevelopmental_Syndrome_1.yaml |
95.1% | 95.4% | 388/408 | |
Combined_Immunodeficiency_Due_To_MALT1_Deficiency.yaml |
95.1% | 95.6% | 214/225 | |
CODAS_Syndrome.yaml |
95.1% | 95.4% | 410/431 | |
3-Methylcrotonyl-CoA_Carboxylase_Deficiency.yaml |
95.1% | 95.3% | 176/185 | 1 |
Autosomal_Recessive_Spinocerebellar_Ataxia_16.yaml |
95.2% | 94.6% | 511/537 | 1 |
CRADD-Related_Thin_Lissencephaly.yaml |
95.2% | 95.5% | 277/291 | 1 |
Joint_Laxity_Short_Stature_and_Myopia.yaml |
95.2% | 96.3% | 99/104 | |
Juvenile_Idiopathic_Arthritis.yaml |
95.2% | 95.7% | 199/209 | |
Hereditary_Hemorrhagic_Telangiectasia_Type_1.yaml |
95.2% | 95.0% | 219/230 | |
Inborn_Disorder_of_Methionine_Cycle_and_Sulfur_Amino_Acid_Metabolism.yaml |
95.2% | 95.7% | 319/335 | |
Eosinophilia-Myalgia_Syndrome.yaml |
95.2% | 95.0% | 320/336 | 1 |
Senior-Loken_Syndrome.yaml |
95.2% | 96.0% | 180/189 | |
Triosephosphate_Isomerase_Deficiency.yaml |
95.2% | 96.0% | 200/210 | |
Multiple_Acyl-CoA_Dehydrogenase_Deficiency.yaml |
95.3% | 95.7% | 262/275 | |
Carotid_Stenosis.yaml |
95.3% | 95.4% | 121/127 | 1 |
Hereditary_Gingival_Fibromatosis.yaml |
95.3% | 96.1% | 121/127 | |
Delayed_Sleep_Phase_Syndrome.yaml |
95.3% | 96.3% | 101/106 | |
Dilated_Cardiomyopathy_1Y.yaml |
95.3% | 95.8% | 101/106 | |
Beare-Stevenson_Cutis_Gyrata_Syndrome.yaml |
95.3% | 95.9% | 384/403 | |
Split_Hand_Foot_Malformation.yaml |
95.3% | 96.0% | 162/170 | |
Osteochondrosis.yaml |
95.3% | 96.0% | 183/192 | |
COQ2-Related_Primary_Coenzyme_Q10_Deficiency.yaml |
95.3% | 95.6% | 347/364 | |
Maleylacetoacetate_Isomerase_Deficiency.yaml |
95.3% | 95.1% | 184/193 | 1 |
Hypothalamic_Hamartoma_with_Gelastic_Seizures.yaml |
95.3% | 96.2% | 164/172 | |
Invasive_Candidiasis.yaml |
95.3% | 95.4% | 82/86 | 1 |
Spinal_Cord_Ischemia.yaml |
95.3% | 94.3% | 82/86 | 1 |
HELLP_Syndrome.yaml |
95.4% | 95.4% | 267/280 | 1 |
46_XY_DSD_Due_to_17_Beta_Hydroxysteroid_Dehydrogenase_3_Deficiency.yaml |
95.4% | 95.9% | 186/195 | |
Fibromuscular_Dysplasia.yaml |
95.4% | 96.1% | 62/65 | |
Membranous_Nephropathy.yaml |
95.4% | 95.7% | 186/195 | |
Hepatoblastoma.yaml |
95.4% | 96.0% | 125/131 | |
Apparent_Mineralocorticoid_Excess.yaml |
95.4% | 95.6% | 314/329 | |
Arsenic_Related_Cancers.yaml |
95.5% | 95.5% | 273/286 | |
Fanconi-Bickel_Syndrome.yaml |
95.5% | 96.5% | 105/110 | |
Ichthyosis_Vulgaris.yaml |
95.5% | 95.8% | 210/220 | |
Idiopathic_Triglyceride_Deposit_Cardiomyovasculopathy.yaml |
95.5% | 97.8% | 42/44 | |
Primary_Lateral_Sclerosis.yaml |
95.5% | 100.0% | 21/22 | |
Semantic_Dementia.yaml |
95.5% | 100.0% | 21/22 | |
Spinal_Muscular_Atrophy_Progressive_Myoclonic_Epilepsy.yaml |
95.5% | 97.1% | 63/66 | |
Bannayan-Riley-Ruvalcaba_Syndrome.yaml |
95.5% | 95.4% | 380/398 | |
Hyper-IgM_Syndrome_Type_2.yaml |
95.5% | 96.2% | 169/177 | |
Combined_Oxidative_Phosphorylation_Deficiency_51.yaml |
95.5% | 95.9% | 233/244 | |
PDE6A-Related_Retinopathy.yaml |
95.5% | 96.6% | 85/89 | |
Pompe_Disease.yaml |
95.5% | 95.5% | 213/223 | |
Congenital_Stationary_Night_Blindness.yaml |
95.5% | 96.1% | 256/268 | |
Hereditary_Methemoglobinemia.yaml |
95.6% | 96.3% | 129/135 | |
Tourette_Syndrome.yaml |
95.6% | 95.1% | 172/180 | 1 |
Idiopathic_Pulmonary_Fibrosis.yaml |
95.6% | 95.8% | 498/521 | 1 |
Combined_Malonic_and_Methylmalonic_Aciduria.yaml |
95.6% | 97.0% | 65/68 | |
Wissler_syndrome.yaml |
95.6% | 96.5% | 217/227 | |
Colchicine_Poisoning.yaml |
95.6% | 96.1% | 174/182 | |
Non-Syndromic_X-Linked_Intellectual_Disability.yaml |
95.6% | 95.7% | 348/364 | |
Primary_Cutaneous_Aggressive_Epidermotropic_CD8_T-cell_Lymphoma.yaml |
95.6% | 95.8% | 87/91 | |
Distal_Hereditary_Motor_Neuronopathy_Type_5B.yaml |
95.6% | 96.3% | 109/114 | |
Hereditary_Congenital_Facial_Paresis_3.yaml |
95.6% | 96.4% | 109/114 | |
L1_Syndrome.yaml |
95.6% | 96.7% | 109/114 | |
Anthracycline_Induced_Cardiomyopathy.yaml |
95.6% | 95.7% | 285/298 | |
Endomyocardial_Fibrosis.yaml |
95.7% | 96.2% | 308/322 | |
Multiple_Epiphyseal_Dysplasia_Beighton_Type.yaml |
95.7% | 96.5% | 132/138 | |
Uterine_Leiomyoma.yaml |
95.7% | 95.2% | 330/345 | 1 |
46_XY_Partial_Gonadal_Dysgenesis.yaml |
95.7% | 96.0% | 463/484 | |
Intellectual_Disability_X-linked_Syndromic_33.yaml |
95.7% | 95.9% | 265/277 | |
Neurohypophyseal_Diabetes_Insipidus.yaml |
95.7% | 95.9% | 221/231 | |
Myiasis.yaml |
95.7% | 95.8% | 377/394 | |
Pseudoxanthoma_Elasticum.yaml |
95.7% | 96.6% | 111/116 | |
Short_Stature_Dauber-Argente_Type.yaml |
95.7% | 96.3% | 111/116 | |
Torsade_De_Pointes_Syndrome_With_Short_Coupling_Interval.yaml |
95.7% | 96.9% | 111/116 | |
Perivascular_Epithelioid_Cell_Neoplasm.yaml |
95.7% | 95.9% | 89/93 | |
Conduct_Disorder.yaml |
95.7% | 95.8% | 156/163 | |
Osteochondritis_of_Tarsal_Metatarsal_Bone.yaml |
95.7% | 97.3% | 67/70 | |
Trimethylaminuria.yaml |
95.7% | 97.2% | 67/70 | |
Reticular_Dysgenesis.yaml |
95.7% | 96.2% | 224/234 | |
Choriocarcinoma.yaml |
95.7% | 96.5% | 292/305 | |
RNU12-related_Minor_Spliceopathy.yaml |
95.7% | 97.9% | 45/47 | |
Spaceflight_Associated_Neuro-Ocular_Syndrome.yaml |
95.7% | 96.0% | 90/94 | |
CBL-related_Disorder.yaml |
95.8% | 97.3% | 68/71 | |
Post-Traumatic_Stress_Disorder.yaml |
95.8% | 96.0% | 136/142 | |
SECISBP2_Deficiency.yaml |
95.8% | 97.4% | 68/71 | |
Idiopathic_Gastroparesis.yaml |
95.8% | 96.4% | 205/214 | |
TUBB3-related_Tubulinopathy.yaml |
95.8% | 96.3% | 160/167 | 2 |
Fetal_Growth_Restriction.yaml |
95.8% | 96.6% | 161/168 | |
Gamma-Glutamylcysteine_Synthetase_Deficiency.yaml |
95.8% | 96.8% | 138/144 | |
Osteogenesis_Imperfecta_Type_IX.yaml |
95.8% | 97.2% | 92/96 | |
Snakebite_Envenoming.yaml |
95.8% | 95.9% | 23/24 | |
Esophageal_Atresia.yaml |
95.9% | 95.8% | 185/193 | |
Familial_Visceral_Amyloidosis.yaml |
95.9% | 96.3% | 185/193 | |
Beta-Ketothiolase_Deficiency.yaml |
95.9% | 96.1% | 301/314 | |
Konzo.yaml |
95.9% | 95.9% | 93/97 | |
Glycogen_Storage_Disease_Type_I.yaml |
95.9% | 96.2% | 303/316 | 1 |
Breast_Implant_Associated_Anaplastic_Large_Cell_Lymphoma.yaml |
95.9% | 93.7% | 70/73 | 2 |
Marden-Walker_Syndrome.yaml |
95.9% | 97.5% | 70/73 | |
Bloom_Syndrome.yaml |
95.9% | 95.8% | 281/293 | |
STAT6_Gain_of_Function_Disease.yaml |
95.9% | 96.6% | 164/171 | |
Obesity_Due_to_MC4R_Pathway_Disruption.yaml |
95.9% | 97.4% | 141/147 | |
Urinary_Bladder_Small_Cell_Neuroendocrine_Carcinoma.yaml |
95.9% | 97.0% | 94/98 | |
Familial_Hemiplegic_Migraine.yaml |
95.9% | 96.2% | 518/540 | 1 |
Sarcoglycanopathy.yaml |
95.9% | 96.5% | 212/221 | |
Cardiospondylocarpofacial_Syndrome.yaml |
95.9% | 96.0% | 283/295 | |
Sotos_Syndrome.yaml |
96.0% | 96.2% | 403/420 | 1 |
EYS_Related_Retinitis_Pigmentosa.yaml |
96.0% | 96.9% | 119/124 | |
Inherited_Threoninemia.yaml |
96.0% | 96.8% | 119/124 | |
Yersinia_Enterocolitica_Infectious_Disease.yaml |
96.0% | 96.6% | 143/149 | |
Hypertrophic_Cardiomyopathy_14.yaml |
96.0% | 96.6% | 167/174 | 1 |
ALPK3-Related_Hypertrophic_Cardiomyopathy.yaml |
96.0% | 95.8% | 431/449 | |
Dilated_Cardiomyopathy_1B.yaml |
96.0% | 97.2% | 72/75 | |
GNAS-related_pituitary_adenoma_3.yaml |
96.0% | 98.0% | 96/100 | |
Northern_Epilepsy.yaml |
96.0% | 98.1% | 48/50 | |
Portal_Hypertension_Noncirrhotic_2.yaml |
96.0% | 96.5% | 192/200 | 1 |
Primary_Progressive_Aphasia.yaml |
96.0% | 100.0% | 24/25 | |
Progressive_Retinal_Dystrophy_Due_To_Retinol_Transport_Defect.yaml |
96.0% | 97.0% | 120/125 | |
Glomus_Tumor.yaml |
96.0% | 97.1% | 265/276 | |
Sitosterolemia.yaml |
96.0% | 97.1% | 169/176 | |
Hepatitis_C.yaml |
96.0% | 96.0% | 314/327 | |
DTYMK-Related_Neurodegeneration.yaml |
96.0% | 96.8% | 267/278 | |
Musculocontractural_Ehlers-Danlos_Syndrome.yaml |
96.0% | 97.1% | 267/278 | |
Cri-du-Chat_Syndrome.yaml |
96.0% | 97.2% | 243/253 | |
Rabies.yaml |
96.0% | 96.3% | 243/253 | |
Immunodeficiency_37.yaml |
96.1% | 96.8% | 146/152 | |
X-linked_Dystonia-Parkinsonism.yaml |
96.1% | 96.1% | 195/203 | |
Takotsubo_Cardiomyopathy.yaml |
96.1% | 96.8% | 293/305 | |
3-M_Syndrome.yaml |
96.1% | 95.4% | 416/433 | |
Biliary_Atresia.yaml |
96.1% | 96.0% | 465/484 | 1 |
Amyotrophic_Lateral_Sclerosis.yaml |
96.1% | 96.1% | 710/739 | 1 |
Auroneurodental_Syndrome.yaml |
96.1% | 96.3% | 343/357 | |
COG8-Congenital_Disorder_of_Glycosylation.yaml |
96.1% | 96.3% | 320/333 | |
Combined_Oxidative_Phosphorylation_Defect_Type_21.yaml |
96.1% | 96.9% | 197/205 | |
Giant_Cell_Arteritis.yaml |
96.1% | 96.5% | 148/154 | |
SCAD_Deficiency.yaml |
96.1% | 96.2% | 124/129 | |
Adult-Onset_Autosomal_Dominant_Demyelinating_Leukodystrophy.yaml |
96.1% | 96.2% | 273/284 | 2 |
Developmental_And_Epileptic_Encephalopathy_38.yaml |
96.1% | 97.3% | 149/155 | |
Visceral_Heterotaxy_9.yaml |
96.1% | 96.9% | 199/207 | |
Acoustic_Neuroma.yaml |
96.2% | 96.1% | 150/156 | 2 |
Chondrodysplasia_Blomstrand_Type.yaml |
96.2% | 96.4% | 175/182 | |
Cone-rod_Dystrophy_And_Hearing_Loss_2.yaml |
96.2% | 96.7% | 150/156 | |
Cough_Variant_Asthma.yaml |
96.2% | 97.5% | 75/78 | |
Intellectual_Disability_X-linked_102.yaml |
96.2% | 96.9% | 300/312 | |
Bailey-Bloch_Congenital_Myopathy.yaml |
96.2% | 96.7% | 427/444 | |
Van_Maldergem_Syndrome.yaml |
96.2% | 96.8% | 176/183 | |
Hyperprolinemia_Type_1.yaml |
96.2% | 97.3% | 126/131 | |
Infantile_Hypercalcemia.yaml |
96.2% | 96.5% | 252/262 | |
Methylmalonic_Aciduria_cblA_Type.yaml |
96.2% | 96.5% | 353/367 | |
Acquired_Thrombotic_Thrombocytopenic_Purpura.yaml |
96.2% | 96.1% | 202/210 | |
Kikuchi-Fujimoto_Disease.yaml |
96.2% | 97.3% | 101/105 | |
Noma.yaml |
96.2% | 97.2% | 101/105 | |
Traumatic_Brain_Injury.yaml |
96.2% | 96.7% | 202/210 | |
Alveolar_Soft_Part_Sarcoma.yaml |
96.2% | 95.2% | 152/158 | 2 |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_12.yaml |
96.2% | 96.6% | 152/158 | |
Relapsing_Polychondritis.yaml |
96.2% | 97.1% | 152/158 | |
Heparin-Induced_Thrombocytopenia.yaml |
96.2% | 96.9% | 203/211 | |
Autosomal_Dominant_Cerebellar_Ataxia.yaml |
96.2% | 96.3% | 381/396 | |
IL21R_Deficiency.yaml |
96.2% | 96.4% | 127/132 | 1 |
Raine_Syndrome.yaml |
96.2% | 96.7% | 305/317 | |
Eosinophilic_Granulomatosis_with_Polyangiitis.yaml |
96.2% | 96.6% | 178/185 | |
Chondrodysplasia_Punctata_Tibial-metacarpal_Type.yaml |
96.2% | 97.3% | 102/106 | |
Hospital-Acquired_Acute_Kidney_Injury.yaml |
96.2% | 96.3% | 153/159 | |
Hypotrichosis_with_Juvenile_Macular_Dystrophy.yaml |
96.2% | 96.9% | 153/159 | |
IRF1_Deficiency.yaml |
96.2% | 97.3% | 77/80 | |
Metaphyseal_Chondrodysplasia_Jansen_Type.yaml |
96.3% | 96.8% | 181/188 | |
RAB23-Related_Carpenter_Syndrome.yaml |
96.3% | 96.4% | 259/269 | 1 |
Genitopatellar_Syndrome.yaml |
96.3% | 97.3% | 104/108 | |
Mycetoma.yaml |
96.3% | 96.2% | 104/108 | |
RDH5-Related_Retinopathy.yaml |
96.3% | 97.4% | 104/108 | |
Taeniasis_Cysticercosis.yaml |
96.3% | 96.9% | 104/108 | |
PPP2R3C-Related_Gonadal_Dysgenesis_Syndrome.yaml |
96.3% | 97.3% | 183/190 | |
X-linked_Nonsyndromic_Hearing_Loss.yaml |
96.3% | 96.8% | 157/163 | 1 |
Radioulnar_Synostosis_with_Amegakaryocytic_Thrombocytopenia.yaml |
96.3% | 96.5% | 393/408 | |
Carotid_Artery_Occlusion.yaml |
96.3% | 96.7% | 105/109 | 1 |
Intellectual_Disability_Autosomal_Dominant_52.yaml |
96.3% | 97.2% | 315/327 | |
FAS-related_Autoimmune_Lymphoproliferative_Syndrome.yaml |
96.3% | 96.7% | 184/191 | |
Auriculocondylar_Syndrome.yaml |
96.3% | 96.2% | 421/437 | |
Congenital_Thrombotic_Thrombocytopenic_Purpura.yaml |
96.3% | 96.3% | 158/164 | 1 |
COA3-Related_COX_Deficiency.yaml |
96.4% | 98.1% | 53/55 | |
Meacham_syndrome.yaml |
96.4% | 97.2% | 106/110 | |
Propionic_Acidemia.yaml |
96.4% | 96.8% | 239/248 | |
ornithine_aminotransferase_deficiency.yaml |
96.4% | 97.2% | 160/166 | |
BBSome-Related_Retinitis_Pigmentosa.yaml |
96.4% | 96.4% | 267/277 | 1 |
Bone_Giant_Cell_Tumor.yaml |
96.4% | 96.5% | 294/305 | |
Sly_syndrome.yaml |
96.4% | 97.5% | 107/111 | |
Ataxia-Telangiectasia-Like_Disorder_2.yaml |
96.4% | 96.6% | 134/139 | 1 |
Intellectual_Disability_Autosomal_Dominant_30.yaml |
96.4% | 97.4% | 134/139 | |
Androgenetic_Alopecia.yaml |
96.4% | 96.8% | 456/473 | |
Schneckenbecken_Dysplasia.yaml |
96.4% | 97.3% | 188/195 | |
Adenine_Phosphoribosyltransferase_Deficiency.yaml |
96.4% | 96.0% | 296/307 | |
Common_Variable_Immunodeficiency.yaml |
96.4% | 96.5% | 323/335 | |
Disabling_Pansclerotic_Morphea_Of_Childhood.yaml |
96.4% | 97.0% | 243/252 | |
Endophthalmitis.yaml |
96.4% | 97.0% | 162/168 | |
Hemochromatosis.yaml |
96.4% | 96.4% | 378/392 | |
Laryngotracheoesophageal_Cleft.yaml |
96.4% | 97.2% | 162/168 | |
MPDU1-congenital_disorder_of_glycosylation.yaml |
96.4% | 97.0% | 189/196 | |
Metaphyseal_Anadysplasia.yaml |
96.4% | 96.4% | 108/112 | 1 |
Toxoplasmosis.yaml |
96.4% | 96.8% | 324/336 | |
Ataxia_Telangiectasia.yaml |
96.5% | 96.5% | 327/339 | |
Corticobasal_Syndrome.yaml |
96.5% | 97.8% | 82/85 | |
Noonan_Syndrome-like_Disorder_with_Loose_Anagen_Hair.yaml |
96.5% | 97.9% | 82/85 | |
Oculopharyngeal_Muscular_Dystrophy.yaml |
96.5% | 97.2% | 137/142 | |
RPE65-Related_Retinopathy.yaml |
96.5% | 97.3% | 137/142 | |
Triple_A_Syndrome.yaml |
96.5% | 97.4% | 137/142 | |
CNS_Vasculitis.yaml |
96.5% | 96.3% | 302/313 | 1 |
Central_Precocious_Puberty.yaml |
96.5% | 96.4% | 110/114 | |
Exstrophy-Epispadias_Complex.yaml |
96.5% | 97.4% | 110/114 | |
IRX5-related_Craniofacial_Dysostosis_with_Osteopenia_Intellectual_Disability_and_Dental_Anomalies.yaml |
96.5% | 96.3% | 110/114 | 1 |
Primary_Pigmented_Nodular_Adrenocortical_Disease.yaml |
96.5% | 97.2% | 165/171 | |
Salla_Disease.yaml |
96.5% | 96.2% | 165/171 | 1 |
PRKN-Related_Juvenile_Parkinson_Disease.yaml |
96.5% | 96.8% | 193/200 | 1 |
Anti-NMDA_Receptor_Encephalitis.yaml |
96.5% | 96.8% | 221/229 | |
Liberfarb_syndrome.yaml |
96.5% | 97.8% | 83/86 | |
Migraine.yaml |
96.5% | 96.0% | 222/230 | |
Rothmund-Thomson_Syndrome.yaml |
96.5% | 97.2% | 195/202 | |
Charcot-Marie-Tooth_Disease_Axonal_Type_2T.yaml |
96.6% | 97.1% | 336/348 | |
Johanson-Blizzard_Syndrome.yaml |
96.6% | 97.5% | 140/145 | |
Neuronopathy_Distal_Hereditary_Motor_Autosomal_Recessive_7.yaml |
96.6% | 96.5% | 280/290 | 1 |
Oculofaciocardiodental_Syndrome.yaml |
96.6% | 97.7% | 196/203 | |
Acute_Myeloid_Leukemia_with_CEBPA_Somatic_Mutations.yaml |
96.6% | 97.7% | 253/262 | |
Alpha-gal_Syndrome.yaml |
96.6% | 96.8% | 169/175 | |
Coccidioidomycosis.yaml |
96.6% | 97.0% | 310/321 | |
AIPL1-Related_Retinopathy.yaml |
96.6% | 97.5% | 113/117 | |
Cerebellar_Ataxia_Intellectual_Disability_and_Dysequilibrium.yaml |
96.6% | 97.7% | 113/117 | |
Combined_Oxidative_Phosphorylation_Defect_Type_30.yaml |
96.6% | 97.3% | 113/117 | |
RLBP1-Related_Retinopathy.yaml |
96.6% | 97.6% | 113/117 | |
Congenital_Hypothyroidism.yaml |
96.6% | 96.7% | 283/293 | |
Congenital_Total_Pulmonary_Venous_Return_Anomaly.yaml |
96.6% | 97.9% | 86/89 | |
Silver_Russell_Syndrome.yaml |
96.6% | 97.5% | 115/119 | |
Coffin_Siris_Syndrome.yaml |
96.6% | 97.0% | 403/417 | |
Anaplastic_Large_Cell_Lymphoma.yaml |
96.6% | 95.7% | 288/298 | 3 |
Glycogen_Storage_Disease_Type_0b.yaml |
96.6% | 97.7% | 144/149 | |
Juvenile_Amyotrophic_Lateral_Sclerosis.yaml |
96.7% | 97.0% | 231/239 | |
Chlorophacinone_Poisoning.yaml |
96.7% | 97.3% | 232/240 | |
VLCAD_Deficiency.yaml |
96.7% | 97.1% | 261/270 | 2 |
Hidradenitis_Suppurativa.yaml |
96.7% | 96.8% | 320/331 | |
Rubella.yaml |
96.7% | 97.0% | 88/91 | |
Gitelman_Syndrome.yaml |
96.7% | 96.7% | 177/183 | |
Methylmalonyl-CoA_Epimerase_Deficiency.yaml |
96.7% | 96.4% | 177/183 | 1 |
COG7-Congenital_Disorder_of_Glycosylation.yaml |
96.7% | 97.5% | 207/214 | |
Hyperinsulinemic_Hypoglycemia.yaml |
96.7% | 96.5% | 504/521 | 2 |
ECHS1_Deficiency.yaml |
96.7% | 96.9% | 89/92 | |
IgG4-Related_Disease.yaml |
96.7% | 96.5% | 445/460 | 2 |
Spermatogenic_Failure_18.yaml |
96.7% | 97.8% | 89/92 | |
Multiple_Endocrine_Neoplasia_Type_2.yaml |
96.7% | 97.6% | 119/123 | |
Immunodeficiency_73B.yaml |
96.8% | 97.4% | 149/154 | |
Peroxisome_Biogenesis_Disorder_6B.yaml |
96.8% | 96.8% | 179/185 | 1 |
Combined_Immunodeficiency_Due_To_CD3gamma_Deficiency.yaml |
96.8% | 97.0% | 418/432 | |
Cowden_Syndrome.yaml |
96.8% | 97.1% | 299/309 | |
Adult_T_Cell_Leukemia_Lymphoma.yaml |
96.8% | 97.2% | 180/186 | |
COL11A2_Hearing_Loss.yaml |
96.8% | 97.3% | 60/62 | 1 |
Mantle_Cell_Lymphoma.yaml |
96.8% | 96.8% | 210/217 | |
Metaphyseal_Chondrodysplasia_Schmid_Type.yaml |
96.8% | 97.5% | 150/155 | |
Progressive_Muscular_Atrophy.yaml |
96.8% | 98.5% | 60/62 | |
Hashimoto_Encephalopathy.yaml |
96.8% | 97.4% | 151/156 | |
Hereditary_Sensory_and_Autonomic_Neuropathy_Type_1E.yaml |
96.8% | 97.4% | 151/156 | |
Refeeding_Syndrome.yaml |
96.8% | 97.2% | 182/188 | |
22q11.2_Duplication_Syndrome.yaml |
96.8% | 96.9% | 152/157 | |
CRB1_Retinal_Dystrophies.yaml |
96.8% | 97.8% | 152/157 | |
PAX1-Related_Otofaciocervical_Syndrome.yaml |
96.8% | 97.5% | 152/157 | |
Chronic_Neurovisceral_Acid_Sphingomyelinase_Deficiency.yaml |
96.8% | 98.5% | 61/63 | |
Glutaryl-CoA_Dehydrogenase_Deficiency.yaml |
96.8% | 97.1% | 366/378 | |
KIF1A_Related_Neurological_Disorder.yaml |
96.8% | 97.2% | 305/315 | 1 |
Phenylketonuria.yaml |
96.8% | 96.7% | 488/504 | |
ARX-Related_Lissencephaly_and_Interneuronopathy.yaml |
96.8% | 97.2% | 275/284 | 1 |
Autosomal_Recessive_Ataxia_Beauce_Type.yaml |
96.8% | 97.7% | 245/253 | |
Gastrointestinal_Lymphoma.yaml |
96.8% | 98.1% | 184/190 | |
COG4-Congenital_Disorder_of_Glycosylation.yaml |
96.9% | 97.2% | 246/254 | |
Isovaleric_Acidemia.yaml |
96.9% | 97.3% | 247/255 | |
Kyphoscoliotic_Ehlers-Danlos_Syndrome.yaml |
96.9% | 97.0% | 249/257 | 1 |
X-linked_Agammaglobulinemia.yaml |
96.9% | 97.6% | 156/161 | |
Menke-Hennekam_Syndrome.yaml |
96.9% | 97.4% | 281/290 | |
Pinta.yaml |
96.9% | 97.6% | 125/129 | |
Adult_Polyglucosan_Body_Disease.yaml |
96.9% | 97.4% | 219/226 | |
GM1_Gangliosidosis_Type_2.yaml |
96.9% | 98.0% | 94/97 | |
Infantile_Parkinsonism-Dystonia.yaml |
96.9% | 98.2% | 94/97 | |
PRPS1_Deficiency_Spectrum.yaml |
96.9% | 97.4% | 188/194 | |
Polymicrogyria_Perisylvian_With_Cerebellar_Hypoplasia_And_Arthrogryposis.yaml |
96.9% | 97.8% | 188/194 | |
Raynaud_Disease.yaml |
96.9% | 99.0% | 94/97 | |
D-2-Hydroxyglutaric_Aciduria.yaml |
96.9% | 97.0% | 251/259 | 1 |
Acute_Annular_Outer_Retinopathy.yaml |
96.9% | 96.6% | 157/162 | 1 |
Familial_Episodic_Pain_Syndrome_With_Predominantly_Lower_Limb_Involvement.yaml |
96.9% | 97.2% | 157/162 | 1 |
Ichthyosiform_Erythroderma_Corneal_Involvement_And_Hearing_Loss.yaml |
96.9% | 96.9% | 220/227 | |
Achromatopsia.yaml |
96.9% | 96.2% | 252/260 | 1 |
Familial_Glucocorticoid_Deficiency.yaml |
96.9% | 97.4% | 189/195 | |
Semicircular_Canal_Dehiscence_Syndrome.yaml |
96.9% | 97.1% | 221/228 | |
Autosomal_Recessive_Nonsyndromic_Hearing_Loss_15.yaml |
96.9% | 97.6% | 158/163 | |
Bacterial_meningitis.yaml |
96.9% | 96.9% | 285/294 | |
Furunculosis.yaml |
96.9% | 97.8% | 127/131 | |
Inborn_Disorder_of_Bile_Acid_Synthesis.yaml |
96.9% | 97.9% | 127/131 | |
Cranial_Dysinnervation_Disorder_Congenital_With_Absent_Corneal_Reflex_And_Developmental_Delay.yaml |
97.0% | 97.3% | 191/197 | |
FADD-related_Immunodeficiency.yaml |
97.0% | 97.7% | 191/197 | |
Beckwith-Wiedemann_Syndrome.yaml |
97.0% | 97.7% | 160/165 | |
Glucose-Galactose_Malabsorption.yaml |
97.0% | 98.6% | 64/66 | |
Porphyria_due_to_ALA_Dehydratase_Deficiency.yaml |
97.0% | 97.4% | 193/199 | |
Glycogen_Storage_Disease_Type_IV.yaml |
97.0% | 97.4% | 292/301 | |
Constitutional_Mismatch_Repair_Deficiency.yaml |
97.0% | 97.8% | 296/305 | |
Short_Stature_Amelogenesis_Imperfecta_And_Skeletal_Dysplasia_With_Scoliosis.yaml |
97.0% | 97.8% | 296/305 | |
Brain_Small_Vessel_Disease_1_With_Or_Without_Ocular_Anomalies.yaml |
97.1% | 97.3% | 396/408 | |
Myeloproliferative_Neoplasm_Unclassifiable.yaml |
97.1% | 100.0% | 66/68 | |
Peroxisome_Biogenesis_Disorder_6A_Zellweger.yaml |
97.1% | 98.0% | 99/102 | |
Autosomal_Recessive_Non-Syndromic_Intellectual_Disability.yaml |
97.1% | 97.3% | 694/715 | 1 |
Autosomal_Dominant_Charcot-Marie-Tooth_Disease_Type_2K.yaml |
97.1% | 97.1% | 298/307 | |
Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml |
97.1% | 97.0% | 333/343 | 1 |
Autosomal_Recessive_Osteopetrosis_3.yaml |
97.1% | 97.3% | 334/344 | |
Glycogen_Storage_Disease_Type_V.yaml |
97.1% | 98.4% | 101/104 | |
Acute_Lymphoblastic_Leukemia.yaml |
97.1% | 97.6% | 237/244 | |
Hartnup_Disease.yaml |
97.1% | 97.6% | 237/244 | |
Citrullinemia_Type_I.yaml |
97.1% | 97.5% | 271/279 | |
Adrenal_Cortex_Adenoma.yaml |
97.1% | 97.7% | 339/349 | |
Holocarboxylase_Synthetase_Deficiency.yaml |
97.1% | 97.4% | 272/280 | 1 |
Behr_Syndrome.yaml |
97.2% | 97.6% | 307/316 | |
Arthrogryposis-Renal_Dysfunction-Cholestasis_Syndrome.yaml |
97.2% | 97.4% | 444/457 | 1 |
ABCC9-Related_Intellectual_Disability_and_Myopathy_Syndrome.yaml |
97.2% | 97.9% | 308/317 | |
Congenital_Fibrosis_of_the_Extraocular_Muscles.yaml |
97.2% | 97.8% | 274/282 | |
3MC_Syndrome.yaml |
97.2% | 97.5% | 310/319 | |
Zellweger_Spectrum_Disorders.yaml |
97.2% | 97.4% | 379/390 | |
Usher_Syndrome_Type_2.yaml |
97.2% | 97.5% | 138/142 | 1 |
Hemophilia_B.yaml |
97.2% | 95.9% | 381/392 | 2 |
Antiphospholipid_Syndrome.yaml |
97.2% | 96.4% | 383/394 | 2 |
Nonketotic_Hyperglycinemia.yaml |
97.2% | 97.7% | 209/215 | |
Transaldolase_Deficiency.yaml |
97.2% | 97.3% | 418/430 | |
Polycystic_Kidney_Disease_2.yaml |
97.2% | 97.6% | 175/180 | |
Sensory_Ataxic_Neuropathy_Dysarthria_Ophthalmoparesis.yaml |
97.2% | 98.8% | 70/72 | |
THG1L-Related_Disorder.yaml |
97.2% | 98.5% | 105/108 | |
Tonne-Kalscheuer_Syndrome.yaml |
97.2% | 97.8% | 210/216 | |
Acute_Radiation_Syndrome.yaml |
97.2% | 97.3% | 386/397 | |
CHARGE_Syndrome.yaml |
97.3% | 97.9% | 248/255 | |
Acromesomelic_Dysplasia_Grebe_Type.yaml |
97.3% | 97.9% | 142/146 | |
IFNAR2_Deficiency.yaml |
97.3% | 97.7% | 142/146 | 1 |
Tetanus.yaml |
97.3% | 96.7% | 71/73 | 1 |
Achondroplasia.yaml |
97.3% | 97.3% | 463/476 | 2 |
RHO-Related_Retinopathy.yaml |
97.3% | 98.3% | 107/110 | |
3-Phosphoglycerate_Dehydrogenase_Deficiency.yaml |
97.3% | 97.6% | 250/257 | |
Bjornstad_Syndrome.yaml |
97.3% | 97.6% | 143/147 | |
Hypotonia-Cystinuria_Syndrome.yaml |
97.3% | 97.9% | 180/185 | |
Yersinia_Pseudotuberculosis_Infectious_Disease.yaml |
97.3% | 98.2% | 108/111 | |
MSMO1_Deficiency.yaml |
97.3% | 98.0% | 326/335 | |
Neurodevelopmental_Disorder_With_or_Without_Autism_or_Seizures.yaml |
97.3% | 97.5% | 326/335 | |
Short-rib_Thoracic_Dysplasia_21_Without_Polydactyly.yaml |
97.3% | 97.7% | 326/335 | |
Sclerosteosis.yaml |
97.3% | 98.0% | 145/149 | |
Tay-Sachs_Disease.yaml |
97.3% | 96.7% | 472/485 | 1 |
Du_Pan_Syndrome.yaml |
97.3% | 98.2% | 109/112 | |
N-Acetylglutamate_Synthase_Deficiency.yaml |
97.3% | 97.8% | 218/224 | |
RNASEH1-Related_Progressive_External_Ophthalmoplegia.yaml |
97.3% | 97.9% | 183/188 | |
Chronic_Myelomonocytic_Leukemia.yaml |
97.3% | 97.5% | 110/113 | |
Wolf-Hirschhorn_Syndrome.yaml |
97.3% | 97.8% | 367/377 | |
Acrofacial_Dysostosis_Cincinnati_Type.yaml |
97.4% | 97.6% | 481/494 | |
Biliary_Renal_Neurologic_And_Skeletal_Syndrome.yaml |
97.4% | 97.4% | 259/266 | |
Breast_Fibroadenoma.yaml |
97.4% | 97.2% | 37/38 | |
Combined_Pituitary_Hormone_Deficiencies_Genetic_Form.yaml |
97.4% | 97.8% | 260/267 | |
Cleft_Lip_Palate.yaml |
97.4% | 97.5% | 112/115 | |
Carnitine_Palmitoyltransferase_1A_Deficiency.yaml |
97.4% | 98.1% | 150/154 | |
Arboleda-Tham_Syndrome.yaml |
97.4% | 97.3% | 303/311 | 1 |
2-Methylbutyryl-CoA_Dehydrogenase_Deficiency.yaml |
97.4% | 98.2% | 190/195 | |
Kufor-Rakeb_syndrome.yaml |
97.4% | 98.4% | 114/117 | |
Alopecia_Areata.yaml |
97.5% | 97.6% | 153/157 | |
Autosomal_Recessive_Spinocerebellar_Ataxia_20.yaml |
97.5% | 97.3% | 459/471 | |
Progressive_Pseudorheumatoid_Arthropathy_Of_Childhood.yaml |
97.5% | 98.1% | 153/157 | |
Campylobacteriosis.yaml |
97.5% | 97.3% | 192/197 | |
Pycnodysostosis.yaml |
97.5% | 98.2% | 155/159 | |
Immunodeficiency_62.yaml |
97.5% | 98.2% | 194/199 | |
CDH23-associated_pituitary_adenoma_5.yaml |
97.5% | 100.0% | 39/40 | |
Ludwigs_Angina.yaml |
97.5% | 98.2% | 157/161 | |
CTLA4_Haploinsufficiency.yaml |
97.5% | 97.6% | 398/408 | |
GM3_Synthase_Deficiency.yaml |
97.5% | 98.0% | 199/204 | |
Autosomal_Agammaglobulinemia.yaml |
97.6% | 97.8% | 599/614 | |
Arteriosclerotic_Retinopathy.yaml |
97.6% | 100.0% | 40/41 | |
Hemolytic_Disease_of_the_Fetus_and_Newborn.yaml |
97.6% | 98.3% | 200/205 | |
Peroxisome_Biogenesis_Disorder_5B.yaml |
97.6% | 97.6% | 240/246 | 1 |
Polycystic_Kidney_Disease_3.yaml |
97.6% | 98.8% | 80/82 | |
Noonan_Syndrome_6.yaml |
97.6% | 98.1% | 362/371 | 1 |
Selective_IgA_Deficiency.yaml |
97.6% | 97.5% | 161/165 | |
Age_Related_Macular_Degeneration.yaml |
97.6% | 97.5% | 243/249 | 1 |
CPT1C-Related_Hereditary_Spastic_Paraplegia.yaml |
97.6% | 98.0% | 243/249 | |
Homocystinuria.yaml |
97.6% | 97.8% | 405/415 | |
Menkes_Disease.yaml |
97.6% | 97.6% | 243/249 | |
Bosch-Boonstra-Schaaf_Optic_Atrophy_Syndrome.yaml |
97.6% | 97.6% | 244/250 | |
Baraitser-Winter_Cerebrofrontofacial_Syndrome.yaml |
97.6% | 97.4% | 611/626 | 3 |
Hyperphosphatemic_Familial_Tumoral_Calcinosis.yaml |
97.6% | 97.8% | 367/376 | |
SUFU-related_Nevoid_Basal_Cell_Carcinoma_Syndrome.yaml |
97.6% | 98.7% | 82/84 | |
Autosomal_Dominant_Osteopetrosis_Type_I.yaml |
97.6% | 98.0% | 206/211 | |
Pulmonary_Veno_Occlusive_Disease_And_Or_Pulmonary_Capillary_Haemangiomatosis.yaml |
97.6% | 98.3% | 124/127 | |
RECON_Progeroid_Syndrome.yaml |
97.6% | 98.2% | 207/212 | |
Erythrokeratodermia_Variabilis.yaml |
97.6% | 98.3% | 166/170 | |
Mucolipidosis_Type_III_Alpha_Beta.yaml |
97.6% | 98.0% | 332/340 | |
AIP-related_pituitary_adenoma_predisposition.yaml |
97.7% | 98.2% | 209/214 | |
FOXE3_Anterior_Segment_Dysgenesis.yaml |
97.7% | 98.8% | 84/86 | |
Juvenile_Polyposis_Syndrome.yaml |
97.7% | 97.8% | 213/218 | |
Placental_Abruption.yaml |
97.7% | 98.0% | 256/262 | |
Orofaciodigital_Syndrome.yaml |
97.7% | 98.0% | 300/307 | |
Hypomyelinating_Leukodystrophy_10.yaml |
97.7% | 98.2% | 259/265 | |
Amyloidosis.yaml |
97.7% | 97.6% | 216/221 | 1 |
Severe_Congenital_Neutropenia_1_Autosomal_Dominant.yaml |
97.7% | 98.2% | 216/221 | |
Thrombocytopenia-Absent_Radius_Syndrome.yaml |
97.7% | 97.7% | 173/177 | |
Neuropsychiatric_SLE.yaml |
97.8% | 98.6% | 218/223 | |
Succinic_Semialdehyde_Dehydrogenase_Deficiency.yaml |
97.8% | 98.2% | 218/223 | |
Leber_Optic_Atrophy_and_Dystonia.yaml |
97.8% | 97.9% | 175/179 | |
45_X_46_XY_Mixed_Gonadal_Dysgenesis.yaml |
97.8% | 98.1% | 307/314 | |
Anti-GBM_Disease.yaml |
97.8% | 97.6% | 176/180 | 1 |
Grange_syndrome.yaml |
97.8% | 98.9% | 88/90 | |
Shashi_X-Linked_Intellectual_Disability_Syndrome.yaml |
97.8% | 98.7% | 132/135 | |
MELAS_Syndrome.yaml |
97.8% | 97.7% | 707/723 | |
ALG6-Congenital_Disorder_of_Glycosylation.yaml |
97.8% | 98.2% | 310/317 | |
Alopecia-Intellectual_Disability_Syndrome_1.yaml |
97.8% | 98.4% | 133/136 | |
Alopecia-Intellectual_Disability_Syndrome_4.yaml |
97.8% | 98.5% | 134/137 | |
Renal_Nutcracker_Syndrome.yaml |
97.8% | 98.5% | 134/137 | |
Persistent_Mullerian_Duct_Syndrome.yaml |
97.8% | 97.8% | 269/275 | |
Adult-Onset_Ataxia_and_Polyneuropathy.yaml |
97.8% | 98.4% | 225/230 | |
Bohring-Opitz_syndrome.yaml |
97.8% | 97.8% | 180/184 | 1 |
CKD-Mineral_Bone_Disorder.yaml |
97.8% | 98.6% | 270/276 | |
Metaphyseal_Dysplasia_Spahr_Type.yaml |
97.8% | 99.0% | 91/93 | |
Turner_Syndrome.yaml |
97.9% | 97.9% | 367/375 | |
ADNP-Related_Syndrome.yaml |
97.9% | 98.1% | 323/330 | 2 |
Jervell_and_Lange-Nielsen_Syndrome_2.yaml |
97.9% | 98.5% | 231/236 | |
Listeriosis.yaml |
97.9% | 98.2% | 186/190 | |
Usher_Syndrome_Type_3.yaml |
97.9% | 98.2% | 93/95 | 1 |
CHD2-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
97.9% | 99.1% | 140/143 | |
Lead_Poisoning.yaml |
97.9% | 97.9% | 374/382 | 1 |
Fabry_Disease.yaml |
97.9% | 97.9% | 421/430 | |
EEFSEC_Deficiency.yaml |
97.9% | 100.0% | 47/48 | |
Familial_Focal_Epilepsy_With_Variable_Foci.yaml |
97.9% | 99.0% | 94/96 | |
Treacher_Collins_Syndrome.yaml |
97.9% | 97.4% | 331/338 | 1 |
Dry_Eye_Disease.yaml |
97.9% | 97.9% | 190/194 | 1 |
Sanfilippo_syndrome.yaml |
97.9% | 98.4% | 238/243 | |
Ageing_Associated_Decline_in_Intrinsic_Capacity.yaml |
98.0% | 98.3% | 239/244 | |
Hypertrophic_Cardiomyopathy_17.yaml |
98.0% | 98.9% | 96/98 | |
Metaphyseal_Dysplasia_with_Maxillary_Hypoplasia_and_Brachydactyly.yaml |
98.0% | 99.0% | 96/98 | |
Schnitzler_Syndrome.yaml |
98.0% | 98.1% | 96/98 | |
UV-Sensitive_Syndrome.yaml |
98.0% | 98.0% | 144/147 | |
Takayasu_Arteritis.yaml |
98.0% | 98.6% | 241/246 | |
Appendiceal_Neoplasm.yaml |
98.0% | 98.4% | 145/148 | |
Developmental_And_Epileptic_Encephalopathy_80.yaml |
98.0% | 98.9% | 145/148 | |
ANK2_Ankyrin_B_Syndrome.yaml |
98.0% | 98.5% | 194/198 | |
Arterial_Calcification_of_Infancy.yaml |
98.0% | 98.7% | 147/150 | |
SLC45A1-Related_Neuronal_Glucose_Transporter_Deficiency.yaml |
98.0% | 100.0% | 49/50 | |
Jervell_and_Lange-Nielsen_Syndrome_1.yaml |
98.0% | 98.5% | 295/301 | |
46_XX_Testicular_DSD.yaml |
98.0% | 98.4% | 247/252 | |
AHCY_Deficiency.yaml |
98.0% | 98.3% | 348/355 | |
Hyperprolinemia_Type_2.yaml |
98.1% | 98.7% | 151/154 | |
Kasabach-Merritt_Syndrome.yaml |
98.1% | 98.2% | 151/154 | 1 |
Wolman_Disease.yaml |
98.1% | 98.7% | 252/257 | |
Tangier_Disease.yaml |
98.1% | 97.8% | 354/361 | |
Central_Congenital_Hypothyroidism.yaml |
98.1% | 98.7% | 152/155 | |
Ethylmalonic_Encephalopathy.yaml |
98.1% | 99.1% | 103/105 | |
Majeed_Syndrome.yaml |
98.1% | 99.0% | 206/210 | |
Larsen_Syndrome.yaml |
98.1% | 99.1% | 104/106 | |
ALK_Rearranged_NSCLC.yaml |
98.1% | 99.3% | 157/160 | |
MEDNIK_syndrome.yaml |
98.1% | 99.1% | 106/108 | |
Smith-Lemli-Opitz_syndrome.yaml |
98.1% | 98.1% | 159/162 | |
Bilateral_Microtia-Deafness-Cleft_Palate_Syndrome.yaml |
98.2% | 98.4% | 268/273 | |
Alstrom_Syndrome.yaml |
98.2% | 97.5% | 218/222 | 1 |
Vitamin_K_Dependent_Coagulation_Factor_Deficiency.yaml |
98.2% | 98.8% | 274/279 | |
PGM2L1_Deficiency.yaml |
98.2% | 100.0% | 55/56 | |
Southern_Tick-Associated_Rash_Illness.yaml |
98.2% | 100.0% | 55/56 | |
Toxic_Shock_Syndrome.yaml |
98.2% | 98.3% | 220/224 | |
ANK2_Related_Complex_Neurodevelopmental_Disorder.yaml |
98.2% | 99.4% | 168/171 | |
Congenital_Epulis.yaml |
98.2% | 100.0% | 56/57 | |
EFL1-related_Shwachman-Diamond_syndrome.yaml |
98.2% | 99.1% | 112/114 | |
MCM3AP-Related_Peripheral_Neuropathy.yaml |
98.2% | 99.1% | 112/114 | |
Polycystic_Echinococcosis.yaml |
98.2% | 100.0% | 56/57 | |
Fetal_Alcohol_Spectrum_Disorder.yaml |
98.3% | 99.1% | 113/115 | |
Limb-Girdle_Muscular_Dystrophy_Autosomal_Dominant.yaml |
98.3% | 99.2% | 113/115 | |
Hypotonia_Infantile_with_Psychomotor_Retardation_and_Characteristic_Facies_3.yaml |
98.3% | 98.6% | 397/404 | 1 |
3-Hydroxy-3-Methylglutaryl-CoA_Synthase_Deficiency.yaml |
98.3% | 98.5% | 228/232 | 1 |
Uner_Tan_Syndrome.yaml |
98.3% | 100.0% | 57/58 | |
Acute_Tricyclic_Antidepressant_Poisoning.yaml |
98.3% | 98.5% | 457/465 | |
Allergic_Cutaneous_Vasculitis.yaml |
98.3% | 98.6% | 116/118 | |
Ebstein_Anomaly.yaml |
98.3% | 98.5% | 290/295 | |
Livedoid_Vasculopathy.yaml |
98.3% | 100.0% | 58/59 | |
Retrograde_Cricopharyngeus_Dysfunction.yaml |
98.3% | 100.0% | 58/59 | |
Vitamin_D-Dependent_Rickets_Type_1B.yaml |
98.3% | 99.2% | 175/178 | |
Cleidocranial_Dysplasia.yaml |
98.3% | 99.2% | 117/119 | |
RPGR-Related_Retinopathy.yaml |
98.3% | 99.2% | 117/119 | |
Wiedemann-Steiner_Syndrome.yaml |
98.3% | 98.9% | 293/298 | |
Acute_Megakaryoblastic_Leukemia.yaml |
98.3% | 98.6% | 352/358 | |
Sifrim-Hitz-Weiss_Syndrome.yaml |
98.3% | 99.2% | 118/120 | |
Tetrahydrobiopterin_Deficiency.yaml |
98.3% | 98.9% | 177/180 | |
L-2-Hydroxyglutaric_Aciduria.yaml |
98.3% | 98.8% | 237/241 | |
Hereditary_Fructose_Intolerance.yaml |
98.3% | 98.9% | 178/181 | |
Arthrogryposis_Multiplex_Congenita.yaml |
98.3% | 97.6% | 119/121 | 1 |
Jeavons_Syndrome.yaml |
98.4% | 99.2% | 120/122 | |
Acromesomelic_Dysplasia_Demirhan_Type.yaml |
98.4% | 98.7% | 242/246 | |
Atypical_Teratoid_Rhabdoid_Tumor.yaml |
98.4% | 98.2% | 183/186 | |
Adult-Onset_Myasthenia_Gravis.yaml |
98.4% | 97.9% | 491/499 | 1 |
Frontonasal_Dysplasia.yaml |
98.4% | 99.2% | 123/125 | |
Otosclerosis.yaml |
98.4% | 97.8% | 246/250 | 2 |
Alpers-Huttenlocher_Syndrome.yaml |
98.4% | 98.3% | 431/438 | |
Autosomal_Recessive_Multiple_Pterygium_Syndrome.yaml |
98.4% | 99.2% | 124/126 | |
Isolated_Woolly_Hair.yaml |
98.4% | 99.2% | 124/126 | |
Benign_Paroxysmal_Positional_Vertigo.yaml |
98.4% | 98.7% | 250/254 | |
Diabetes_Mellitus.yaml |
98.4% | 98.1% | 567/576 | 2 |
Stiff_Person_Syndrome.yaml |
98.4% | 99.0% | 189/192 | |
SRD5A3-Congenital_Disorder_of_Glycosylation.yaml |
98.4% | 98.5% | 253/257 | 2 |
Foodborne_Trematodiases.yaml |
98.5% | 100.0% | 64/65 | |
Williams_Syndrome.yaml |
98.5% | 98.6% | 322/327 | |
Acetaminophen_Hepatotoxicity.yaml |
98.5% | 98.4% | 258/262 | |
Erdheim-Chester_Disease.yaml |
98.5% | 98.6% | 65/66 | |
Arthrochalasia_Ehlers-Danlos_Syndrome.yaml |
98.5% | 98.7% | 391/397 | |
Cystinosis.yaml |
98.5% | 98.7% | 457/464 | |
VAMP2-Related_Disorder.yaml |
98.5% | 99.0% | 328/333 | |
Axenfeld-Rieger_syndrome.yaml |
98.5% | 98.7% | 198/201 | 1 |
Idiopathic_Phalangeal_Acro-osteolysis.yaml |
98.5% | 100.0% | 66/67 | |
Bachmann-Bupp_Syndrome.yaml |
98.5% | 98.5% | 463/470 | |
Immunodeficiency_19.yaml |
98.5% | 99.0% | 199/202 | |
Prune_Belly_Syndrome.yaml |
98.5% | 98.6% | 199/202 | 1 |
Atransferrinemia.yaml |
98.5% | 98.8% | 332/337 | |
Arterial_Tortuosity_Syndrome.yaml |
98.5% | 98.6% | 133/135 | |
Nemaline_Myopathy.yaml |
98.5% | 98.5% | 401/407 | |
COL11A2_Skeletal_Spectrum.yaml |
98.5% | 98.8% | 134/136 | 1 |
Collagenous_Sprue.yaml |
98.5% | 99.3% | 134/136 | |
Attenuated_Mucopolysaccharidosis_Type_I.yaml |
98.5% | 99.0% | 405/411 | |
Distal_Myopathy_6_Adult-Onset_Autosomal_Dominant.yaml |
98.5% | 99.1% | 203/206 | |
TFRC-Related_Combined_Immunodeficiency.yaml |
98.5% | 99.0% | 203/206 | |
Hereditary_Xanthinuria.yaml |
98.6% | 99.5% | 137/139 | |
Acute_Intermittent_Porphyria.yaml |
98.6% | 98.7% | 344/349 | |
Osteosarcoma.yaml |
98.6% | 98.3% | 138/140 | 1 |
Mucous_Membrane_Pemphigoid.yaml |
98.6% | 99.0% | 279/283 | |
Akinetopsia.yaml |
98.6% | 100.0% | 70/71 | |
MCAD_Deficiency.yaml |
98.6% | 98.6% | 210/213 | |
Meningioma.yaml |
98.6% | 99.0% | 211/214 | |
Adult-Type_Hypolactasia.yaml |
98.6% | 98.8% | 214/217 | 1 |
Apert_Syndrome.yaml |
98.6% | 98.2% | 287/291 | 1 |
Carnitine_Palmitoyltransferase_II_Deficiency.yaml |
98.6% | 98.9% | 288/292 | 1 |
Agnathia-Otocephaly_Complex.yaml |
98.6% | 98.5% | 362/367 | |
CHRNA1-associated_Fetal_Hypo-akinesia_Disorder_of_Prenatal_Onset.yaml |
98.6% | 100.0% | 73/74 | |
Congenital_Lactase_Deficiency.yaml |
98.6% | 100.0% | 73/74 | |
FGFR1_Hypogonadotropic_Hypogonadism.yaml |
98.6% | 99.3% | 146/148 | |
AL_Amyloidosis.yaml |
98.7% | 98.7% | 295/299 | |
Methylmalonic_Acidemia.yaml |
98.7% | 98.9% | 371/376 | |
Hennekam_Lymphangiectasia-Lymphedema_Syndrome_2.yaml |
98.7% | 99.4% | 149/151 | |
Mullegama-Klein-Martinez_Syndrome.yaml |
98.7% | 99.4% | 149/151 | |
Postpoliomyelitis_Syndrome.yaml |
98.7% | 100.0% | 75/76 | |
Amyotrophic_Lateral_Sclerosis-Parkinsonism-Dementia_Complex.yaml |
98.7% | 98.5% | 226/229 | 1 |
Congenital_Sucrase-Isomaltase_Deficiency.yaml |
98.7% | 99.4% | 151/153 | |
MGAT2-congenital_disorder_of_glycosylation.yaml |
98.7% | 99.4% | 151/153 | |
FICUS_syndrome.yaml |
98.7% | 100.0% | 76/77 | |
SETD5_Haploinsufficiency_Syndrome.yaml |
98.7% | 99.2% | 383/388 | |
Parvovirus_B19_Infection.yaml |
98.7% | 98.6% | 156/158 | |
Seizures-scoliosis-macrocephaly_Syndrome.yaml |
98.7% | 99.0% | 393/398 | |
Cranial_Neuralgia.yaml |
98.7% | 98.3% | 236/239 | 1 |
OTUD6B-Related_Neurodevelopmental_Disorder.yaml |
98.7% | 99.2% | 236/239 | |
3-methylglutaconic_Aciduria_With_Deafness_Encephalopathy_And_Leigh-like_Syndrome.yaml |
98.8% | 98.9% | 395/400 | 1 |
Marinesco-Sjogren_Syndrome.yaml |
98.8% | 99.4% | 158/160 | |
Neurodegeneration_With_Brain_Iron_Accumulation.yaml |
98.8% | 98.9% | 158/160 | |
Pyruvate_Carboxylase_Deficiency_Disease.yaml |
98.8% | 99.4% | 158/160 | |
Immunodeficiency_18.yaml |
98.8% | 99.4% | 159/161 | |
Peroxisome_Biogenesis_Disorder_4B.yaml |
98.8% | 99.0% | 159/161 | |
Kallmann_Syndrome.yaml |
98.8% | 99.2% | 239/242 | |
Cronkhite-Canada_syndrome.yaml |
98.8% | 100.0% | 80/81 | |
Hao-Fountain_syndrome.yaml |
98.8% | 100.0% | 80/81 | |
Renal_Tubular_Acidosis_Distal_4_with_Hemolytic_Anemia.yaml |
98.8% | 99.4% | 160/162 | |
Tyrosinemia_Type_I.yaml |
98.8% | 99.2% | 242/245 | |
Appendiceal_Neuroendocrine_Tumor.yaml |
98.8% | 100.0% | 81/82 | |
Arterial_Dissection_Lentiginosis_Syndrome.yaml |
98.8% | 100.0% | 81/82 | |
Aspartylglucosaminuria.yaml |
98.8% | 98.9% | 324/328 | 2 |
Thymus_Neoplasm.yaml |
98.8% | 100.0% | 81/82 | |
SPOP-Related_Neurodevelopmental_Disorder.yaml |
98.8% | 99.2% | 326/330 | |
Peroxisome_Biogenesis_Disorder_1B.yaml |
98.8% | 99.0% | 164/166 | |
Galactosemia.yaml |
98.8% | 98.8% | 247/250 | |
Stevens-Johnson_Syndrome.yaml |
98.8% | 98.9% | 247/250 | |
Schaaf-Yang_Syndrome.yaml |
98.8% | 99.2% | 250/253 | |
Sialidosis_Type_1.yaml |
98.8% | 99.2% | 250/253 | |
Late-Onset_Pompe_Disease.yaml |
98.8% | 98.9% | 336/340 | |
Spondylodysplastic_Ehlers-Danlos_Syndrome.yaml |
98.8% | 99.3% | 253/256 | |
Hereditary_Diffuse_Leukoencephalopathy_with_Spheroids.yaml |
98.8% | 100.0% | 85/86 | |
Lane_Hamilton_Syndrome.yaml |
98.8% | 100.0% | 85/86 | |
Pyruvate_Dehydrogenase_Deficiency.yaml |
98.8% | 99.1% | 511/517 | |
Atelosteogenesis_Type_III.yaml |
98.8% | 99.4% | 171/173 | |
Contact_Dermatitis.yaml |
98.9% | 98.9% | 258/261 | |
Oculomotor_Nerve_Palsy.yaml |
98.9% | 99.4% | 258/261 | |
Landau-Kleffner_Syndrome.yaml |
98.9% | 100.0% | 87/88 | |
Lesch-Nyhan_Syndrome.yaml |
98.9% | 99.2% | 262/265 | |
Hyper-IgM_Syndrome_Type_1.yaml |
98.9% | 99.4% | 176/178 | |
Hereditary_Orotic_Aciduria.yaml |
98.9% | 99.4% | 177/179 | |
Developmental_And_Epileptic_Encephalopathy_8.yaml |
98.9% | 99.2% | 266/269 | |
ReNU_Syndrome.yaml |
98.9% | 99.0% | 271/274 | |
ALG1-Congenital_Disorder_of_Glycosylation.yaml |
98.9% | 99.6% | 182/184 | |
Usher_Syndrome_Type_1.yaml |
98.9% | 99.5% | 183/185 | |
Atelosteogenesis_Type_II.yaml |
98.9% | 99.0% | 276/279 | 1 |
Houge-Janssens_Syndrome.yaml |
98.9% | 99.5% | 186/188 | |
Amyotrophic_Lateral_Sclerosis_Type_1.yaml |
98.9% | 98.8% | 373/377 | |
Hennekam_Lymphangiectasia-Lymphedema_Syndrome_1.yaml |
98.9% | 99.3% | 280/283 | |
Beta_Mannosidosis.yaml |
99.0% | 99.3% | 285/288 | |
Limbic_Encephalitis.yaml |
99.0% | 99.0% | 190/192 | |
Melkersson_Rosenthal_syndrome.yaml |
99.0% | 100.0% | 96/97 | |
Atelosteogenesis_Type_I.yaml |
99.0% | 99.5% | 193/195 | |
COX14-Related_COX_Deficiency.yaml |
99.0% | 99.0% | 195/197 | |
6q16_Deletion_Syndrome.yaml |
99.0% | 99.3% | 294/297 | |
Sandestig-Stefanova_Syndrome.yaml |
99.0% | 99.2% | 394/398 | |
Alpha_Mannosidosis.yaml |
99.0% | 99.2% | 494/499 | |
CFAP418-related_Retinal_Ciliopathy.yaml |
99.0% | 100.0% | 99/100 | |
Adenosine_Kinase_Deficiency.yaml |
99.0% | 99.5% | 199/201 | |
Achoo_Syndrome.yaml |
99.0% | 100.0% | 100/101 | |
PRPH2-Related_Retinopathy.yaml |
99.0% | 100.0% | 100/101 | |
Schimke_Immuno-osseous_Dysplasia.yaml |
99.0% | 99.5% | 200/202 | |
Acrocallosal_Syndrome.yaml |
99.0% | 99.5% | 202/204 | |
Snyder-Robinson_Syndrome.yaml |
99.0% | 99.4% | 306/309 | |
Yaws.yaml |
99.0% | 98.9% | 204/206 | |
Autosomal_Dominant_Nonsyndromic_Hearing_Loss_9.yaml |
99.0% | 99.3% | 309/312 | |
47_XYY_Syndrome.yaml |
99.0% | 99.5% | 208/210 | |
Hereditary_Intrinsic_Factor_Deficiency.yaml |
99.0% | 100.0% | 104/105 | |
Alkaptonuria.yaml |
99.1% | 99.1% | 314/317 | |
Achondrogenesis_Type_II.yaml |
99.1% | 99.5% | 211/213 | |
Friedreich_Ataxia.yaml |
99.1% | 99.0% | 423/427 | |
Hunter_syndrome.yaml |
99.1% | 99.5% | 212/214 | |
Tyrosinemia_Type_II.yaml |
99.1% | 100.0% | 106/107 | |
Farber_Disease.yaml |
99.1% | 99.5% | 213/215 | |
Acrodysostosis.yaml |
99.1% | 99.6% | 220/222 | |
Hairy_Cell_Leukemia.yaml |
99.1% | 99.1% | 110/111 | |
Ulnar-Mammary_Syndrome.yaml |
99.1% | 99.6% | 222/224 | |
ATF6-Related_Retinopathy.yaml |
99.1% | 100.0% | 112/113 | |
Mitochondrial_Neurogastrointestinal_Encephalomyopathy.yaml |
99.1% | 100.0% | 113/114 | |
Temtamy_Syndrome.yaml |
99.1% | 100.0% | 114/115 | |
Carbonic_Anhydrase_VA_Deficiency.yaml |
99.1% | 99.6% | 230/232 | |
Parathyroid_Hyperplasia.yaml |
99.1% | 99.2% | 116/117 | |
Autosomal_Dominant_Striatal_Neurodegeneration.yaml |
99.2% | 100.0% | 117/118 | |
Myxedema.yaml |
99.2% | 100.0% | 117/118 | |
Transverse_Myelitis.yaml |
99.2% | 100.0% | 117/118 | |
A20_Haploinsufficiency.yaml |
99.2% | 100.0% | 118/119 | |
Anal_Canal_Adenocarcinoma.yaml |
99.2% | 100.0% | 118/119 | |
Bile_Duct_Cyst.yaml |
99.2% | 100.0% | 118/119 | |
Maple_Syrup_Urine_Disease.yaml |
99.2% | 99.2% | 354/357 | |
Morquio_syndrome.yaml |
99.2% | 99.6% | 236/238 | |
Bells_Palsy.yaml |
99.2% | 99.3% | 238/240 | |
CALFAN_Syndrome.yaml |
99.2% | 100.0% | 120/121 | |
Hemophagocytic_Lymphohistiocytosis.yaml |
99.2% | 99.2% | 241/243 | |
Brown-Vialetto-Van_Laere_Syndrome.yaml |
99.2% | 100.0% | 122/123 | |
Pars_Planitis.yaml |
99.2% | 100.0% | 122/123 | |
Nager_Acrofacial_Dysostosis.yaml |
99.2% | 100.0% | 123/124 | |
Activated_PI3K-delta_Syndrome.yaml |
99.2% | 99.1% | 247/249 | 1 |
Spondyloepimetaphyseal_Dysplasia_Bieganski_Type.yaml |
99.2% | 100.0% | 124/125 | |
Dimethylglycine_Dehydrogenase_Deficiency.yaml |
99.2% | 100.0% | 125/126 | |
Adenovirus_Respiratory_Infection.yaml |
99.2% | 99.2% | 126/127 | |
Aortic_Valve_Disease_2.yaml |
99.2% | 100.0% | 126/127 | |
Scimitar_Syndrome.yaml |
99.2% | 99.2% | 126/127 | |
Twin_to_Twin_Transfusion_Syndrome.yaml |
99.2% | 99.2% | 127/128 | |
Type_B_Insulin_Resistance_Syndrome.yaml |
99.2% | 100.0% | 127/128 | |
Cyclic_Hematopoiesis.yaml |
99.2% | 100.0% | 129/130 | |
Urticaria.yaml |
99.2% | 99.2% | 130/131 | |
Borderline_Personality_Disorder.yaml |
99.3% | 99.2% | 133/134 | |
Pseudopseudohypoparathyroidism.yaml |
99.3% | 99.6% | 271/273 | |
Ainhum.yaml |
99.3% | 100.0% | 136/137 | |
Classic_Familial_Adenomatous_Polyposis.yaml |
99.3% | 99.3% | 274/276 | |
Glycogen_Storage_Disease_XV.yaml |
99.3% | 100.0% | 137/138 | |
Carnitine-Acylcarnitine_Translocase_Deficiency.yaml |
99.3% | 99.7% | 275/277 | |
Acute_Lichenoid_Pityriasis.yaml |
99.3% | 99.6% | 278/280 | |
Blount_Disease.yaml |
99.3% | 100.0% | 139/140 | |
Meckel_Syndrome.yaml |
99.3% | 99.7% | 278/280 | |
Aneurysmal_Bone_Cyst.yaml |
99.3% | 100.0% | 140/141 | |
Arts_syndrome.yaml |
99.3% | 99.7% | 280/282 | |
UGDH-Related_Developmental_and_Epileptic_Encephalopathy_84.yaml |
99.3% | 100.0% | 140/141 | |
Autosomal_Dominant_Hypercholesterolemia_3.yaml |
99.3% | 99.3% | 422/425 | |
Blue_Rubber_Bleb_Nevus_Syndrome.yaml |
99.3% | 99.5% | 282/284 | 1 |
Giardiasis.yaml |
99.3% | 99.3% | 285/287 | |
Alcohol_Use_Disorder.yaml |
99.3% | 99.5% | 571/575 | |
Body_Dysmorphic_Disorder.yaml |
99.3% | 100.0% | 143/144 | |
Cone_Dystrophy.yaml |
99.3% | 100.0% | 146/147 | |
Lysinuric_Protein_Intolerance.yaml |
99.3% | 100.0% | 147/148 | |
TUBGCP6-related_Microcephaly_and_Chorioretinopathy.yaml |
99.3% | 100.0% | 147/148 | |
Chorea-acanthocytosis.yaml |
99.3% | 100.0% | 148/149 | |
Seborrheic_Dermatitis.yaml |
99.3% | 100.0% | 150/151 | |
MEF2C-Related_Disorder.yaml |
99.3% | 100.0% | 151/152 | |
ACAD9_Deficiency.yaml |
99.3% | 99.3% | 152/153 | |
SHORT_Syndrome.yaml |
99.3% | 99.7% | 304/306 | |
Adult-Onset_Still_Disease.yaml |
99.4% | 100.0% | 153/154 | |
Fucosidosis.yaml |
99.4% | 99.7% | 306/308 | |
SHH_Holoprosencephaly_Spectrum.yaml |
99.4% | 99.7% | 311/313 | |
Acquired_Immunodeficiency_Syndrome.yaml |
99.4% | 100.0% | 157/158 | |
BLOC1S1-related_Complex_Neurodevelopmental_Disorder_with_Leukodystrophy.yaml |
99.4% | 100.0% | 157/158 | |
ACys_Amyloidosis.yaml |
99.4% | 100.0% | 158/159 | |
ALDH18A1_Cutis_Laxa.yaml |
99.4% | 100.0% | 158/159 | |
Acquired_Angioedema.yaml |
99.4% | 100.0% | 160/161 | |
Ameloblastoma.yaml |
99.4% | 100.0% | 160/161 | |
T-cell_Immunodeficiency_Congenital_Alopecia_and_Nail_Dystrophy.yaml |
99.4% | 100.0% | 161/162 | |
WAGR_Syndrome.yaml |
99.4% | 99.4% | 323/325 | |
Acatalasia.yaml |
99.4% | 100.0% | 162/163 | |
3p-_Syndrome.yaml |
99.4% | 99.7% | 330/332 | |
Leptospirosis.yaml |
99.4% | 99.4% | 332/334 | |
Lafora_Disease.yaml |
99.4% | 99.7% | 333/335 | |
Arsenic_Poisoning.yaml |
99.4% | 100.0% | 168/169 | |
Glycogen_Storage_Disease_Type_VII.yaml |
99.4% | 100.0% | 168/169 | |
Immunodeficiency_35.yaml |
99.4% | 100.0% | 168/169 | |
Bone_Fragility_With_Contractures_Arterial_Rupture_And_Deafness.yaml |
99.4% | 99.7% | 337/339 | |
Budd-Chiari_Syndrome.yaml |
99.4% | 99.4% | 170/171 | |
Desmoid_Tumor.yaml |
99.4% | 100.0% | 170/171 | |
COFS_Syndrome.yaml |
99.4% | 100.0% | 172/173 | |
Infantile-Onset_Pompe_Disease.yaml |
99.4% | 99.5% | 344/346 | |
MMACHC-related_Methylmalonic_Aciduria_and_Homocystinuria_cblC_Type.yaml |
99.4% | 100.0% | 173/174 | |
Sandhoff_Disease.yaml |
99.4% | 100.0% | 173/174 | |
BEST1-Related_Dominant_Retinopathy.yaml |
99.4% | 100.0% | 174/175 | |
CACNA1A_Related_Disorder.yaml |
99.4% | 100.0% | 174/175 | |
X-linked_Lymphoproliferative_Disease_Due_To_XIAP_Deficiency.yaml |
99.4% | 100.0% | 175/176 | |
BRAF_V600E_Mutant_NSCLC.yaml |
99.4% | 100.0% | 176/177 | |
Spinocerebellar_Ataxia_Type_17.yaml |
99.4% | 100.0% | 177/178 | |
Bart-Pumphrey_Syndrome.yaml |
99.4% | 100.0% | 178/179 | |
Deficiency_of_the_Interleukin-1_Receptor_Antagonist.yaml |
99.4% | 100.0% | 178/179 | |
Schnyder_Corneal_Dystrophy.yaml |
99.4% | 100.0% | 180/181 | |
IKBKG_Ectodermal_Dysplasia_with_Immunodeficiency.yaml |
99.5% | 99.7% | 362/364 | |
ZTTK_syndrome.yaml |
99.5% | 100.0% | 183/184 | |
Neurosarcoidosis.yaml |
99.5% | 100.0% | 184/185 | |
CD27-related_lymphoproliferative_and_immune_disorder.yaml |
99.5% | 100.0% | 186/187 | |
Cortisone_Reductase_Deficiency.yaml |
99.5% | 100.0% | 186/187 | |
Christianson_Syndrome.yaml |
99.5% | 100.0% | 187/188 | |
Blepharophimosis_Intellectual_Disability_Syndrome_MKB_Type.yaml |
99.5% | 100.0% | 188/189 | |
Amyotrophic_Lateral_Sclerosis_27_Juvenile.yaml |
99.5% | 99.7% | 380/382 | |
Clostridioides_difficile_Infection.yaml |
99.5% | 99.5% | 190/191 | |
Vertebral_Artery_Insufficiency.yaml |
99.5% | 100.0% | 190/191 | |
Becker_Muscular_Dystrophy.yaml |
99.5% | 99.7% | 382/384 | |
Autosomal_Recessive_Cerebellar_Ataxia_With_Late_Onset_Spasticity.yaml |
99.5% | 100.0% | 194/195 | |
Melorheostosis.yaml |
99.5% | 100.0% | 194/195 | |
Susac_Syndrome.yaml |
99.5% | 100.0% | 195/196 | |
Chylomicron_Retention_Disease.yaml |
99.5% | 99.7% | 392/394 | |
Machado_Joseph_Disease.yaml |
99.5% | 99.5% | 197/198 | |
STK4_Deficiency.yaml |
99.5% | 100.0% | 198/199 | |
ALG12_Congenital_Disorder_of_Glycosylation.yaml |
99.5% | 100.0% | 199/200 | |
ATRX_Syndrome.yaml |
99.5% | 100.0% | 199/200 | |
CADASIL_Type_1.yaml |
99.5% | 100.0% | 199/200 | |
Autoimmune_Autonomic_Ganglionopathy.yaml |
99.5% | 100.0% | 202/203 | |
ALG9-congenital_disorder_of_glycosylation.yaml |
99.5% | 100.0% | 203/204 | |
SETD1B-Related_Neurodevelopmental_Disorder.yaml |
99.5% | 100.0% | 204/205 | |
Evans_Syndrome.yaml |
99.5% | 100.0% | 205/206 | |
Asparagine_Synthetase_Deficiency.yaml |
99.5% | 100.0% | 207/208 | |
GABRB3-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
99.5% | 100.0% | 209/210 | |
Aggressive_NK-cell_Leukemia.yaml |
99.5% | 100.0% | 212/213 | |
Secondary_Erythromelalgia.yaml |
99.5% | 100.0% | 219/220 | |
Vogt-Koyanagi-Harada_Disease.yaml |
99.5% | 99.6% | 220/221 | |
AGAT_Deficiency.yaml |
99.5% | 100.0% | 221/222 | |
Autoimmune_Pancreatitis.yaml |
99.5% | 99.8% | 442/444 | |
Ependymoma.yaml |
99.6% | 100.0% | 227/228 | |
Agenesis_of_the_Corpus_Callosum_with_Peripheral_Neuropathy.yaml |
99.6% | 100.0% | 228/229 | |
Autosomal_Recessive_Ataxia_Due_to_Ubiquinone_Deficiency.yaml |
99.6% | 100.0% | 228/229 | |
Biotin_Thiamine_Responsive_Basal_Ganglia_Disease.yaml |
99.6% | 100.0% | 228/229 | |
Antisynthetase_Syndrome.yaml |
99.6% | 99.6% | 233/234 | |
Genetic_Developmental_and_Epileptic_Encephalopathy.yaml |
99.6% | 99.6% | 707/710 | |
Adult_Neuronal_Ceroid_Lipofuscinosis.yaml |
99.6% | 100.0% | 237/238 | |
Anaplastic_Thyroid_Carcinoma.yaml |
99.6% | 99.6% | 237/238 | |
Anorexia_Nervosa.yaml |
99.6% | 99.6% | 243/244 | |
Paraneoplastic_Neurological_Syndromes.yaml |
99.6% | 100.0% | 247/248 | |
COG1-congenital_disorder_of_glycosylation.yaml |
99.6% | 100.0% | 252/253 | |
Aromatase_Deficiency.yaml |
99.6% | 100.0% | 255/256 | |
Cystinuria.yaml |
99.6% | 99.6% | 255/256 | |
ALDH18A1_De_Barsy_Spectrum.yaml |
99.6% | 100.0% | 256/257 | |
Acute_Disseminated_Encephalomyelitis.yaml |
99.6% | 100.0% | 256/257 | |
Lethal_Congenital_Contracture_Syndrome.yaml |
99.6% | 99.8% | 515/517 | |
APL_PML_RARA.yaml |
99.6% | 100.0% | 263/264 | |
Say-Barber-Biesecker-Young-Simpson_Syndrome.yaml |
99.6% | 100.0% | 263/264 | |
Epidermolysis_Bullosa.yaml |
99.6% | 99.6% | 267/268 | |
Acquired_Partial_Lipodystrophy.yaml |
99.6% | 100.0% | 268/269 | |
Fraser_Syndrome.yaml |
99.6% | 100.0% | 272/273 | |
Acromesomelic_Dysplasia_Maroteaux_Type.yaml |
99.6% | 100.0% | 276/277 | |
COX15-Related_COX_Deficiency.yaml |
99.6% | 100.0% | 276/277 | |
Sick_Sinus_Syndrome_2_Autosomal_Dominant.yaml |
99.7% | 99.6% | 295/296 | |
Botulism.yaml |
99.7% | 99.7% | 296/297 | |
Amniotic_Band_Syndrome.yaml |
99.7% | 100.0% | 297/298 | |
Adult_Onset_Dystonia_Parkinsonism.yaml |
99.7% | 100.0% | 308/309 | |
Diphtheria.yaml |
99.7% | 100.0% | 314/315 | |
Porokeratosis.yaml |
99.7% | 100.0% | 316/317 | |
Biotinidase_Deficiency.yaml |
99.7% | 100.0% | 335/336 | |
Zimmermann_Laband_Syndrome.yaml |
99.7% | 100.0% | 340/341 | |
Hyperornithinemia_Hyperammonemia_Homocitrullinuria_Syndrome.yaml |
99.7% | 100.0% | 345/346 | |
Atrioventricular_Septal_Defect.yaml |
99.7% | 100.0% | 362/363 | |
46_XX_Gonadal_Dysgenesis.yaml |
99.7% | 100.0% | 366/367 | |
Amniotic_Fluid_Embolism.yaml |
99.7% | 100.0% | 376/377 | |
46_XY_complete_gonadal_dysgenesis.yaml |
99.7% | 100.0% | 384/385 | |
Bosma_Arhinia_Microphthalmia_Syndrome.yaml |
99.7% | 99.6% | 389/390 | |
Autosomal_Recessive_Dopa_Responsive_Dystonia.yaml |
99.7% | 100.0% | 395/396 | |
Stargardt_Disease.yaml |
99.8% | 99.8% | 400/401 | |
Cerebrotendinous_Xanthomatosis.yaml |
99.8% | 100.0% | 433/434 | |
Pontocerebellar_Hypoplasia.yaml |
99.8% | 100.0% | 435/436 | |
Aortic_Valve_Stenosis.yaml |
99.8% | 100.0% | 451/452 | |
Berardinelli_Seip_Congenital_Lipodystrophy.yaml |
99.8% | 100.0% | 514/515 | |
Basel-Vanagaite-Smirin-Yosef_Syndrome.yaml |
99.8% | 100.0% | 605/606 | |
Acne_Vulgaris.yaml |
100.0% | 100.0% | 179/179 | |
Acute_Flaccid_Myelitis.yaml |
100.0% | 100.0% | 236/236 | |
Atrial_Septal_Defect.yaml |
100.0% | 100.0% | 280/280 | |
Attention_Deficit-Hyperactivity_Disorder.yaml |
100.0% | 100.0% | 170/170 | |
Auto-Brewery_Syndrome.yaml |
100.0% | 100.0% | 137/137 | |
Autoimmune_Hepatitis.yaml |
100.0% | 100.0% | 212/212 | |
Autoinflammation_Immune_Dysregulation_and_Eosinophilia.yaml |
100.0% | 100.0% | 222/222 | |
Autosomal_Dominant_Cerebellar_Ataxia_Type_I.yaml |
100.0% | 100.0% | 396/396 | |
Autosomal_Dominant_Cerebellar_Ataxia_Type_III.yaml |
100.0% | 100.0% | 268/268 | |
Autosomal_Dominant_Dopa_Responsive_Dystonia.yaml |
100.0% | 100.0% | 213/213 | |
Autosomal_Dominant_Epilepsy_with_Auditory_Features.yaml |
100.0% | 100.0% | 370/370 | |
Autosomal_Recessive_Primary_Microcephaly.yaml |
100.0% | 100.0% | 517/517 | |
BCKDK_Deficiency.yaml |
100.0% | 100.0% | 238/238 | |
BRAF_V600_Mutant_Melanoma.yaml |
100.0% | 100.0% | 250/250 | |
Babesiosis.yaml |
100.0% | 100.0% | 358/358 | |
Binge_Eating_Disorder.yaml |
100.0% | 100.0% | 123/123 | |
Bird_Fanciers_Lung.yaml |
100.0% | 100.0% | 275/275 | |
Blau_Syndrome.yaml |
100.0% | 100.0% | 238/238 | |
Borjeson-Forssman-Lehmann_syndrome.yaml |
100.0% | 100.0% | 250/250 | |
Cholesteatoma.yaml |
100.0% | 100.0% | 224/224 | |
Folliculitis.yaml |
100.0% | 100.0% | 296/296 | |
Hand_Foot_and_Mouth_Disease.yaml |
100.0% | 100.0% | 232/232 | |
Left_Ventricular_Noncompaction_8.yaml |
100.0% | 100.0% | 284/284 | |
Lynch_Syndrome.yaml |
100.0% | 100.0% | 269/269 | |
SETBP1_Disorder.yaml |
100.0% | 100.0% | 84/84 | |
Taurodontism.yaml |
100.0% | 100.0% | 140/140 | |
Thallium_Poisoning.yaml |
100.0% | 100.0% | 245/245 | |
Trehalase_Deficiency.yaml |
100.0% | 100.0% | 120/120 | |
UGP2-Related_Developmental_and_Epileptic_Encephalopathy_83.yaml |
100.0% | 100.0% | 147/147 | |
Vitamin_D-Dependent_Rickets_Type_1A.yaml |
100.0% | 100.0% | 176/176 |
Tracking 3,300 curated entries, 228,943 evidence items, 148,879 ontology-grounded terms, and 23,140 pathophysiology nodes. Average weighted compliance is 90.1%. MONDO human-disease coverage includes 3,215 exact-page terms and 11,277 exact-or-parent represented terms.
Found 772 referenced MONDO disease terms without local pages across 865 linking page references.
The median disease appears in 5 HPO top-level systems but spans 4.2 effectively; 57.4% of diseases have a combination of systems no other disease shares.
25917 of 31557 MONDO candidates remain after accounting for 5640 already curated diseases. Top remaining candidate: Castleman disease (79.5).
3160 of those remaining candidates carry a
Named Entity Confusion (NEC) risk flag — names a deep-research tool may resolve to the
wrong disease. Risk classes: research/nec_risk_disease_classes.md.